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National Bioproducts Institute (NBI) is a key plasma fractionator within the Southern African 
countries.  Human serum albumin (HSA), is the most abundant plasma protein in human blood 
and has significant physiological and therapeutic benefits.  The global demand for HSA is 
steadily increasing and this has compelled plasma fractionators to optimize the key processes 
that are used to manufacture this plasma derived medicinal product (PDMP).  A key process in 
the manufacture of HSA is the use of ultrafiltration (UF), a key membrane separation 
technology, to remove unwanted salts and solvents from the dissolved active pharmaceutical 
ingredient (API).  UF of protein solutions consists of several key steps including first 
concentration step, diafiltration steps one to five and second concentration step.  Ultrafiltration 
performance is limited by inherent process characteristics such as concentration polarization 
(CP) and membrane fouling (MF).  During this study, the key factors that influence the UF of 
HSA namely protein concentration, ethanol concentration, temperature and ionic strength, 
were optimized within pre-defined ranges to evaluate their impact on permeate flux and 
membrane performance.  Permeate flux is a key determinant of process time, which directly 
impacts annual production capacity with a particular UF unit (C200 UF rig).  A key objective 
of this study was to maximize production capacity through optimization of the key factors 
above, using the C200 UF rig.  The results of this study show that protein concentration is the 
key factor that influenced the various steps of UF of HSA and overall production capacity.  The 
optimum protein concentration range for maximum productivity was 60.00g/L to 100.00g/L.  
The optimum protein concentration for UF of HSA was approximately 100.00g/L, determined 
using the gel concentration model.  Ionic strength diafiltration diluent (1M – 3M) reduced 
permeate flux during UF of HSA.  Ethanol (<10% v/v) also had a reducing effect on, permeate 
flux during UF of HSA, with the optimum range specified between 0% (v/v) to 7.75% (v/v).  
Optimum permeate flux is achieved at a temperature of 25°C for UF of HSA.  The optimum 
protein concentration for UF is within the protein concentration range for optimum 
productivity.  Further, the proposed increase in protein concentration during UF results in a 
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ABSTRAKTE 
Die National Bioproducts Institute (NBI) is 'n belangrike bloed-plasma fraksioneerder in 
Suider-Afrika.  Menslike serum albumien (MSA), is die plasma-proteïen in die grootste 
konsentrasie in menslike bloed, met beduidende fisiologiese en terapeutiese voordele. Die 
toenemende wêreldwye vraag na MSA het plasma fraksioneerders verplig om sleutel prosesse 
wat gebruik word om hierdie plasma-afgelei geneesmiddel te vervaardig, te verbeter. 'n 
Belangrike proses-stap in die vervaardiging van MSA is ultrafiltrasie (UF), 'n membraan-
skeidingstegnologie wat gebruik word om ongewenste soute en oplosmiddels van die aktiewe 
farmaseutiese bestanddeel te verwyder. UF van proteïenoplossings bestaan uit verskeie 
opeenvolgende stappe, naamlik die eerste konsentrasie stap, diafiltrasie stappe 1 tot 5, en die 
tweede konsentrasie stap. Die werkverrigting van UF word tipies beperk deur meganismes soos 
konsentrasie polarisasie (KP) en membraan aankorsing (MA), inherent aan die membraan-
filtrasie proses.  In hierdie studie word die impak van die belangrikste proses-parameters op 
die UF van MSA proses ondersoek, naamlik proteïen-konsentrasie, etanol-konsentrasie, 
temperatuur en ioniese sterkte, binne ‘n vooraf-gedefinieerde operasionele gebied.  Die impak 
hiervan op permeaat-deurvloei produksie-tempo en membraan prestasie is ëvalueer, met in 
agneming van KP en MA meganismes.  Permeaat-deurvloei-tempo het ‘n kritiese invloed op 
die totale prosesseringstyd, wat 'n direkte impak jaarlikse produksie kapasiteit met 'n bepaalde 
UF eenheid het, in hierdie geval die C200 UF opstelling. 'n Belangrike doelwit van die huidige 
studie was om jaarlikse produksie kapasiteit te maksimeer, deur optimering van 
proseskondisies vir hierdie opstelling.  Die eksperimentele resultate het getoon dat 
proteïenkonsentrasie is grootste invloed op die verskillende stappe in die UF van MSA, sowel 
as die jaarlikse produksie kapasiteit  gehad het. Die voorkeur proteïen-konsentrasie vir 'n 
maksimum jaarlikse produksie kapasiteit was tussen 60 g/L en 100 g/L.  ‘n Optimum proteïen-
konsentrasie in hierdie gebied van 90 g/L tot 100 g/L, is bepaal deur toepassing van die 
konsentrasie polarisasie (gel konsentrasie) model. Aanpassing van die ioniese sterkte van die 
diafiltrasie verdunningsmiddel tot 1M-3M hetdie permeaat-deurvloei-temp verminder.  Op 
soortgelyke wyse het toenames in die etanol tot by 10% (v/v) ook die deurvloei-tempo 
verminder, met ‘n verminderde effek in die voorkeur gebied van etanol konsentrasies tussen 
0% (v/v) en 7.75% (v/v).  Die voorkeur temperatuur vir maksimering van die permeaat-
deurvloei-tempo was 25 °C, terwyl verdere toenames in temperatuur MSA-proteïen-
onstabiliteit sal veroorsaak.  Implementering van die voorgestelde verhoging in proteïen-
konsentrasie tydens UF van MSA sal ‘n toename van meer as 30% in die grootte van ‘n 
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1 INTRODUCTION 
Human serum albumin (HSA) is the most abundant plasma protein in human blood and 
functions as a carrier of steroids, fatty acids and some hormones.  It is a lifesaving plasma 
protein used in the treatment of shock, thermal injuries (e.g. burns), therapeutic 
plasmapheresis and restoration/maintenance of circulating blood volume (Hastings and 
Wolf, 1992; Liumbruno et al., 2009).  The ability of HSA to act as a drug transfer molecule 
due to its high ligand binding affinity and especially high plasma concentration 
(5g/100mL) has long been established through various studies (Bosse et al., 2005; Sugio 
et al., 1999).  Most recently, several investigations have shown the potential of this plasma 
protein to bind and transfer other beneficial drugs including the hepatitis B drug, adefovir 
dipivoxil (Shahabadi et al., 2015); stilebene compounds (Nair, 2015) and Z-ligustilide 
(Chen et al., 2015).  During the period from 1950 to 1960 HSA was the key market driver 
for the plasma derived medicinal products (PDMP) industry; in the subsequent years HSA 
was superseded by polyvalent immunoglobulin as the key PDMP (Robert, 2009).  As a 
renowned “transport plasma protein”, HSA is fast re-establishing itself as the key market 
driver in the plasma fractionation industry.       
 
The global demand for PDMP’s has shown a consistent growth rate of approximately 13% 
per annum, for the period 2002 to 2009 (Robert, 2011) and this trend has been maintained 
through to 2015.  Further, the marketing research bureau has estimated that the worldwide 
plasma derived products industry is worth in excess of $11.5 billion, with albumin sales 
staking a claim of 10% of the total market (Robert, 2011).  The African and Asian markets 
show the most potential for the sale of PDMP’s.  The National Bioproducts Institute (NBI), 
a key fractionator within the Southern African countries, is ideally positioned within the 
African market to satisfy the demand for PDMP’s within this region.      
   
The market demand for HSA, driven by the therapeutic benefits of this drug, including its 
use as a novel drug delivery system, will ensure that this plasma derived product is a key 
contributor to the global plasma market.  It is therefore essential that organizations that 
produce HSA continuously improve their production processes, in an effort to satisfy the 
ever increasing demand for these lifesaving drugs.  NBI manufactures HSA according to 
the methods of plasma fractionation defined by Kistler and Nitschmann (1962).  These 
plasma fractionation methods will be discussed in detail in chapter two.  Briefly, this 
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manufacturing process can be classified into two phases.  In the first phase (Figure 2:3), 
Fraction V paste containing HSA is separated from a starting pool of human blood plasma 
by exploiting temperature, pH, ethanol (ETOH) concentration and protein concentration.  
This plasma fractionation process also separates various other fractions that contain 
plasma proteins e.g. Fraction II paste which contains immunoglobulin.  Various solid-
liquids separation techniques such as centrifugation and filtration are used to separate the 
protein fractions.  The second phase (Figure 2:4) in the production of HSA involves the 
dissolution of a fixed mass of Fraction V paste in a water for injection-ethanol (WFI-
ETOH) admixture.  HSA in the dissolved Fraction V paste is purified through the 
processes of depth filtration and ultrafiltration (UF), formulated (addition of stabilizers) 
and dispensed into final product containers.  Although, the first stage in the manufacture 
of HSA is well documented and optimized according to protein yields and purity, the 
second stage in this process (purification, which includes dissolution of Fraction V paste 
containing HSA and subsequent refining of HSA) can be optimized further by evaluating 
the effects on process performance of key process parameters.    
 
Ultrafiltration, a novel membrane separation technology, is a key unit operation in the 
purification of HSA, where UF epitomizes the need for removal of unwanted impurities, 
solvents and other molecules.  UF as a unit operation generates an active pharmaceutical 
ingredient (API), which is HSA, at specified protein concentration, ready for final filling 
and parenteral use.  Following a careful analysis of all the unit operations involved in the 
purification of HSA, UF bears the greatest expense due to the high membrane costs, 
investment of capital for equipment and extended man hours.  These costs can be reduced 
by optimization of the UF process.  The optimization of the UF of HSA will ultimately 
lead to decrease in costs and increase in productivity.  A key process improvement point 
will be to maximize the mass of Fraction V paste dissolved during the purification of HSA 
(Figure 2:4), i.e. maximize the protein concentration at which UF of HSA is completed.  
One method of increasing process capacity is to increase the size of peripheral equipment, 
however, this may not be a feasible process improvement strategy since larger equipment 
generally requires increased capital expenditure.  A more productive approach is to 
determine the range of protein concentration that favours the purification of HSA at 
optimum permeate flux.  The impact of ionic solutions on permeate flux during UF of 
HSA has been investigated by several authors (Swaminathan et al., 1981; Fane et al., 1983; 
Lim and Mohammad, 2010).  A key objective of this study is to determine the effect of 
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ionic solutions on permeate flux during UF of HSA, determine the nature of the effect and 
if permeate flux can be maximized by using ionic salt solution of certain concentration.  
NBI completes the UF of dissolved Fraction V paste containing HSA using WFI as a 
diafiltration diluent to maintain constant volume during diafiltration.  A further 
optimization initiative will be to determine the optimum temperature at which to complete 
the UF of HSA since the impact of temperature on proteins and membranes is well 
documented and discussed further in chapter two.       
  
This study will be dedicated towards the optimization of the UF of HSA by evaluation of 
key process parameters that govern this process, and thereby provide guidelines for 
process optimization and control.  The guidelines for process design and control will be 
derived from process engineering principles as well as evaluating protein biochemistry at 
various steps in the process.  The current UF process, as practiced by NBI, has the potential 
to increase productivity (kg HSA protein refined per year) by evaluating key factors that 
influence this process.  Therefore, strategic optimization of the productivity of HSA will 
also be considered during this work.    
 
1.1 MEMBRANE BASED SEPARATION TECHNOLOGY:  ULTRAFILTRATION 
Membrane based separation technologies have risen to prominence in the last 60 years 
and has become a suitable alternative to the traditional separation techniques such as 
distillation, precipitation and crystallization, in many industrial processes (Muralidhara, 
2010).  Membrane technologies are typically described as energy efficient with low 
environmental impact, high selectivity attributes, with the ability to produce increased 
yields of desired products at high throughput rates (Strathmann, 2005).  However, the 
most appealing benefit of membrane based technologies to the engineering arena is the 
achievable separation efficiencies, when compared to conventional techniques, and the 
ease with which they can be integrated into various manufacturing processes (Saxena et 
al., 2009).   
 
Due to these attributes, membrane based technologies such as microfiltration and UF are 
used extensively in protein purification and separation processes.  These pressure driven 
processes with membranes of specified molecular weight cut off (MWCO) points, are 
well suited to the high retention of the protein of interest whilst removing unwanted 
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macromolecules (Saxena et al., 2009).  Ultrafiltration is used in the processing of HSA, 
following the dissolution of Fraction V paste (containing HSA), to remove unwanted 
micromolecules (e.g. citrate and aluminium) and solvents (such as ETOH) to produce a 
PDMP’s suitable for parenteral use.  The key disadvantages of UF includes decrease in 
membrane performance due to membrane fouling (MF) and concentration polarization 
(CP), high capital costs for membranes, and the requirement for regular cleaning of 
membranes.  It is therefore imperative to optimize the process parameters that govern 
MF and CP in an effort to decrease the overall processing costs for the UF of proteins, 
whilst maintaining the yield, safety, quality and efficacy of the HSA produced.   
 
1.2 PROJECT AIMS AND OBJECTIVES 
The project aim is to evaluate the factors that influence the permeate flux during the UF 
of HSA, and to provide guidelines for process design and control of this key unit 
operation.  The key objectives in achieving the stated aim include: 
 Determine the impact of protein concentration on the UF of HSA.  This study 
will aim to determine the maximum protein concentration at which to complete 
UF of HSA.  Further, this study will evaluate the effects on permeate flux with 
change in protein concentration.  Establishing this optimum protein concentration 
has significant impact on the quantity of Fraction V paste that can be used per 
batch, which is key to increasing production capacity.  This has significant impact 
on process improvement strategies and process control with respect to 
productivity i.e. kilograms of Fraction V paste processed per year.  
 Determine the impact of an ionic solution (of a particular concentration), e.g. 
sodium chloride (NaCl) when used as a diafiltration diluent, on permeate flux 
during the UF of HSA.  Currently, WFI is used as the diafiltration diluent during 
UF.  Screening experiments and literature indicate that ionic solutions have an 
impact on permeate flux during UF.  This study will attempt to evaluate the 
impact of ionic solutions of varying concentration, on permeate flux during UF 
of HSA.  The ionic solution used in this study is NaCl.     
 Determine the optimal processing temperature at which the UF of HSA can occur.  
Numerous authors have noted the impact of temperature in the UF of proteins and 
this study will aim to establish the optimum temperature for UF of HSA.    
 During the refining of HSA, the Fraction V paste is dissolved in an admixture of 
WFI and ETOH, with ETOH having a final concentration of 10% (v/v) in the 
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dissolved Fraction V paste.  This present study will determine the impact of 
ETOH concentration on permeate flux during UF of HSA.   
 
1.3 DESIGN OF EXPERIMENTS 
Design of experiments (DOE) utilizes statistical methods such as central composite 
design (CCD) to analyse and interpret key factors that influence product processes or 
product quality by conducting controlled, scientific based tests on the experimental unit 
(Telford, 2007). The statistical application of DOE in the pharmaceutical environment 
results in the scientific understanding of key factors that affect critical process parameters 
(CPP) and critical quality attributes (CQP) of products (Shivhare and McCreath, 2010).  
Thus the effect of CPP’s and related impact on CQP allows the optimization of 
production processes leading to improvement in quality of products with a subsequent 
positive impact on market share, decreased costs and improved profits (Anderson and 
Kraber, 1999). The principles of DOE is utilized in a wide range of applications including 
optimal use of industrial equipment e.g. stationary hook hoppers (Kukreja et al., 2011), 
improving tablet coating quality and performance applications (Porter et al., 1997), and 
increasing the yields of pharmaceutical intermediate products (Wilson, 2012).   
 
The methodology of DOE, which includes statistical techniques such as central 
composite design (CCD) encompasses a multi-factor approach to determine the effects 
on the experimental unit, in a limited number of runs through use of scientific and 
statistical techniques.  Therefore, a key benefit of DOE is to determine critical factors 
that have significant impact on CQP or output variables in the shortest time, when 
compared to other experimental strategies such as one-factor-at-a-time (OFAT) 
experiments (Kukreja et al., 2011).  Another key advantage of DOE is that it allows the 
evaluation of interactive effects between factors that may not be evident in OFAT 
experimental methodologies (Anderson and Kraber, 1999).  Further benefits of DOE 
include: 
 Improve product design (Telford, 2007) 
 Focal point for quality by design initiatives in pharmaceutical manufacturing by 
determining CPP (Shivhare and McCreath, 2010) 
 Analysis of variability with respect to raw materials, operators and process 
variability (Shivhare and McCreath, 2010).  
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In this study, DOE was used to evaluate the active factors (protein concentration, 
temperature, ETOH concentration and ionic strength) at various levels, using the CCD 
statistical technique.  Experimental runs were completed at the minimum and maximum 
start points as well as the centre points, for each factor.  The output variable in this study 
was membrane performance which was defined by permeate flux during UF of HSA, 
membrane flux recovery and protein retention.  Further, UF of HSA productivity was 
evaluated as a function of process time and other manufacturing constraints.  The 
permeate flux data from all experimental runs was statistically analysed using the 
analysis of variance (ANOVA) technique, in particular the Fischer’s Test.  The 
relationship between predicted responses for each factor, across the selected level and 
the desired response (maximizing permeate flux during UF of HSA) is defined as the 
desirability function.  Desirability is measured on a scale from 0 to 1 were 0 is an 
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2 PLASMA FRACTIONATION AND PLASMA PROTEINS 
2.1 INTRODUCTION 
Human PDMP’s such as HSA, Factor VIII, Factor IX and immunoglobulin are 
lifesaving, therapeutic drugs that are renowned for their treatment of chronic diseases 
and disorders, including haemophilia and Kawasaki disease (Hastings and Wolf, 1992; 
Berger, 2002).  The Dublin Consensus Statement asserted that the plasma fractionation 
industry (including other sectors of the blood industry such as blood collection agencies) 
has a critical responsibility to provide a safe, sufficient and sustainable supply of PDMP’s 
to the patients who depend on these lifesaving therapies (Mahony and Turner, 2010).  
The growing global requirements for safe (free of viruses and bacteria), therapeutically 
effective human PDMP’s and the growing number of patients that require these 
therapeutic products has driven plasma fractionation organizations to continuously 
evaluate and improve related production processes.   
 
The increasing demand for PDMP’s coupled with a shortage of source raw material (i.e. 
human plasma) has compelled fractionation organizations to optimize manufacturing 
processes, to increase process capacity (i.e. productivity), product yields and product 
purity (Roberts, 2011).  Process optimization is a value adding initiative, since it 
increases yield and process efficiency, whilst reducing process time and associated costs.  
The integration of new technology and improvement of current techniques is critical to 
the process optimization strategy.  The increased demand for high quality, viral safe 
products and the increasing regulatory requirements towards sustainable good 
manufacturing practice (GMP) has ensured that the plasma fractionation industry 
continuously focuses on process improvement strategies.         
 
NBI is one of South Africa’s largest biopharmaceutical institutes specializing in the 
production of PDMP’s.  The key products manufactured by NBI include albumin, 
immunoglobulin and clotting factors which are all prepared as sterile, injectable solutions 
(parenteral solutions).  NBI is committed to producing high quality blood plasma 
products by following the principles of GMP as well as Good Engineering Practise 
(GEP).  In the South African market, the demand for HSA and immunoglobulin shows a 
similar trend to that represented in the global market – a steady year on year increase is 
projected until 2015 and beyond (Roberts, 2011; Roberts, 2009).  Further, there is an 
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increasing need for plasma derived products to be supplied to the developing countries 
that form the Southern African Development Community (SADC) region.  International 
competitors are evaluating business opportunities within the untapped, African plasma 
market and some organizations have already registered certain products for sale in South 
Africa.  It is therefore imperative that the NBI optimize processes related to the 
manufacture of plasma derived products to ensure that supply and demand is satisfied 
and that NBI remains a market leader in Africa with respect to the production of plasma 
derived products.   
 
A careful analysis (conducted by NBI) of the product profile, market requirements and 
process strategy for production of human PDMP’s has resulted in the selection of two 
critical products (and related processes), i.e. HSA and immunoglobulin, as the focal 
point for capacity expansion and process optimization.  The current process 
optimization study will focus specifically on the UF of HSA, since the upstream process 
of separating proteins into fractions of paste from plasma pools, using cold ETOH 
fractionation techniques, was optimized as part of an earlier initiative.  Further, the UF 
of HSA was selected for optimization since currently accepted process improvement 
strategies can be used to improve product yield, process productivity (process time and 
capacity) and product purity.  The inherent flux decline during UF of HSA, due to CP 
and MF, coupled to the denaturation of proteins observed during present industrial 
operations, have provided enough scope to warrant a full process evaluation and 
optimization study.    
 
The critical goals in optimization of membrane process such as UF of proteins is to 
achieve a maximum permeate flux with maximum solute rejection and minimal 
operational and consumable costs with no negative impact on product yields or purity 
(Sablani et al., 2001).  The key process objectives of this study will be to increase 
productivity whilst maintaining or improving the current process yields and product 
purity.  This study will also investigate the synergy between process parameters in 
achieving the stated objective and suggest an optimal process design that will also 
consider a possible trade-off between the objectives.     
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2.2 PLASMA FRACTIONATION AND THE GLOBAL DEMAND FOR PLASMA 
FRACTIONATED PRODUCTS 
2.2.1 PLASMA AND PLASMA PROTEINS 
Human plasma is a unique biological material and is described by the world health 
organization as the “liquid portion remaining after separation of the cellular 
components from blood” (Burnouf, 2012).  The modernization of common protein 
identification techniques such as 2D-electrophoresis, mass spectrophotometry and 
antibody arrays has resulted in identification of approximately 300 proteins in human 
plasma – some of which have significant clinical value, e.g. HSA, immunoglobulin, 
protease inhibitors, Factor VIII and Factor IX (Burnouf, 2012; Anderson and Anderson, 
2002; Putnam, 1975).     
 
In a study conducted by Laub et al., (2010) plasma recovered from remunerated and 
non-remunerated donors from several European countries, including Germany, France, 
Belgium and the United States of America, were analysed for total protein and key 
plasma protein markers such as albumin and immunoglobulin.  This study confirmed 
that human plasma has a high total protein concentration of approximately 60g/L, with 
more than 90% (approximately 55g) of these proteins having recognized clinical and 
therapeutic significance (Burnouf, 2006; Laub et al., 2010).  This study also revealed 
two major plasma protein groups across all donor groups namely albumin (30-40g/L) 
and immunoglobulin (7-10g/L).  Transferrin and fibrinogen have similar concentrations 
(2-3g/L) in human plasma and constitutes the third major group of plasma proteins 
(Burnouf, 2006; Laub et al., 2010).  Plasma proteins that have the lowest concentration 
in plasma include interleukin proteins (e.g. interleukin 6 concentration is 0-5 x 10-12 
g/L) and tissue factors (Anderson and Anderson, 2002).  Figure 2:1, derived from 
Putnam (1975), shows the maximum concentration (g/L) of key plasma proteins in 1L 
of human plasma.  The concentrations of these plasma proteins listed herein are in close 
agreement with those listed by Burnouf (2006) and Laub et al., (2010)    
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Figure 2:1:  Pie chart indicating the maximum concentration (g/L) of key plasma proteins found in human serum 
(Putnam, 1975).  Albumin and immunoglobulin are the most abundant plasma proteins, whilst transferrin, 
glycoproteins and fibrinogen make up the third major class of plasma proteins.  
 
Human plasma is the unique, primary raw material used to manufacture essential 
protein based medicines (e.g. albumin, immunoglobulin), through a process called 
fractionation, which are used to treat various diseases and disorders including 
haemophilia A/B, primary immunodeficiency, renal failure and liver failure.  In South 
Africa, the main source of plasma for fractionation is derived from non-remunerated, 
tested donors, who either donate whole blood (blood components, e.g. red blood cells, 
plasma are separated after collection of blood) or donate the plasma component of blood 
through a process known as apheresis (El-Ekiaby et al., 2009).  Blood and related 
components are collected by two stringently controlled and regulated national blood 
collection agencies namely the South African National Blood Service (SANBS) and the 
Western Province Blood Transfusion Service (WBTS).  The viral safety of human 
plasma is critical to the use of this raw material to manufacture PDMP’s.  The 
identification and transmission of key pathogenic viruses such as human 
immunodeficiency virus (HIV), Hepatitis B virus (HBV) and Hepatitis C virus (HCV) 
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has forced the plasma fractionation industry to implement viral testing and removal 
strategies to ensure the safety of human plasma used to produce medicinal products 
(Burnouf, 2006; Burnouf, 2012).  These viral safety strategies include: 
 Comprehensive screening and testing of blood donors, which is normally 
conducted by the national blood collection agencies  
 Viral testing of source plasma before use in fractionation processes using 
specialized diagnostic method such as the enzyme linked immunosorbent assays 
(ELISA).  
 Viral reduction methods implemented in the production of plasma derived 
medicines, e.g. solvent detergent methods, pasteurization and nanofiltration 
methods (Burnouf, 2012).            
 
Human plasma contains more than 300 different plasma proteins, some with important 
clinical significance.  HSA is a key plasma protein derived from human plasma.  The 
collection of plasma is stringently controlled due to the high risk of infection by 
pathogenic viruses such as HIV.  Patient safety is a key component of the manufacture 
of PDMP’s and the safety of the manufactured parenteral products are enhanced by 
ensuring that products such as HSA are manufactured from safe, raw materials (human 
plasma).       
 
2.2.2 GLOBAL DEMAND FOR PLASMA DERIVED PRODUCTS 
The global demand for plasma derived products has shown a consistent growth rate of 
approximately 13% per annum for the period 2002 to 2009, this trend is expected to be 
maintained through to 2015.  The marketing research bureau has estimated that the 
worldwide plasma derived products industry is worth in excess of $11.5 billion, with 
intravenous immunoglobulin sales holding up to 46% of the market and HSA sales 
making up 10% of the total market (Robert, 2011).  During the period 1950 to 1960, 
albumin was the key market driver for the PDMP’s industry.  During the late 1960’s, 
the therapeutic potential of factor VIII and factor IX was discovered and these products 
superseded albumin as the key market driver for plasma derived products.  By the mid 
1990’s polyvalent immunoglobulin superseded factor VIII and factor IX as the market 
driver for plasma derived products (Robert, 2009).  The latest market research indicates 
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that HSA is not a key market driver in the plasma fractionation industry.  However, the 
therapeutic value of this plasma protein coupled to its novel use in gene delivery 
systems ensures that albumin is a highly valued PDMP.  This is further highlighted by 
the increasing worldwide demand for albumin, as depicted in Figure 2:2.  Current 
figures compiled by the marketing research bureau showed a compounded annual 
growth rate for the demand of albumin of +4.8% since the year 2000.  Further, in a 
presentation delivered by Patrick Robert (2014), at a global symposium on the future 
of blood and plasma donations, it was proposed that the demand for HSA is expected 
to supersede 1000 metric tons by the year 2020.  The African and Asian markets show 
the most potential for the sale of plasma derived products.  The Asian HSA markets are 
expected to grow at greater than 7% per year whilst Africa represents a unique, 
untapped market for plasma derived products.  
     
 
Figure 2:2:  Graphical representation of the worldwide global demand for human serum albumin (metric 
tons/year) from 1984 to 2014.  The trend shows a year on year increase in demand for albumin, with a global 
drop in demand from 1998 to 2000.  Increase in demand of albumin is expected to continue through to 2002, 
with more than 1000 metric tons expected to be used worldwide in this year (Robert, 2014). 
 
In the plasma fractionation industry, the cost of the raw material (i.e. human plasma) is 
extremely high, when compared to the raw materials of other biopharmaceutical 
industries.  The Department of Transfusion Medicine in Italy undertook a recent study 
to determine the cost of 1L of plasma, collected via. several methods including whole 
blood and apheresis.  In this study, Eandi et al., (2015) calculated the cost of 1L of 
plasma from collection to delivery at fractionation centres, including donor testing 
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costs, plasma testing cost, material and transport costs, is approximately €113, for 
plasma recovered from whole blood, and €276, for plasma recovered via apheresis 
methods.  The cost of manufacturing PDMP’s is further increased by other factors 
including (Burnouf, 2012): 
 The economics of producing PDMP’s requires that several products be 
produced from 1L of human plasma, to make the fractionation process cost 
effective and profitable.  This leads to a complex manufacturing processes to 
extract several plasma proteins at the required yields and purity levels to have 
significant therapeutic values.   
 Plasma fractionation facilities must conform to GMP and stringent design 
standards to ensure safety, efficacy and quality of products manufactured.   
 The advent of viral reduction strategies and implementation during fractionation 
processes leads to further increases in manufacturing costs. 
 
The projected demand for HSA is expected to increase year on year with at least 1000 
metric tons of HSA required by the year 2020.  The African and Asian markets show 
the most potential for growth with respect to the sale of PDMP’s, especially HSA.  The 
production cost of HSA is increased by the cost of recovery and testing of human 
plasma, which is the raw material used manufacture plasma derived products.  The cost 
of human plasma in South Africa varies, therefore, the costs of this raw material is 
illustrated by using a recent study conducted by Eandi et al., 2015 who estimated the 
cost of plasma at  €113/L (approximately R1700/L; exchange rate R15.11).  
 
2.2.3 THE HISTORY OF PLASMA FRACTIONATION 
Plasma fractionation methods were developed in the early 1940’s in response to the 
requirement for human albumin and immunoglobulin during World War II (Burnouf, 
2012; Curling and Bryant, 2005).  In 1946 Edward J Cohn, a world renowned protein 
biochemist, and his colleagues proposed a method for the separation and purification 
of protein components from human plasma (Cohn et al., 1946).  The Cohn fractionation 
method is based on exploiting the solubility characteristics of proteins by controlling 
ionic strength, pH, temperature, protein concentration and organic precipitant (ETOH) 
concentration (Cohn et al., 1946). The methods proposed by Cohn et al., (1946) are 
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recognised as the cornerstone process strategy for fractionation of human plasma 
(Burnouf, 2012).   
 
Several scientists contributed significantly to improving the process schemes described 
by Cohn et. al., (1946).  In 1962, Kistler and Nitschmann described a method for the 
large scale fractionation of plasma proteins from human plasma (Kistler and 
Nitschmann, 1962).  The Kistler and Nitschmann (1962) method is largely based on the 
Cohn cold ETOH fractionation scheme and is optimized for process time, improved 
product yields and purity whilst using reduced volumes of reagents and materials.  The 
purity of albumin extracted by the Kistler and Nitschmann (1962) method is 2-3% purer 
than that extracted by other methods, whilst the yield of albumin remains unchanged.  
The purity of immunoglobulin extracted by the Kistler and Nitschmann (1962) method 
is approximately 99% (similar to alternate methods).  However the yield of 
immunoglobulin is more than 1% higher in the Kistler and Nitschmann (1962) method.  
A further key benefit of the Kistler and Nitschmann (1962) method is that the 
fractionation process is specifically optimized for the recovery of Fraction V paste and 
Fraction II paste which contains HSA and immunoglobulin respectively, through 
separate process steps.  Also, Kistler and Nitschmann (1962) method  of fractionation 
is preferred since it has the added advantage of virus removal through partitioning of 
viruses during the various solid-liquid separation steps conducted during the process.  
However, cold ETOH fractionation is also supported by other viral inactivation steps 
e.g. inactivation at elevated temperatures to ensure complete removal of viruses 
(Dichtelmüller et al., 2011).     
 
An alternate method to the Cohn Cold Ethanol Fractionation scheme is the 
chromatographic plasma separation technique, devised by Curling et al., in the 1970’s.  
In this process plasma proteins are separated based on their size and charge and not on 
their solubility characteristics. Today, most organizations have developed their own 
methods of fractionation to improve productivity, yield and purity.  Many fractionation 
methods are based on those described by Cohn et al., (1946), Kistler and Nitschmann 
(1962) or Curling et al., (1977); it is not uncommon for organizations to use a 
combination of all three methods.  The fractionation processes utilized at NBI are based 
on the Kistler and Nitschmann method of 1962.  
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2.2.4 PLASMA FRACTIONATION AT NBI 
The cold ethanol fractionation scheme, based on the methods described by Kistler and 
Nitschmann (1962), to manufacture various plasma proteins on an industrial scale is 
shown in Figure 2:3.  In this process,  plasma proteins such as albumin and 
immunoglobulin are precipitated from human plasma by specifically exploiting the 
solubility characteristics of proteins, which depend on ionic strength, pH, temperature, 
protein concentration and changes in solvent polarity which is influenced by organic 
precipitant concentration e.g. ETOH concentration.  Plasma proteins of interest are then 
recovered by using various solid-liquid separation techniques such as centrifugation or 
depth filtration.  The intermediate protein precipitates/paste, referred to as Fractions, 
are reconstituted and subjected to purification processes (which include dissolution of 
the Fractions, depth filtration of the dissolved Fraction, to remove larger particles and 
finally polishing of the protein solution through UF) prior to formulation and final 
filling into product containers.   
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SUPERNATANT: cryo poor plasma.  used for  the 
manufacture of HSA and IvIG
Pool fresh frozen plasma, control thaw with 
stirring.  Temperature  0°C.  
Supernatant  is pumped to holding tank.  
Add ionic strength using NaCl (0.9%); 
Adjust ph to pH 5.8 ± 0.05
Adjust ETOH to final concentration of 19% (v/v)
PRECIPITATE:  contains fract ion I, II and II I. 
Centrifuge plasma pool.  
SUPERNATANT:  contains Fraction IV, V.   
PRECIPITATE:.  Solid paste = Cryoprecipitate.  used for  
the manufacture of Factor VII I and Factor IX
SUPERNATANT:  FRACTION IV, V
Adjust pH 5.8 ± 0.05
Add ETOH (96.4%) to final concentration of 40% (v/v), 
St ir O/N, Adjust pH 5.85 ± 0.05
PRECIPITATE:  isolated in depth f ilter pads; 
contains fract ion IV
Add ppt buffer to supernatant (with st irring), reduce 
temperature to -10°C after 48 hrs fraction V ppt out of  
solution
SUPERNATANT:  is discarded
SUPERNATANT:  contains fract ion V, 
transferred to holding tank
Depth Filtrat ion
PRECIPITATE: isolated in depth f ilter 
pads; contains fract ion V
Depth Filtrat ion
FRACTION I, II, III  PASTE
Adjust pH 5.1 ± 0.05
Sodium acetate buffer 2
Acetic acid buffer 1
Dissolve in WFI -  Temperature - 1°C ± 0.5 °C, 
with cont inous stirring
Dilute with WFI
Add ETOH to final concentration of 12% (v/v)
Decrease  temperature to -4°C ± 0,5 °C,
 pH 5.13 ± 0.05
Adjust pH 4.8 ± 0.05
PRECIPITATE:  contains fract ion I  and I II. SUPERNATANT:  contains Fraction II.
Depth Filtrat ion
Add NaCl (0.9%) to adjust ionic strength
Add ETOH (96.4%) to final concentration of 25% (v/
v) Ramp  temperature to -10°C ± 0,5 °C,
Adjust  pH 7.23 ± 0.05
Stop stirrer, maint ian temperature, allow fraction II 




STEP 1:  THAWING OF FROZEN PLASMA AND 
SUBSEQUENT SEPARATION INTO CRYO-POOR 
PLASMA AND CRYOPRECIPITATE
STEP 2:  SEPARATION OF CRY-POOR PLASMA 













































































































































































































































































































HSA – Human Serum Albumin
IvIG – Human Immunoglobulin
NaCl – Sodium Chloride
ETOH – Ethanol (96%)
WFI – Water for Injection
  
Figure 2:3:  Process flow diagram showing the fractionation of Fraction V paste (containing albumin) and Fraction 
II paste according to the methods of Kistler and Nitschmann (1962); as practised by the National Bioproducts 
Institute 
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The methods of Kistler and Nitschmann (1962) adopted by NBI to manufacture HSA 
can be divided into two unique stages.  In the first stage, referred to as the extraction of 
Fraction V paste from human plasma pools (Section 2.2.4.1), the protein of interest is 
separated from other plasma proteins by exploiting their specific solubility 
characteristics, and thereafter using solid-liquids separation techniques to separate 
proteins.  During this stage, HSA is produced in the form of a paste, referred to as 
Fraction V paste.  Also, immunoglobulin are separated as a paste and referred to as 
Fraction II paste.  In stage two of the fractionation process, referred to as the purification 
of Fraction V paste (Section 2.2.4.2), this paste containing HSA is dissolved in a WFI-
ETOH admixture and polished to remove all impurities, solvents and salts by UF.  The 
optimization of the ultrafiltration of dissolved Fraction V paste containing HSA is the 
core focus of this study.  The Fraction II paste containing immunoglobulin is also 
refined using similar methods, but these will not form part of this study.  In the 
following sections, the two unique stages of the Kistler and Nitschmann (1962) method, 
as practised by NBI, will be discussed in more detail.          
 
2.2.4.1 EXTRACTION OF FRACTION V PASTE FROM HUMAN PLASMA POOLS 
Initially, Fraction V paste containing HSA is separated from pools of human plasma 
(Figure 2:3).  The process can be separated in various steps and is described in detail 
as follows: 
 In step one of this process, frozen human blood plasma, generally in plastic 
packs of approximately 250 - 400mL volume are pooled and control thawed 
in temperature controlled vessels.  The thawed plasma is subjected to 
centrifugation and the precipitate (also known as cryoprecipitate) contains 
fibrinogen and other clotting factors (approximately 50% concentration), 
which is used for the manufacture of Factor VIII and Factor IX.  The 
supernatant (also known as cryo-poor plasma) contains various serum proteins 
including albumin and immunoglobulin and is transferred to a holding tank.    
 In step two, ETOH, to a final volume of 19% (v/v) is added to the cryo-poor 
plasma (supernatant from the preceding step) and the pH is adjusted to 5.8 ± 
0.02, the solution is subjected to centrifugation.  The precipitate recovered 
after centrifugation contains immunoglobulin (approximately 80% 
concentration) and is known as Fraction I/II/III.  The supernatant recovered 
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after centrifugation contains albumin (approximately 80% concentration) and 
is referred to as Fraction IV/V.  
 In step three, Fraction I/II/III is reconstituted in WFI, at low temperatures (1°C 
± 0.5°C).  Acetic acid and sodium carbonate buffers are added to the 
reconstituted Fraction I/II/III solution, to maintain pH (5.13 ± 0.05) and ionic 
strength (0.0014).  Thereafter, ETOH (12%, v/v) is added to the solution.  This 
solution is subjected to depth filtration, the precipitate (containing 90% α and 
β globulins, 7% clotting factors and 2% other proteins) is known as Fraction 
I/III and is discarded.  The supernatant (containing 92% immunoglobulin and 
8% albumin) is retained for further processing.  The ionic strength of this 
supernatant is increased (from 0.014 to 0.04) using buffer, pH adjusted to 7.3 
± 0.05 and temperature lowered to -10°C ± 0.5°C.  These process conditions 
facilitate the precipitation of Fraction II paste which contain approximately 
95% immunoglobulin, which is recovered by centrifugation.  Fraction II paste 
is reconstituted and refined prior to formulation and filling into product 
containers.    
 During step four, ETOH of 40% (v/v) is added to Fraction IV/V, thereafter, 
the pH is adjusted to 5.8 ± 0.05.  This solution is subjected to depth filtration, 
the recovered precipitate known as Fraction IV is discarded since it contains 
transferrin (80% concentration), immunoglobulin (10% concentration) and 
little albumin (6% concentration).  The supernatant is transferred to a holding 
tank, acetate buffer is added and the temperature is decreased to -10°C ± 
0.5°C.  These process conditions cause the precipitation of albumin into a 
paste form known as Fraction V.  This Fraction V paste is separated from the 
bulk liquid by depth filtration.  Fraction V paste is reconstituted and refined 
prior to formulation and filling into product containers.  As mentioned 
previously, this process is the focus of this study and as such will be discussed 





Stellenbosch University  https://scholar.sun.ac.za
Page 36 of 238 
 
2.2.4.2 PURIFICATION (REFINING AND POLISHING) OF FRACTION V PASTE 
CONTAINING HSA 
Fraction V paste, containing approximately 28% albumin is recovered as a paste (by 
depth filtration), after step four of the fractionation process, described in section 
2.2.4.1 and Figure 2:3.  Fraction V paste is weighed,  bagged and stored in a freezer, 
set at temperatures below -20°C.  This API (Fraction V paste) will be dissolved and 
purified to produce HSA, suitable for parenteral administration (Figure 2:4).  The 
purification of HSA begins with the dissolution of a certain mass (currently 195kg) of 
Fraction V paste.  This paste is dissolved in an admixture of WFI and ETOH (96%, 
v/v); ETOH final concentration is 10% (v/v).  The Fraction V paste is added to this 
WFI-ETOH admixture when the temperature of the solute is 4°C ± 1°C.  The pH is 
adjusted (using 2M NaOH or 2M HCL) to 4.57 ± 0.05 and the temperature reduced to 
-3.5°C ± 0.5°C.  The solution is stirred overnight and is depth filtered, using a 
horizontal filter press.  Following depth filtration, the precipitate (salts and other 
proteins) is discarded and the filtrate (containing HSA) is recovered and concentrated 
(first concentration step) to a protein concentration of approximately 80g/L, while the 
pH is adjusted to neutral (7.2 ± 0.02).  Ethylenediaminetetracetic (EDTA) acid is 
added to the solution as a chelating agent.  The solution is then ultrafiltered by the 
method of constant volume diafiltration (CVD) using WFI as the diafiltration diluent.  
The volume of diafiltration diluent used during CVD is equivalent to five times the 
volume of solution measured at the start of CVD, were each volume of diafiltration 
diluent constitutes one diafiltration step.  Following CVD, the HSA solution is 
concentrated (second concentration step) to a final protein concentration acceptable 
for parenteral use, e.g. 20% or 4% protein concentration.  This HSA bulk liquid is 
formulated with stabilizers and then submitted for sterile filling.  Following aseptic, 
sterile filling of HSA into final containers, the product is pasteurized at 60°C for 10 
hours.      
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195kg of Fraction V paste
Add ethanol to final concentration of 10% (v/v)
Dissolve in 600L of WFI – Temperature 
of 5°C ± 0.5°C with continuous stirring
Depth Filtration using horizontal filter press, AF9 
and AF140 filter pads. 
REFINED ALBUMIN 
SOLUTION
When filtration is about 
halfway through add NaOH to 





Adjust to pH 4.57 ± 0.03 using 2M HCl.






PRECIPITATE:  Contains salts, 
ethanol, discarded 
FILTRATE:  Contains HSA 
 
 
Figure 2:4:  Process flow diagram depicting the dissolution, depth filtration and ultrafiltration of Fraction V paste 
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2.3 HUMAN SERUM ALBUMIN 
2.3.1 INTRODUCTION 
Human serum albumin (HSA) was one of the first plasma proteins discovered and is 
greatly valued for its various physiological and therapeutic properties. HSA has been 
used in various biotechnology applications such as fusion proteins and drug delivery 
systems (Fanali et al., 2012).  The structural topology of HSA confirms its ability to 
bind a large range of hydrophobic molecules and other materials including metals 
(Cu2+; Zn2+), amino acids, fatty acids and metabolites (Zunszain et al., 2003; Dockal et 
al., 1999; Sugio et al., 1999).  HSA is the most abundant protein found in human 
plasma, constituting more than half of the plasma protein content (Bosse et al., 2005; 
Anderson and Anderson, 2002; Sugio et al., 1999; Putnam, 1975).  HSA is a common 
contaminant in various other preparations of plasma derived products, due to its high 
concentration in human plasma (Putnam, 1975).  This extraordinary ability of HSA to 
bind compounds, coupled with its exceptional abundance in human blood systems, 
makes it an ideal molecule for carrier of key blood metabolites and to determine the 
pharmacokinetics of key drugs (Fanali et al., 2012).     
 
This plasma protein is highly soluble in water and is known for its stability under 
denaturing conditions, when compared to other plasma proteins.  This stability under 
denaturing conditions is conferred to HSA by strengthening of the structural backbone 
of the molecule by disulphide bridges (Matejtschuk et al., 2000; Sugio et al., 1999).  
This structural stability of HSA allows for significant variation and optimization of the 
manufacturing process used to fractionate this product. 
 
2.3.2 PRIMARY STRUCTURE 
Human serum albumin (HSA) is a globular protein made up of a single polypeptide 
chain containing 585 amino acid residues with 17 disulphide bridges (Fanali et al., 
2012; Sugio et al., 1999; Dockal et al., 1999).  The 17 disulphide bridges are formed 
from 34 cysteine amino acid residues and confers structural stability to the protein 
molecule, such that environmental conditions that may denature other proteins can be 
used to purify HSA (Matejtschuk et al., 2000).  The disulphide bridges are not easily 
accessible by solvents or reducing agents (Carter and Ho, 1994).  The geometry and 
position of these intra-domain disulphide bonds not only provides structural stability to 
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the protein, but also clusters aliphatic and aromatic amino acid residues towards the 
inner zones of the protein molecule thus creating a hydrophobic core (Sugio et al., 
1999).  Human serum albumin is a helical protein (approximately 67%), showing a 
typical internal atomic structure of hydrogen bonded loops and several turns (Carter 
and Ho, 1994).  This protein (HSA) is composed of three similar domains, coded I, II, 
III; each domain is made up of two subdomains coded IA, IB, IIA, IIB, IIIA, IIIB 
(Dockal et al., 1999).  The arrangement of the 3 domains resembles a heart shape 
structure.       
 
Human serum albumin contains a high concentration of aspartic acid (39 residues per 
molecule of HSA), glutamic acid (60 residues per molecule of HSA), lysine (58 
residues per molecule of HSA) and leucine (61 residues per molecule of HSA) amino 
acids (Table 2:1).  HSA has a net negative charge (-15) at neutral pH.  Furthermore, the 
large number of ionisable amino acids makes HSA an extremely soluble molecule 
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Table 2:1:  Table showing the amino acid residues of human serum albumin.  Glutamic acid (60), Leucine (61) 
and Lysine (58) are the most common amino acid residues in human serum albumin. 
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2.3.3 PHYSICAL AND CHEMICAL PROPERTIES 
Human serum albumin (HSA) has a molecular weight of 66438 Daltons (Fanali et al., 
2012). The molecule has an isoelectric point of 4.7, which is the lowest of all major 
plasma proteins (Matejtschuk et al., 2000).  Other key physical properties of HSA 
include (Schultze and Heremans, 1966): 
 Intrinsic viscosity of 0.042 
 Extinction co-efficient of 5.8g/L at absorbance of 280nm. 
HSA in blood plasma has a half-life of approximately 12-16 hours, whilst HSA 
endogenous to the blood system in human beings has a half-life of approximately 3-4 
weeks (Liumbruno et al., 2009).         
 
2.3.4 PHYSIOLOGY AND THERAPEUTIC SIGNIFICANCE 
Human serum albumin (HSA) is synthesized in the hepatic cells of the liver at a rate of 
approximately 200mg of HSA/kg body mass, i.e. approximately 15g of HSA per day 
in a 70kg man (Hastings and Wolf, 1992; Tulis, 1977).  HSA has a typical blood 
concentration level of approximately 5g/100mL (30-40g/L) (Anderson and Anderson, 
2002; Sugio et al., 1999).  The primary physiological role of HSA includes transporting 
of exogenous compounds such as pharmaceutical drugs and endogenous compounds 
such as bilirubin (Zunszain et al., 2008) and heme (Zunszain et al., 2003).  This ability 
to transport various substances is aided by a high net negative charge and increased 
solubility that allows efficient binding of various substances (Hastings and Wolf, 1992).  
Due to its high solubility and high net negative charge, HSA generates the colloid 
osmotic pressure that regulates the movement of water and diffusible salts through 
capillaries (Olsen et al., 2004).     
 
The therapeutic uses of albumin include treatment of shock, thermal injuries (e.g. 
burns), therapeutic plasmapheresis and restoration and maintenance of circulating 
blood volume (Hastings and Wolf, 1992; Liumbruno et al., 2009).  HSA is regarded as 
a reference point for identifying several disease conditions including cancer, 
rheumatoid arthritis and ischemia (Fanali et al., 2012).            
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2.3.5 A MODEL SUBSTITUTE:  BOVINE SERUM ALBUMIN 
Bovine serum albumin (BSA) is used in many UF experiments as a test protein since it 
is readily available at low cost and is biochemically very similar to HSA.  Albumin 
isolated from different mammalian species share many similar physic-chemical 
properties including surface hydrophobicity, isoelectric point and molecular weight 
(Putnam, 1975; Michnik et al., 2006).  Akram et al., (2011) used sequence alignment 
techniques to evaluate (at the molecular DNA level) the similarity and identity of HSA 
with albumin derived from other mammalian species (BSA, cat serum albumin, rat 
serum albumin, pig serum albumin).  This study showed that HSA and BSA have a 
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Table 2:2:  Table showing the amino acid residues of bovine serum albumin.  Note the strong homogeneity with 
human serum albumin amino acid content.  Glutamic acid (58), Leucine (65) and Lysine (60) are the most 
common amino acid residues in bovine serum albumin. 
 
 























The minor differences between HSA and BSA lies in the number (HSA has 585 amino 
acids whilst BSA has 582) and composition of amino acid residues (Table 2:2).  Also, 
BSA has a net negative charge of -17 whilst HSA has a net negative charge of -15.  
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3 ULTRAFILTRATION:  A KEY MEMBRANE 
TECHNOLOGY AND ITS APPLICATION IN PLASMA 
FRACTIONATION 
3.1 INTRODUCTION TO MEMBRANE TECHNOLOGY 
Membrane technologies are used extensively in various industries including 
pharmaceutical, biotechnology, waste water treatment, textile, dairy and beverage 
industries (Vincent-Vela et al., 2012).  Membrane technologies include reverse osmosis 
(RO), UF, nanofiltration (NF) and microfiltration and can be generally described as the 
pressure driven separation of liquid solutions across a medium (e.g. porous membranes) 
into separate components, where separation is primarily based on the size of the molecule 
being recovered (Peeva et al., 2012; Bowen and Williams, 1996).  RO has the propensity 
to remove inorganic contaminants, ions, endoxtoxins and pyrogens due to its very small 
pore size (approximately 0.001µm).  RO requires significant capital investment costs and 
pre-treatment of feed solutions, but with the main advantage of removing low molecular 
constituents (< 20000Da).  RO is generally used in the waste water industry and in the 
manufacture of fruit juice concentrate.  NF is used mainly to remove divalent ions and 
molecules in the range 1000 – 100000 Da.  NF is generally used in de-salting processes 
such as production of lactose from cheese whey.  The membrane process of UF is 
primarily based on size exclusion, i.e. molecules with a molecular weight lower than the 
molecular weight cut off (MWCO) rating of the membrane will pass through the 
membrane, whilst those molecules higher than the MWCO rating will be retained.  UF is 
used in the diafiltration and concentration of various proteins, purification of 
recombinant drugs and enzymes (Lim and Mohammad, 2010).  MF is used as a pre-
treatment in waste water applications and other purification processes that requires 
separation of large molecules.  Microfiltration is characterized by membranes with large 
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Figure 3:1:  Figure showing the size spectrum of various membrane technologies.  Ultrafiltration is used to 
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Figure 3:2:  Figure shows the rejection profile for various membrane technologies.  During ultrafiltration solvents 
such as water and different ions pass through the membrane whilst macromolecules e.g. albumin and suspended 
solids are retained. 
 
Membrane technologies are generally used as downstream separation, purification or 
clarification steps or as part of a sequence of separation processes, e.g. purification or 
refining of human serum proteins (Shao and Zydney, 2003).  Membrane technologies 
have numerous advantages when compared to other methods of purification.  The most 
significant advantages of membrane technologies are (Shirazi et al., 2010): 
 High yield recovery of the product of interest 
 Separation of components can be achieved under mild conditions 
 Reduced operating cost 
 Less labour intensive 
 Improved automation of process  
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 Scale up from laboratory experiments to pilot scale and manufacturing scale is 
easily achieved  
 
The key disadvantages of membrane technologies include (Shirazi et al., 2010): 
 Concentration polarization 
 Membrane fouling 
 Reduced membrane life due to negative impact of CP and MF 
 Cost of consumables; 
 
The membranes used during UF of proteins act as selective barriers since they contain 
pores of a defined size that exclude components larger than the pore size. The size rating 
of the pores, represented as the MWCO value, depends on the size of molecules present 
in the liquid and the size exclusion criteria or selectivity of the UF process.  There are 
two modes of UF of proteins that are universally recognized (Figure 3:3) namely normal 
flow filtration (also known as dead end filtration) and tangential flow filtration (also 
known as cross flow filtration).  These modes of UF are distinguished on the basis of 
liquid flow as follows (Millipore Application Note, 2003): 
 Normal Flow Filtration (NFF) – in NFF, the liquid or feed stream is driven 
perpendicularly towards the membrane.  This technique aims to pass 100% of the 
liquid through the membrane.  
 Tangential Flow Filtration (TFF) – in TFF, the liquid or feed stream is driven 
parallel to the surface of the membrane.  In this technique, a portion of the liquid 
passes through the membrane and the other portion is recirculated back to the 
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Figure 3:3:  Figure showing the difference between normal flow filtration and tangential flow filtration.  In normal 
flow filtration the pressure driving force and the direction of the feed flow are in the same direction.  In tangential 
flow filtration the direction of the pressure driving force and the feed flow are perpendicular to each other 
(Millipore Application Note, 2003).  
 
 
3.2 MEMBRANES IN MEMBRANE TECHNOLOGIES 
The ability of membranes to separate a diverse range of molecules or components has 
been well known since the 1800’s; the fundamental theories of membranes and 
membrane separations were in part established during these initial years culminating in 
the first key applications of membranes in separation processes where they were used in 
World War II for the examination of water (Cuperus and Smolders, 1991).  Membranes 
can be broadly described as a selective barrier between two separate phases and thus 
regulates the transport of components between the two phases; where this selective 
transport of components is based on both the physic-chemical properties of the 
membrane and the feed solution (Shirazi et al., 2010; Saxena et al., 2009; Ulbricht, 
2006).  The key advantage of membranes is the efficient size exclusion separation 
principle with defined uses in microfiltraiton, UF, NF and RO applications.  This size 
exclusion principle is characterized by the porous, anisotropic nature of membranes 
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Smolders, 1991).  Most recently, researchers have explored the potential of charged 
membranes to separate charged proteins/biomolecules.  These high performance 
tangential flow filtration (HPTFF) techniques are an emerging membrane separation 
technology that is gaining in popularity due to its ability to minimize CP and MF (Saxena 
et al., 2009).  Membranes are particularly useful in the pharmaceutical industry; 
therefore, membrane manufacturers are committed to developing membranes that 
efficiently remove viruses whilst maintaining high protein separation efficiency 
(Charcosset, 2006).  Further, membranes are designed to minimize MF i.e. have excellent 
anti-fouling properties which include high retention of the protein of interest (rejection 
co-efficient), low permeate flux decline, low filtration resistance and low surface 
roughness (Corbatón-Báguena et al., 2015).      
 
3.2.1 CHARACTERIZATION OF MEMBRANES 
Membranes are generally classified into several broad classes based on their material 
of construction (organic polymers, inorganic materials); cross section type (isotropic, 
anisotropic, thin-layer, multilayer); membrane shape/configuration (flat sheets, hollow 
fibres, capsules) and method of preparation (Ulbricht, 2006).  Polymeric, anisotropic, 
flat sheet polyethersulfone (PES) membranes are commonly used in UF processes, 
especially in the UF of proteins such as HSA.  PES membranes have a high degree of 
thermal stability, chemical stability, increased mechanical strength with high selectivity 
and permeability (Zhao et al., 2013; Ubricht, 2006).  PES membranes are inert, 
hydrophobic membranes with a net negative charge; it is these factors that assist in 
reducing MF during UF of proteins (Zhao et al., 2013).     
 
Membrane performance is defined by the unique characteristics of that membrane 
whose selection is primarily based on its relevant application in a particular process.  
Characterization of membranes can be divided into two categories namely performance 
related parameters (separation efficiency, protein retention, permeability, 
hydrophobicity and diffusion co-efficient) and morphology related parameters which 
include surface roughness, porosity, pore size and pore distribution  (Cuperus and 
Smolders, 1991).  Porous membranes are defined as membranes that separate 
macrosolutes and microsolutes based on particle size and sieving.  Non-porous 
membranes separate macrosolute and microsolutes based on the solubility 
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characteristics and diffusivity of solvents and the related interactions with the 
membrane (Shirazi et al., 2010).  The separation efficiency/selectivity or protein 
retention of a membrane is defined by its molecular weight cut off (MWCO) where 
MWCO is broadly defined as the lowest molecular weight of a solute that is rejected 
by the membrane with an efficiency of ≥90% (Mehta and Zydney, 2005; Cuperus and 
Smolders, 1991).  This MWCO value is directly related to pore size and the rejection 
efficiency value of ≥90% is not a defined scientific standard but rather an industry based 
norm for evaluating different membranes (Mehta and Zydney, 2005).  Pall Life 
Sciences User Guide for Membrane Cassette Care and Use Procedures, R00640 Rev B 
recommends that the MWCO of the membrane be at least 3-6 times smaller than that 
of the solute being retained.  In this study the solute or protein of interest is HSA with 
a molecular weight of approximately 66kDa, therefore, the membrane selected for these 
experiments had a MWCO of 10kDa.  A PES membrane of 10kDa is currently in use 
for UF of HSA in the current manufacturing process.  The membrane has shown 
excellent retention of HSA, good permeate flux during UF and good membrane flux 
recovery after UF.   
 
3.2.2 MEMBRANE MATERIALS AND CONFIGURATIONS/MODULES 
Membranes are constructed from organic polymers (PES, cellulose, polyimides) and 
inorganic materials (metals, oxides and carbon) (Verweij, 2012; Ulbricht, 2006).  
Inorganic membranes are more complex in structure when compared to organic 
polymeric membranes and are typically used for the separation of gases e.g. separation 
of hydrogen (H2) from coal-derived gas (Verweij, 2012).  The key advantages of 
inorganic membranes include increased chemical, thermal and mechanical stability 
when compared to polymeric membranes (Shirazi et al., 2010).  Polymeric membranes 
are commonly used in UF applications, especially PES; which is a common material 
used to manufacture membranes since it has well defined physic-chemical 
characteristics and is readily available in unlimited quantities (Saxena et al., 2009). 
 
Traditional membrane configurations include flat sheet (plate and frame), spiral wound, 
and tubular and hollow fibre configurations.  The flat sheet or plate and frame 
configuration resembles a depth filter assembly with membranes arranged in stacks.  
These configurations are typically used in microfiltration and UF applications, 
especially in the use of high viscosity feed solutions such as those used in the 
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fermentation industry (Lipnizki, 2008).  The spiral wound configuration is a high 
surface area configuration consisting of two or more sheets of membrane that are wound 
around a porous support layer creating a free space for permeate flow and a central 
space for retentate flow.  Spiral wound membrane configurations are very economical 
membranes since they give a very good price per area membrane ratio.  However, these 
membrane types are difficult to clean and have irregular cross flow patterns (Lipnizki, 
2008).  The tubular and hollow fibre configurations are similar in structure and are 
made up of membrane material that is cast on tubes which are connected to end plates.  
Tubular configuration membranes are generally used with high viscosity feed solutions, 
but has low packing densities (increased porosity) and requires large energy 
consumption (Lipnizki, 2008).  New membrane configurations are continuously being 
developed to decrease MF and CP during membrane separation processes (Charcosset, 
2006).  These new membrane configurations, described as dynamic filtration modules, 
use vibrating or shaking membranes (pulsating); or rotating disks to destabilize the gel 
boundary layer that is formed during membrane separation processes (Jaffrin, 2012).  
Pulsed UF, although not investigated in this study will be discussed in the later part of 
this literature review (Section 3.4.5).     
 
3.2.3 MEMBRANE CLEANING STRATEGIES 
Cleaning of membranes used in membrane separation technologies are critical for 
maintaining membrane efficiency (hydraulic permeability, permeate flux and protein 
retention) and overcoming the effects of CP and MF, which is an inherent characteristic 
of membrane technologies (Levitsky et al., 2012).  The membrane cleaning strategy 
has a direct impact on the life time or ageing of the membrane (Kuzmenko et al., 2005).  
Ageing is generally defined as changes in physic-chemical structure of the membrane 
and includes changes in pore size, pore geometry, surface roughness, density, and 
change in hydrogen patterns (Donose et al., 2013).  The effect of a defined cleaning 
procedure for a particular process is limited by the process conditions that influence 
MF e.g. protein concentration, TMP, cross flow velocity (CFV), temperature (Diagne 
et al., 2013).  All cleaning strategies will involve the following steps (Levitsky et al., 
2012; Corbatón-Báguena et al., 2014): 
 An initial rinse of the membrane, after fouling, generally using pure water  
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 Thereafter, the membrane will be rinsed and soaked in a cleaning solution of 
relevant concentration.  Generally sodium hydroxide or sodium hypochlorite is 
used but most recently cocktail cleaning solutions (combination of two or more 
cleaning agents) have been used 
 Final rinse of the membrane with pure water to remove the cleaning solution.  
 Membrane is stored in a storage buffer e.g. 0.5M NaOH till required for further 
use.       
 
Chemical cleaning of membranes occurs through chemical interactions between the 
chemical cleaning reagent, proteins and membrane.  The chemical cleaning is 
dependent on the concentration of the cleaning reagent and the amount of time the 
membranes are exposed to this reagent (Kuzmenko et al., 2005).  In an effort to 
determine the cleaning efficiency of various chemical reagents including sodium 
hydroxide (NaOH), sodium hypochlorite (NaOCl) and hydrogen peroxide (H2O2); 
Kuzmenko et al., (2005) fouled PES membranes, of 20kDa, with BSA (0.3g/L) using 
fixed hydrodynamic and environmental conditions.  Thereafter, membranes were 
cleaned with pure water, NaOH (100, 500, 1000, 3000ppm), NaOCl (100, 1000, 3000, 
5000ppm) and H2O2 (100, 1000, 3000ppm).  The flux recovery, measured after 
completing chemical cleaning with the mentioned reagents revealed that pure water is 
ineffective when cleaning membranes fouled by proteins and serves only to remove 
loosely adhered proteins.  NaOH cleaned membranes were only able to restore the 
permeate flux to 70% of the original permeate flux.  NaOCl was the most efficient 
cleaning reagent, achieving a permeate flux recovery of 95%.  Although NaOCl was 
the most efficient cleaning reagent in this study, the concentration at which the reagent 
was used is critical to the degree of cleaning.  The experimental results showed that as 
NaOCl concentration increased, the propensity for fouling also increased, after each 
use of NaOCl as a cleaning reagent.  The effectiveness of NaOCl as a cleaning agent is 
based on its ability to denature proteins thus causing protein aggregates to be removed 
from the membrane surface and within pores, thereby improving hydraulic permeability 
of the membrane.          
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In a study conducted by Carbatón-Báguena et al., (2014), the relationship between 
hydraulic cleaning efficiency (HCE - %), salt solutions (NaCl – 0mM to 12.5mM), 
temperature (25°C; 37.5°C and 50°C) and CFV (1.2m/s to 4.2m/s) was evaluated for 
different membranes (PES, hydrophilic PES and ceramic) with different MWCO 
(5kDa, 15kDa and 30kDa).  The HCE (%) was analysed by first fouling the membrane 
with BSA (1%, w/w) and CaCl2 (0.06%, w/w); thereafter rinsing with deionized water, 
cleaning and then a second rinse with deionized water.  The high CFV (3.19m/s to 
4.2m/s) with fixed NaCl concentration and temperature achieved the highest HCE, for 
all membranes tested.  High CFV induces high shear forces that removes protein 
molecules from the surface of the membrane.  High temperature (50°C) also produced 
highest HCE at fixed NaCl concentration and CFV.  This finding was explained by the 
increased hydrodynamic flow to the membrane interface resulting in increased 
interaction of salt molecules with protein.  Salt solutions increased HCE with increasing 
molarity of NaCl, up to a critical concentration beyond which HCE declined.  This was 
true for all membranes tested.  This effect was linked to the relationship between salt 
concentration and surface tension.  At low salt concentration, surface tension is low 
which favours high solubility of the proteins.  Carbatón-Báguena et al., (2014) showed 
that the most effective cleaning procedures for the 5kDa, PES membrane, was achieved 
with 10mM NaCl, CFV of 3.15m/s at a temperature of 50°C.   
 
The membranes used for the UF of HSA at NBI are cleaned after every use; membranes 
are flushed with WFI and then cleaned with a low concentration, NaOCl-WFI mix.  
Thereafter, the cleaning reagent is completely rinsed from the membranes.  The 
membranes are then stored in formaldehyde until required for next use.  NaOCl is 
generally considered a harsh cleaning reagent with the ability to increase ageing of 
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3.3 ULTRAFILTRATION:  A KEY MEMBRANE SEPARATION TECHNOLOGY 
3.3.1 THE KEY STEPS OF ULTRAFILTRATION 
The process of UF of proteins is sometimes referred to as traditional diafiltration and 
can be described by seven key steps based on the addition of diafiltration diluent (or 
buffer) to the retentate (Paulen et al., 2011; Fikar et al., 2010).  These key steps, 
illustrated in Figure 3:4, are first concentration step, diafiltration step one, diafiltration 
step two, diafiltration step three, diafiltration step four, diafiltration step five and second 
concentration step (Wang et al., 2014; Lipnizki et al., 2002).  In the first concentration 
step, the solute to be ultrafiltered (containing macromolecules and micromolecules) is 
concentrated to an optimum concentration of the macromolecule i.e. the protein of 
interest, by removal of permeate with no addition of diluent to the retentate thus 
resulting in a decrease in volume of the feed solution (Fikar et al., 2010).  This optimum 
concentration is based on the propensity for CP and MF and is therefore dependent on 
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Figure 3:4:  The seven steps of ultrafiltration with respect to proteins are first concentration step, diafiltration 





•Concentrate protein solution to optimum 
concentration for diafiltration.




•Constant volume diafiltration i.e. add 1 x 
bed volume of diluent to maintain volume 
as permeate is removed
•Removal of unwanted salts and solvents
DIAFILTRATION STEP 1
•Step 2 of constant volume diafiltration, 
identical to step 1.DIAFILTRATION STEP 2
•Step 3 of constant volume diafiltration, 
identical to step 1.
DIAFILTRATION STEP 3
•Step 4 of constant volume diafiltration, 
identical to step 1.
DIAFILTRATION STEP 4
•Step 5 of constant volume diafiltration, 
identical to step 1.
DIAFILTRATION STEP 5
•Concentrate protein solution to optimum 
concentration for final filling. 
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The diafiltration steps one to five is characterized by the removal of micromolecules 
(e.g. sodium) and unwanted solvents (e.g. ETOH) through a “washing” process – by 
the addition of diluent to the retentate (Figure 3:5).  The diluent (e.g. WFI) can be added 
to the retentate via two methods: 
 Continuous feed diafiltration (CFD);  also known as continuous volume 
diafiltration (CVD) – where diluent is added to the retentate at approximately 
the same rate at which permeate is removed.  During CFD the macromolecule 
concentration remains constant (Foley, 2006).   
 Intermittent feed diafiltration (IFD) or variable volume diafiltration (VVD) – 
where diluent is added to the retentate at rate lower than which permeate is 
removed such that concentration and diafiltration occur simultaneously.  During 
IFD the macromolecule concentration changes (Fikar et al., 2010; Jaffrin and 
Charrier, 1994).   
In the second concentration step the solute is concentrated to the final concentration 
recommended for formulation, in a mode similar to the first concentration step i.e. 
permeate is removed and no diluent is added to the retentate until the required volume 
is achieved.  Figure 3:5 shows the typical protein concentration for each step of the UF 
of the protein solution and the removal of unwanted solvent such as ETOH, from the 
protein solution.  Protein concentration increases during first concentration step whilst 
remaining constant during CVD and increasing again in the second concentration step.  
Ethanol and unwanted micromolecules such as Na follow a similar trend and are 
removed, in a logarithmic function during UF.       
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Figure 3:5:  Indicates the seven steps of ultrafiltration and the logarithmic removal of unwanted solvents e.g. 
ethanol and the protein concentration of each step.  In this study, constant volume diafiltration (CVD) method 
was utilized.   
 
In a study conducted by Lipnizki et al., (2002), the author’s critically analysed three 
modes of UF of proteins namely batch UF, continuous UF and counter-current UF 
(Lipnizki et al., 2002).  Batch UF and continuous UF of proteins are widely accepted 
as the traditional methods of completing this process.  In batch UF of proteins the three 
phases of UF described above are completed sequentially, on one membrane stage.  In 
continuous UF of proteins the steps of UF are completed sequentially, but each step is 
assigned to a different membrane stage.  Batch UF requires lower capital expenditure 
and investment costs when compared to continuous UF.  Continuous UF of proteins is 
applicable to UF of components that have low stability, requiring shorter process times.  
Generally, pure water is used as the diluent during diafiltration thus the production of 
pure water adds significantly to the cost of the UF process.  Therefore, the counter-
current UF system recycles the permeate stream and uses it as diluent during the 
diafiltration process.  The counter-current UF of proteins is applied to different 
membrane stages (similar to continuous UF), especially where permeate is not required 
for further processing and generally requires increased membrane surface area.  
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Following a critical analysis of these UF concepts and using a protein test molecule, 
Lipnizki et al., (2002) confirmed the following: 
 Batch UF requires the least membrane area 
 Batch UF consumes the least diafiltration diluent 
 Batch UF consumes the least power 
 The capital investment costs and membrane costs are the least for batch UF.  
The differences between batch and continuous UF of proteins is further highlighted in 
Table 3:1. 
Table 3:1:  Table showing the key differences between batch ultrafiltration process and continuous ultrafiltration 
process.  National Bioproducts Institute utilizes a batch ultrafiltration system.  Although the batch ultrafiltration 
system has a high energy consumption the capital expenditure investment and process control investment are 
low while allowing high volume throughput (Lipnizki et al., 2002).  
 
 BATCH  CONTINOUS 
UF plant investment Low  High 
Batch tank investment High Low 
Process control investment Low High 
Space requirements UF Low High 
Feed volume  High Low 
Protein concentration in permeate Variable  Constant 
Residence time High Low 
Temperature flexibility Low High 
Module efficiency Low High 
Energy consumption High Low 
 
 
NBI completes the UF of HSA according to the three steps described by Wang et al., 
(2014) and detailed above. During this process the batch UF mode is utilized and WFI 
is used as the diafiltration diluent during CVD.     
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3.3.2 ULTRAFILTRATION OPTIMIZATION STRATEGIES 
The benefits of process optimization strategies for UF of proteins relate to reducing 
operational costs whilst producing a high quality product with sufficient yield and 
purity, through sustainable, energy efficient processes (Paulen et al., 2015; Wang et al., 
2014).  A further strategic objective for the optimization of UF of proteins, in 
conjunction with maintaining yields and purity of the macrosolute, lies in the reduction 
of process time to complete UF whilst using the least volume of diluent during the 
diafiltration step of UF (Wang et al., 2014; Fikar et al., 2010).  Greg Foley (2006) 
described a method to minimize diluent usage during the diafiltration step by using the 
VVD method.  In this study of Foley (2006), the macrosolute was concentrated to the 
maximum acceptable concentration, determined by using the gel polarization model 
(Equation 3:1).  Thereafter, the macrosolute was subjected to VVD until the final 
concentration of the macrosolute was achieved.  Although VVD is a unique method of 
completing diafiltration, the overall benefit with respect to diluent minimization is 
sometimes conflicting since some experiments reveal reduction in water usage when 
compared to CVD whilst other experiments reveal results to the contrary of this 
statement.  Further, the economic benefit through the reduction of diluent used is 
dependent on the type of diafiltration diluent used during diafiltration.           
 
Fikar et al., (2010) outlined the key points for the strategic optimization for UF of 
proteins: 
 Membrane performance, determined by evaluation of rejection of macrosolute 
and permeate flux must be evaluated for the protein solution 
 The optimization goals must be defined i.e. minimize diluent usage or minimize 
process time 
 General cost factors must be considered namely energy costs, diluent costs and 
costs related to loss of product during UF 
 Define all process constraints.  
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The key objective functions for the optimization strategy related to the UF of HSA, will 
include the minimization of process time through maximizing permeate flux and 
maximizing productivity by processing the highest kilograms of protein/hour.   
A typical protein concentration, volumetric profile and mass balance for the UF of 
dissolved Fraction V paste containing HSA, as completed by NBI, is indicated below 
(Table 3:2). 
 
Table 3:2:  This table shows typical protein concentration, volumetric profile and mass balance for the current 






Mass of Fraction V paste containing HSA 
(kg) 
195 44 
Start batch volume (L) 800  
ETOH concentration at dissolution (%) 10  
Protein concentration after dissolution of 
Fraction V paste (g/L) 
50-60  
Target protein concentration (g/L) after 1st 
concentration step  
80 43 
Target volume (L) after 1st concentration step  500-600  
Constant volume diafiltration with WFI equal 
to 5 x start bed volume of protein solution 
after 1st concentration step (L) 
 
2500 - 3000 
 
Protein concentration (g/L) at end 
diafiltration  
80 43 
Target protein concentration (g/L) after 2nd 
concentration step  
220  
Target volume (L) after 2nd  concentration 170-210  
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The process above is described in detail in section 2.2.4.2, however, Table 3:2 
highlights several key points for optimization of UF of HSA.  An increase in 
productivity for UF of HSA can be achieved by increasing the mass of Fraction V 
paste dissolved at the start of the process.  An increase in the mass of Fraction V paste 
dissolved, in the current volume of WFI-ETOH (800L) will result in higher than 
normal protein concentrations, at the start of UF.  The negative effect of high protein 
concentration on permeate flux during UF of proteins is well documented. Generally, 
the “quick fix” option would be to increase process equipment size to accommodate 
the increase in batch size such that protein concentration at start of UF is at the current 
level, resulting in increased capital expenditure and larger “equipment footprints” in 
the manufacturing facility, which has a negative impact on space requirements.  It is 
therefore important to determine the range of protein concentration that favours the 
refining of HSA at optimum permeate flux.  Increased batch size results in increased 
volumes of diluent used during diafiltration steps one to five; approximately 2500L to 
3500L of WFI is used in the current process.  The optimization of UF of proteins must 
also investigate the possible reduction of the volume of diluent used during this 
process.  The calculated product recovery (>90%) of the current process is acceptable, 
but greater efficiency is also required in this step.            
 
The NBI carries out the dissolution of Fraction V paste in a WFI-ETOH admixture. 
The impact of EOTH on proteins, membranes and UF is well documented and will be 
discussed in following sections.  Since other fractionation organizations are known to 
dissolve Fraction V paste in WFI only, an objective of this study will be to determine 
the impact of ETOH on the UF of HSA.  In considering the impact of ETOH on UF 
of proteins one must also consider the temperature profile of the depth filtration step 
of purification of HSA since the freezing point of the dissolved HSA in solution will 
change if the ETOH concentration is changed from 10% (v/v) and this implies a 
change in process temperature for the depth filtration step.   
 
The UF of dissolved Fraction V paste uses WFI as a diafiltration diluent to maintain 
constant volume during diafiltration.  Various studies have concluded that an ionic 
salt solution such as NaCl impacts the flux during the UF of albumin (Swaminathan 
et al., 1981; Fane et al., 1983; Lim and Mohammad, 2010).  This study will evaluate 
the effect of an ionic solution namely NaCl on permeate flux during UF of HSA. 
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3.3.3 FLUX DECLINE DURING ULTRAFILTRATION MEMBRANE FOULING 
AND CONCENTRATION POLARIZATION 
An inherent characteristic of UF of proteins is the decline in flux during this process.  
Following extensive investigation of the flux decline during UF of proteins, this 
phenomenon was attributed primarily to two mechanisms namely CP and MF 
(Schausberger et al., 2009; Marshall et al., 1993).   
   
In addition to reducing flux, CP and MF increases feed pressure, decreases product 
quality and reduces membrane life (Shirazi et al., 2010).  Thus these mechanisms have 
a significant impact on process costs, since it increases material costs related to 
cleaning, energy consumption and membranes (larger membrane surface areas are 
required to increase flux).  Therefore it is important to characterize such fouling 
mechanisms and through process optimization and equipment design, reduce their net 
negative impact on the overall process stream. 
 
3.3.3.1 CONCENTRATION POLARIZATION 
Concentration polarization (Figure 3:6) can be broadly defined as the time-dependent 
development of a concentrated layer of solute at the membrane-solution interface, 
which occurs during UF of a solution e.g. solution containing HSA (Marshall et al., 
1993).  CP is a function of the hydrodynamic conditions and feed characteristics of 
the solution being ultrafiltered and is independent of the physical properties of the 
membrane, i.e. membrane pore size and other physical characteristics of the 
membrane are not affected by CP (Sablani et al., 2001; Marshall et al., 1993).  
Concentration polarization is categorized as reversible fouling, since it is not 
characterized by adsorption of solutes to membrane surface or pore channels and can 
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1 – Feed Flow 
2 – Direction of Solute/Retentate Flux 
3 – Direction of Permeate Flux 
4 – Convective Flow 
5 – Back Diffusion 
BL – Boundary Layer 
CP – Concentration Polarization 
. 
Figure 3:6:  Diagrammatic representation of concentration polarization phenomenon.  Also showing the 
formation of the boundary layer, back diffusion of solute particles away from the membrane-solute interface, 
direction of permeate and solute/retentate flux and convective flow of solutes towards the membrane (Sablani 
et al., 2001). 
 
The phenomenon of CP has been characterized according to various models, based on 
the transport mechanisms dominating the UF of protein solutions (Bowen and 
Williams, 1996).  The theoretical aspects of the key models for CP are described in 
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3.3.3.1.1 GEL POLARIZATION MODEL 
The gel polarization model or gel layer model is based on the proposition that during 
UF of proteins and beyond a certain fixed TMP, a gel boundary layer made up of 
retained solute particles, forms in the vicinity of the membrane surface (Sablani et 
al., 2001).  During UF, these solute particles will continue to accumulate in this gel 
boundary layer, and therefore the concentration and the thickness of the gel layer 
boundary layer will increase, until the steady state equilibrium is attained.  This 
steady state equilibrium of solute concentration at the membrane-solute interface is 
known as the limiting or critical concentration of solute particles on the gel boundary 
layer.  It is observed when the rate of back diffusion (due to convective transport of 
the solute, driven by TMP) equals the rate of accumulation of solute particles in the 
gel boundary layer (Shirazi et al., 2010). The hydraulic permeability of the 
membrane is greatly reduced by the formation of the gel boundary layer of certain 
thickness (Shirazi et al., 2010; Sablani et al., 2001).   
 
The permeate flux, J, of a solvent limited by gel boundary layer formation can be 
calculated using the following equation: 
 





J = Permeate flux 
k = Mass transfer co-efficient = D/δ 
Cg = Concentration of the solute in the gel boundary layer 
Cb = Concentration of the solute in the bulk solution 
 
Equation 3:1:  Estimate of permeate flux according to the gel concentration model. 
The gel polarization model has several deficiencies in that the theory of this model 
has not been adequately proven for cross flow filtration due to the assumptions 
related to mass transfer co-efficient determinations.  Further, the concentration of 
the solute particles in the gel boundary layer (Cg) may not necessarily be constant, 
as assumed by this model (Shirazi et al., 2010).  This model is only applicable if a 
linear relationship exists between permeate flux and concentration of the protein in 
the bulk solution (Millipore Application Note, 2013).  
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3.3.3.1.2 RESISTANCE IN SERIES MODEL 
The resistance in series model relates permeate flux during membrane separation 
process to TMP and total hydraulic resistance by using Darcy’s Law.  The total 
hydraulic resistance is the summation of the resistance of the new membrane, 
resistance of the cake or gel layer and the resistance due to adsorption of solute to 
the membrane pores (Corbatón-Báguena et al., 2015).   
The permeate flux, J, of a solvent limited by the resistance in series model can be 




μ (𝑅𝑚 +  𝑅𝑎
`   (1− 𝑒−𝑏𝑡)+ 𝑅𝑔 
    
   
J = Permeate flux 
ΔP = Transmembrane pressure 
µ = Solution viscosity 
𝑅𝑚  = New membrane resistance 
𝑅𝑎
`   = Concentration polarization resistance 
𝑅𝑔   = Cake layer resistance 
𝑏 = Fouling rate 
 
Equation 3:2:  Estimate of permeate flux according to the resistance in series model. 
 
3.3.3.1.3 OSMOTIC PRESSURE MODEL 
This model can only be applied to systems that generate an osmotic pressure 
differential across the membrane due to high concentration of rejected solute 
particles at the membrane interface (Shirazi et al., 2010).  Therefore this model is 
only applicable to systems such as RO filtration and is not applicable to UF or 
microfiltration since the use of porous membranes renders the osmotic pressure 
negligible (Jonsson and Tragardh, 1990).  The osmotic pressure model is based on 
the fact that osmotic pressure greatly increases as solute particles accumulate at the 
membrane interface during CP.  The osmotic pressure model suggests that it is this 
pressure that limits the permeate flux during UF of proteins.  The osmotic pressure 
model can be defined according to the following equation (Shirazi et al., 2010): 
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J = Permeate flux 
ΔP = Transmembrane pressure 
Δπ = Osmotic pressure difference 
µ = Solution viscosity 
RT = Total resistance 
 
Equation 3:3:  Estimate of permeate flux according to the osmotic pressure model. 
 
Several well-known CP models include the film theory model and the Spiegler-
Kedem model.  The film theory model is based on the mass transfer of solutes across 
the membrane where the driving force is the chemical potential of the solute; this 
model is applicable to RO and NF separations (Shirazi et al., 2010).  The Spiegler-
Kedem model is similar to the film theory model but also uses a reflection co-
efficient to estimate permeate flux during CP conditions.   
 
3.3.3.2 MEMBRANE FOULING 
Membrane fouling is an inherent characteristic of UF of proteins and can be described 
as any form of flux decline that is attributable to changes on the surface or on the 
pores of membranes, caused by the deposition of solutes that ultimately results in a 
loss of permeate flux (Marshall et al., 1993; Vincent-Vela et al., 2012; Tijing et al., 
2015).  This definition establishes the distinction between MF and CP: CP is affected 
by hydrodynamic conditions (shear rate, flow velocity and solution viscosity) and 
does not impact the physical properties of the membrane (Choe et al., 1986; Marshall 
et al., 1993), while MF (Figure 3:7) is not only impacted by the hydrodynamic 
conditions of the process but also by the type and concentration of protein being 
ultrafiltered, the type and characteristics (pore size, surface roughness, surface charge 
and hydrophobicity) of the membrane being used, the solution chemistry (e.g. pH and 
ionic strength) and hydrodynamic conditions (Lim and Mohammad, 2010).  
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Figure 3:7:  Key factors, as described by Lim and Mohammad (2010),  that influence membrane fouling including 
hydrodynamic conditions (shear rate, flow velocity); solution chemistry (pH, temperature); membrane properties 
(pore size, surface roughness and charge) and protein characteristics (concentration and solubility). 
 
There are two mechanisms by which MF generally occurs.  In one mechanism, solutes 
adhere to the membrane by physic-chemical interactions, whilst in the second 
mechanism solute becomes entrapped in the membrane pores (Choe et al., 1986).  
These changes to the surface of the membrane due to solute deposition were further 
classified into reversible effects, such as gel and cake layer formations, and 
irreversible effects such as adsorption (Vincent-Vela et al., 2012).  Protein adsorption 
to membrane surfaces is a result of a combination of physical interaction with 
membrane surface, electrostatic and hydrophobic interactions between solute 
components and the membrane and most importantly protein concentration 
(Schausberger et al., 2009; Marshall et al., 1993).       
 
Marshall et al., (1993) evaluated the impact of MF on the UF of proteins with respect 
to permeate flux, protein retention and selectivity.  They also considered the impact 
of process parameters such as feed properties and operating conditions, on the UF of 
protein solutions.  Following extensive investigation of the flux decline during UF of 
protein solutions, Marshall et al., (1993) subdivided the process of flux decline during 
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 Phase one is characterized by a rapid drop in flux, primarily due to 
concentration polarization.  Palecek and Zydney (1994) showed, by using 
electron micrographs, that the rapid drop in flux during this phase is also due 
to the adsorption of protein to the membrane surface thereby causing pore 
blocking or constriction     
 In phase two, this drop in flux continues (although less rapidly than in phase 
1), due to protein deposition on the membrane surface resulting in the 
formation of a protein monolayer.  This protein monolayer is described as a 
dynamic layer, since the thickness and porosity of the layer depends on the 
type of protein being ultrafiltered and the related hydrodynamic conditions    
 Phase three is characterized by a steady state equilibrium, where flux declines 
relatively slowly due to deposition of particles at the protein monolayer.  In 
this phase it is assumed that the protein monolayer or gel layer is completed 
formed and remains consistent provide all hydrodynamic and electro-kinetic 
conditions remain the same.  Palecek and Zydney (1994) documented a similar 
quasi-steady flux phenomenon      
    
The earliest studies related to protein fouling or adsorption was conducted by Fane et 
al., (1983), who described protein adsorption as a solute membrane interaction that 
results in a protein-membrane deposit, and which significantly impacts the rejection 
and flux characteristics of the membrane.  MF and CP occur according to different 
mechanisms however, they are inter-related since both mechanisms are a function of 
protein concentration (Marshall et al., 1993).  Protein adsorption to membranes is a 
complex process and appears to be mainly irreversible.   
 
3.4 INFLUENCE OF OPERATIONAL CONDITIONS ON ULTRAFILTRATION 
3.4.1 pH AND IONIC STRENGTH 
Several studies have confirmed the impact of pH and ionic strength on various 
membrane separation technologies including UF, by elucidating the electrostatic 
interactions between the components of UF, which are the solute (e.g. HSA), solvent 
and membranes. Ultrafiltration performance is dependent on the solution pH and ionic 
strength, since these factors influence the charge, stability and aggregation properties 
of the solute molecules, which in turn directly influence UF performance (Jonsson and 
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Tragardh, 1990).  The pH and ionic strength of the feed solution plays a significant role 
in solute-solute interactions as well as solute-membrane interactions, by influencing the 
electrokinetic interactions between these components, with a direct effect on protein 
transmission and MF (Szymczyk and Rabiller-Baudry, 2012; Lim and Mohammad, 
2010). 
 
3.4.1.1 IMPACT OF pH AND IONIC STRENGTH ON PROTEINS 
Swaminathan et al., (1981) provided initial evidence that flux during UF is a function 
of pH.  This group used various proteins in steady state and time dependent, stirred 
UF experiments, with various types of membranes, to prove the pH dependence of 
flux during UF.  According to Swaminathan et al., (1981), the findings of various 
authors who investigated the pH dependence of flux can be summarized as follows: 
 A decrease in flux during UF of proteins, at all pH values, is evidently due to 
CP and MF that occurs during the process of UF 
 In stirred UF experiments using BSA and other proteins, a decrease in flux as 
described in point above is noted.  However, it is significant that the lowest 
flux has been observed for UF experiments conducted at the isoelectric point 
(IEP) of the protein of interest.  Note that isoelectric point of a protein is 
defined as the pH at which that protein has no net surface charge i.e. surface 
charge equal to 0.  The IEP of HSA is pH 4.7. 
 The results obtained in unstirred UF of proteins is similar to that of stirred UF 
of similar protein solutions, using identical membranes and provide further 
evidence of the impact of pH on flux.  Vilker, Smith and Colton (1975), using 
unstirred BSA UF, showed highest protein membrane surface concentration at 
the isoelectric point, when compared to other pH values 
 Electron micrograph studies showed that the fouling deposits on membranes 
are dependent on pH.   
 
Fane et al., (1983) also conducted investigations into the UF of proteins at various pH 
and ionic concentrations.  They used BSA as a model protein and aimed to determine 
permeate flux during UF across a range of pH and ionic concentrations.  Further, the 
study aimed to measure the extent of protein fouling on the membrane.  Fane et al., 
(1983) noted a distinct minimum flux at the IEP (pH 5.0 – 5.5) of 1% BSA solutions, 
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these results were very similar to those noted by Swaminathan et al., (1981).  Further, 
they noted that in the presence of 0.2M NaCl, this minimum flux at the IEP was absent.  
However, in general, flux during UF of BSA was higher in the absence of salt (0.2M 
NaCl), except at the IEP, where the addition of 0.2M NaCl improved flux by more 
than 20%.  They also noted that adsorption of protein to membranes increased with 
time and was greatest at the IEP.  Also, adsorption of protein increases upon the 
addition of salt solution (0.2M NaCl) to the BSA.  The results obtained were explained 
with respect to conformational change and charge effects of the protein, occurring at 
different pH and ionic environments, which impact the hydraulic permeability of the 
protein gel boundary layer and adsorbed protein.  No quantitative data was presented 
in this study to support the claims of protein conformational changes or charge effects 
on solutes and membranes. 
 
Palecek et al., (1993) provided further evidence that supported the findings of Fane et 
al., (1983).  During the UF of BSA in ionic solutions, permeate flux decreases at pH 
above and below the IEP of the protein.  The charge effects of proteins and the related 
impact on the permeability of the gel boundary layer was explained with reference to 
the relationship between ionic strength, Debye length and the force of repulsion 
between proteins.  An increase in ionic strength results in reduction of the Debye 
length between proteins in solution; the reduction in the Debye length corresponds to 
a decrease in repulsion between proteins and thus proteins become tightly packed.  
The overall effect is the decrease in permeability of the gel boundary layer, resulting 
in loss of hydraulic permeability and therefore decrease in permeate flux.  This paper 
elucidates the critical role of pH and ionic environment on UF of proteins.  NBI carries 
out UF of HSA at pH7.0 – 7.2 and no salt is added during UF of HSA.   
 
Scientists have proven, for numerous proteins e.g. BSA and whey protein, that the 
flux decreases at the IEP of the protein.  Jonsson and Tragardh (1990) also suggested 
that at the IEP, the net charge on the protein is 0 and therefore the lack of electrostatic 
repulsion may result in the formation of tightly packed gel layers or increased 
adsorption onto the membrane.  This decrease in flux at the isoelectric point may be 
in part, due to the decrease in solubility of proteins at the IEP (Swaminathan et al., 
1981).   
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Lim and Mohammad (2010) expanded on the effect of electrostatic forces during UF, 
as suggested by Jonsson and Tragardh (1990), by using gelatin (IEP approximately 
pH 5.3) as a model protein.  Their study revealed the lowest permeate flux at pH values 
close to the IEP of the protein and increasing at pH values away from the IEP of the 
protein.  The gelatin protein, at IEP has no net charge, and therefore repulsion between 
membrane and protein is at lowest – thereby favouring accumulation of protein at the 
membrane-protein interface.  When the pH moves away from the IEP, electrostatic 
forces dominate the membrane-protein interactions resulting in decreased 
accumulation of protein at the membrane protein interface.  In their study, Lim and 
Mohammad (2010) also showed the impact of NaCl of 0.1M concentration on 
permeate flux during the UF of gelatin protein solution.  In this phase of the study a 
4% (w/w) gelatin solution was subjected to UF at constant transmembrane pressure 
(TMP) of 2 bar, at varying pH.  The results indicate that at pH above and below the 
IEP, a slight decrease in permeate flux was noted when compared to solutions at 
identical protein concentrations and pH equivalent to IEP.  Interestingly, at IEP, the 
0.1M NaCl salt solution improved permeate flux when compared to UF of similar 
solutions without 0.1M NaCl       
 
The impact of pH, at fixed ionic concentration, on osmotic pressure was evaluated by 
Vilker et al., (1980). An increase in osmotic pressure reduced the hydraulic flow 
through the semi-permeable resulting in low flux during UF of BSA.  Vilker et al., 
(1980) determined the osmotic pressure of increasing concentrations (84 – 475g/L) of 
BSA solutions at various pH (pH 4.5, 5.4, 7.4).  Osmotic pressure was measured using 
a membrane osmometer cell and ionic concentration was maintained at 0.15M NaCl 
for all experiments.  The results of the experiments indicate that osmotic pressure is 
dependent on solution pH and protein concentration.  Generally, an increase in pH 
coupled with an increase in protein concentration results in increased osmotic 
pressures.  The highest protein concentration evaluated (475g/L) measured an osmotic 
pressure 5 times higher at pH 7.4 than the osmotic pressure measure at the same 
protein concentration but at pH 4.5.     
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3.4.1.2 IMPACT OF pH AND IONIC STRENGTH ON MEMBRANES 
McDonogh et al., (1990) evaluated the effects of CP and MF of serum albumin at the 
membrane channel as a function of various operational parameters including pH.  This 
group used radioactively labelled serum albumin to quantitatively evaluate MF during 
cross flow UF.  The accumulation of protein in the membrane channel, caused by CP 
or MF, was determined as an increase in voltage caused by the radioactively labelled 
protein and measured by a scintillation detector.  The results of investigation showed 
that the membrane surface accumulation of protein was strongest at the IEP of the 
protein and flux was lowest.  The accumulation of protein at the membrane surface 
was greatly reduced at pH lower or higher than IEP.     
 
In a study performed to evaluate the impact of pH on cleaning efficiency of thin film 
composite membranes with respect to ageing, Donose et al., (2013) completed a very 
interesting baseline study on the effect of pH.  Membranes were exposed to solutions 
at pH 4 and pH 1 for durations up to 20 hours.  At pH 10 hydraulic permeability of 
the membrane increased by approximately 10% whilst at pH 4 hydraulic permeability 
of the membrane decreased by 4%.  The rejection efficiency of the membrane 
remained unchanged. 
 
3.4.1.3 INTERACTIONS BETWEEN PROTEINS AND IONS 
The Hofmeister Series (HS) provided one of the earliest explanations for the 
interactions between macromolecules and ions.  In 1888, Lewith and Hofmeister 
provided experimental evidence on the minimum concentration of salts required to 
precipitate proteins and thus the theories of solvation was born (Cacace et al., 1997).  
Through the years several scientists have built on the founding theory of HS.  The HS 
ranks ions according to their effects on physical behaviour of various molecules 
including proteins and colloids (Zhang and Cremer, 2006).  The HS ranks ions into 
two categories namely kosmotropes and chaotropes.  Kosmotropes exhibit strong 
hydration effects, stabilize proteins and cause salting out effects of proteins.  
Chaotropes exhibit strong hydrophobic effects and generally destabilize folded 
proteins and cause salting in effects.   
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The interactions between macromolecules (e.g. proteins) and ions or other molecules 
are defined by several theories.  The Derjaguin, Landau, Vervey and Overbeek 
(DLVO) theory provided one of the earliest explanations for the interactions between 
molecules and there aggregation behaviour.  The DLVO theory identifies molecules 
as point charges and explains the interactions of these molecules through 
determination of the interaction free energy which is characterized by the summative 
effect of attractive London-Van Der Waals’s forces and repulsive electrostatic double 
layer interactions, between these molecules.  The DLVO theory proposes that, as two 
identical molecules (similar surface charge and radius) approach each other, an energy 
barrier exists due to the repulsive force between the molecules and therefore prevents 
interaction between the molecules.  If the interaction energy is high enough to 
overcome this energy barrier then the particles will collide and the London-Van Der 
Waal’s forces will cause the molecules to adhere to one another resulting in 
aggregation of molecules.  Several limitations of the DLVO theory is discussed in 
literature, the two most common are (Zhang and Cremer, 2006; Boström et al., 2001): 
 Inability to account for ion specificity (ions with similar charges have different 
effects in solution), such as that described by the HS, due to assumption that 
molecules act as point charges 
 DLVO theory only works well for solutions with low salt concentrations and 
not at concentrations higher than 0.1M, which is the salt concentration for 
most biological systems.  In solutions with salt concentrations lower than 
0.1M, electrostatic interactions are dominant and the DLVO theory is pertinent 
to explaining the interactions between molecules and ions in this environment.  
However, in solutions with salt concentrations greater than 0.1M, electrostatic 
screening effects dominate the molecular interactions and the DLVO theory 
cannot be used to predict the subsequent interactions.         
    
The stated limitations of the DLVO theory is generally explained through the 
interactions of several non-DLVO forces that act on molecules in solutions e.g. 
hydration force, hydrophobic force.  Ninham and Yaminsky (1997) and Boström et 
al., (2001) catered for specific ion effects in relation to the DLVO theory by 
understanding the impact of ionic dispersion forces in molecular interactions.  These 
authors suggest that at high salt concentrations (>0.1M), the ionic dispersion forces 
are dominant and therefore the main predictor of aggregation behaviour of molecules.  
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However, they also indicate that all forces need to be considered to develop an 
analytical theory that predicts the behaviour of molecules in solutions or colloidal 
suspensions.   
 
3.4.1.4 IMPACT OF pH ON ULTRAFILTRATION OF HSA 
The impact of pH on protein stability and UF performance has been extensively 
studied.  De La Casa et al., (2008) showed that the pore radius of BSA at pH 7 to pH 
9 was greatly increased, when compared to the pore radius of this protein at other pH.  
The large pore radius has a direct impact on protein rejection and protein transmission 
during UF of solutions containing proteins.  The experimental evidence is clear that 
permeate flux is lowest at the IEP of the protein (Swaminathan et al., 1981; Fane et 
al., 1983; Palecek et al., 1993; De La Casa et al., 2008; Lim and Mohammad, 2010).  
The IEP of HSA is 4.7 and is stable at pH 7 (Fanali et al., 2012).     
 
The process step following UF of HSA is the final formulation of product prior to 
sterile filling into containers.  Ideally, the product is required to be at neutral pH prior 
to formulation and sterile filling therefore, there is no benefit in evaluating 
optimization strategies based on variations in pH since it would require a further 
process step to adjust pH prior to formulation and sterile filling.  Based on the 
information above this study will not evaluate the impact of pH on UF of HSA.   
 
3.4.2 PROTEIN FEED CONCENTRATION 
The feed concentration or concentration at which proteins are subjected to UF is critical 
to the efficiency of this unit operation in biotechnology processes.  Protein 
concentration has a significant impact on MF by effecting both protein-protein 
interactions and protein-membrane interactions (Meireles et al., 1991).  High 
concentrations (varies for different types of proteins) of proteins in feed stocks (in 
conjunction with other factors, e.g. stirring speed, solution chemistry) are known to 
result in the denaturation of proteins, which is characterized by aggregation 
(irreversible and reversible) and polymerization (Roberts, 2014; Cromwell et al., 2006; 
Kim et al., 1993; Meireles et al., 1991).  The impact of denatured proteins, which form 
aggregates, on patients using plasma derived products include immunogenic reactions; 
similar to the antibody response exhibited by the human body when reacting to 
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microbial or bacterial pathogens (Rosenberg, 2006).  This is especially important for 
manufacturers of PDMP’s since immune responses to aggregated PDMP’s will reduce 
the therapeutic effect of the drugs.   
 
3.4.2.1 IMPACT OF PROTEIN FEED CONCENTRATION ON PROTEINS 
Various authors have presented scientific evidence to suggest that denaturation of 
proteins plays an equally important role in MF and flux decline during UF, when 
compared to protein adsorption to membrane surfaces.  In 1991, Meireles et al., 
reported the impact of process conditions including feed concentration (and other 
process conditions including temperature, CFV, TMP) on albumin denaturation 
during UF.  Meireles et al., (1991), determined the concentration of protein that 
accumulates at the membrane solute interface (wall concentration) at a given TMP, 
using the osmotic pressure model.  In using this model, they were able to theoretically 
determine wall concentration based on pressure profiles and the limiting permeate 
flux achieved during UF of proteins.  The study revealed, for similar type membrane 
with different MWCO (10kDa, 40kDa and 100kDa), that a limiting flux always 
occurred at a wall concentration of 300g/kg (300g/L), for any set of operational 
parameters.  Further, the wall concentration at which protein deposits were visibly 
noted on the membranes, was experimentally determined to be 400g/kg (400g/L).  The 
film model suggested that the wall concentration is dependent on the concentration of 
the bulk solution; therefore an increase in bulk concentration ultimately results in 
increased concentration of solute at the membrane interface.  The results obtained in 
this study are key points of interest for optimizing protein based UF processes in that 
it sets the boundaries for feed concentration at which UF can take place. 
 
Most recently, Binabaji et al., (2015) evaluated the UF of protein solutions at 
significantly high (225g/L) protein concentrations with the aim of determining the 
hydrodynamic and thermodynamic behaviour of proteins during this process.  In this 
study a monoclonal antibody was used as the model protein and subjected to single 
step UF at constant feed flow rate (45mL/min) and constant TMP (1.03Bar) using a 
30kDa regenerated cellulose membrane with membrane area equivalent to 0.88m2.  
During the UF of monoclonal antibodies, filtrate flux was measured at various 
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concentrations of the protein.  The data collected clearly indicated that permeate flux 
during UF of this protein decreases with an increase in protein concentration provided 
that key UF set points, e.g. feed flow rate, TMP are kept constant (Binabaji et al., 
2015). 
 
3.4.2.2 IMPACT OF PROTEIN FEED CONCENTRATION ON MEMBRANES 
In one of the earliest investigations into the impact of feed concentration on CP and 
MF, Reihanian et al., (1983) evaluated the mechanism of fouling behaviour in UF of 
proteins using BSA as a test protein and several different types of membranes 
(polysulfone membranes of 30kDa; cellulosic membranes of 30kDa; polyion 
membranes of 10kDa).  This study evaluated the impact of feed concentration on 
hydraulic permeability of membranes, in unstirred, dead end filtration systems 
(Reihanian et al., 1983).  The hydraulic permeability of the membrane, after exposure 
to increasing concentrations (0g/L to 10g/L) of BSA solutions was measured and 
analysed against initial hydraulic permeability, which was determined using pure 
water.  This was done to determine the overall impact of feed concentration on 
hydraulic permeability of the membrane.  The results showed that hydraulic 
permeability of the membrane decreased, with exposure to increasing concentrations 
of BSA solutions, thereby reducing permeate flux.  These results also showed that the 
principle cause of MF is adsorption of protein molecules to the membrane surface.   
 
3.4.3 ETHANOL CONCENTRATION 
Organic solvents such as ETOH and acetone are commonly used as precipitating agents 
during the manufacture of pharmaceutical products (Shukla and Cheryan, 2002).  
Plasma fractionation methods that are based on the cold ETOH processes developed by 
Cohn et al., (1946) use ETOH as a precipitating agent, to separate/fractionate various 
plasma proteins of interest, which are subsequently subjected to solid-liquid separation 
methods to extract the precipitated protein, e.g. centrifugation and/or membrane 
solvents are known to impact membrane performance during various membrane 
technologies including MF and UF. 
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3.4.3.1 IMPACT OF ETHANOL CONCENTRATION ON PROTEINS 
In the primary fractionation of fresh frozen plasma, using the methods proposed by 
Kistler and Nitschmann (1962), ETOH is used in varying concentrations (from 19% 
v/v to 40% v/v) to precipitate protein fractions that will contain immunoglobulin 
(Fraction II paste) and albumin (Fraction V paste).  In the purification of HSA (Figure 
2:4), Fraction V paste is dissolved in WFI and ETOH (10% v/v).  The dissolved 
albumin solution is depth filtered and then further refined through the process of UF.  
During UF, the dissolved albumin solution is dialysed using WFI at constant volume, 
to remove salts and lower the ethanol concentration to <1% (v/v).   
Precipitation of plasma proteins with ETOH is conducted at low temperatures 
(between 0°C and 10°C), since organic solvents are known to denature proteins at 
room temperature (Jaffrin et al., 1997; Cohn et al., 1946).  Traditionally, it was 
accepted that the mechanism of precipitation of plasma proteins using ETOH is due 
to a decrease in the dielectric constant of the solution, which increases the electrostatic 
forces of attraction between like protein molecules, thus precipitating these proteins 
out of the solution (Cohn et al., 1946; Van Oss, 1989).  C.J Van Oss (1989) proposed 
an alternate theory for the precipitation of plasma proteins by the admixture of WFI-
ETOH.  He suggested that at low temperatures, the dielectric constant of ETOH is 
close to that of water and therefore has a negligible impact on protein electrostatic 
interactions.  Further, the major mechanism of ETOH precipitation of plasma proteins 
(at low temperatures) is due to the dehydration effect of the ETOH on the protein 
solution (since ETOH binds water more efficiently), which causes increased 
electrostatic attraction between protein molecules, resulting in precipitation of 
proteins.  Pace et al., (2004) evaluated the structural stability and solubility of proteins 
(using RNase SA as a model protein) in water and other solvents by determining the 
conformational stability of a test protein, as described by its free energy of the native 
and denatured states of that protein, in a particular solvent.  They concluded that 
proteins would be extremely unstable and insoluble in polar solvents such as ETOH, 
to the extent that the degree of stability or solubility (or lack thereof) is dependent on 
the concentration of the solvent used. 
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The denaturing properties of ETOH on proteins were shown by Szymanska et al., 
(2012), who evaluated the aggregation of lysozyme in ETOH (96%, v/v) admixtures 
according to the rheological properties (viscosity, shear flow) of ethanol-lysozyme 
solutions (all experiments were conducted at 25°C).  This study showed that the 
viscosity of the ethanol-lysozyme solutions increased (approximately linear), with a 
corresponding increase in ETOH concentration up to 60% (v/v). For ETOH 
concentrations greater than 60% (v/v) the increase in viscosity of the solution was 
more significant and any minor increase in ETOH concentration prompted a large 
increase in viscosity of the solution. The increase in viscosity of lysozyme-ethanol 
solutions was caused by the aggregation of lysozyme protein due to conformational 
change of the protein induced by the increased ETOH concentrations.  It is evident 
that increased concentration of ETOH in protein solutions may result in increased 
viscosity of the solution through denaturation of the protein.  By the application of 
Darcy’s Law, it is anticipated that such an increase in feed solution viscosity will 
result in overall decrease in permeate flux during UF of protein solutions (Szymanska 
et al., 2012).      
 
Jaffrin and Charrier (1994) investigated the optimization of refining processes for 
albumin production. Their research proved that increased concentration of ETOH in 
feed solutions reduced the permeate flux.  In these experiments, albumin solutions of 
30g/L containing no ETOH exhibited higher permeate flux than an albumin solution 
of 15g/L containing 40% (v/v) ETOH.  In comparing the permeate flux of both 
solutions, the researchers noted an approximately 80% reduction in flux, measured 
across a range of CFV (monotonically increasing from 200 – 500L/h) and increasing 
TMP.  All experiments were completed using a 10kDa polysulfone membrane and a 
20kDa cellulose acetate membrane, both with membrane surface area of 0.5m2.  For 
both membrane types, the reduction in flux was explained by an increase in viscosity 
due to increased ETOH concentrations and the formation of a thicker gel layer.  These 
findings reported in 1994 by Jaffrin and Charrier were confirmed by Gupta et al., 
(1995), who investigated the impact of ETOH on UF of albumin solutions using 
mineral membranes.  Gupta et al., (1995) showed that the presence of ETOH in 
albumin feed solutions increased the viscosity of the solution and therefore reduced 
the permeate flux during UF of this protein.  It is noted that an albumin solution of 
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50g/L containing 30% (v/v) ETOH exhibits lower permeate flux at similar TMP than 
an albumin solution of 50g/L containing 20% (v/v) ETOH (Gupta et al., 1995).   
 
Jaffrin et al., (1997) showed that albumin solution of 20g/L containing no ETOH had 
increased permeate flux when compared to albumin solutions of similar concentration 
containing 20% ETOH.  These studies reported in 1997 concurred with the earlier 
research performed by Jaffrin and Charrier (1994) and provided further proof that the 
permeate flux during UF of albumin with ETOH is independent of CFV and does not 
influence the kinetics of concentration polarization.  The decline in flux due to high 
ETOH concentration was explained by the thickening of the gel boundary layer due 
to increase in the viscosity of the protein solution, based on the inverse relationship 
of membrane flux and solution viscosity, as defined by Darcy’s Law.  The viscosity 
(mPa.s) of albumin-ethanol solutions at 20°C and varying concentration of protein, is 
indicated in Table 3:3 to exemplify the impact of ETOH concentration on feed 
solution viscosity.   
 
Table 3:3:  The viscosity (mPa.s) of solutions containing various concentrations of ethanol (0%, 20% and 30%).  
Note that viscosity increases as ethanol concentration increases, irrespective of protein concentration (Jaffrin et 
al., 1997). 
 PROTEIN CONCENTRATION (g/L) 
ETHANOL CONCENTRATION (v/v) 0 (g/L) 10 (g/L) 20 (g/L) 
0 (%) 1.00 1.20 1.25 
20 (%) 2.08 2.40 2.45 
30 (%) 2.40 2.75 2.85 
 
 
3.4.3.2 IMPACT OF ETHANOL CONCENTRATION ON MEMBRANES 
In 1979, Nguyen et al., provided scientific evidence for the impact of organic solvents 
on various types of UF membranes by evaluating the effect on hydraulic permeability 
of the membrane when exposed to organic solvents.  In their study both water miscible 
solvents e.g. ethanol, methanol, butanol and acetone and water immiscible solvents 
e.g. benzene, toluene, heptane, decane and chloroform were used to measure hydraulic 
permeability on various types of membranes, in the absence of solutes.  The hydraulic 
permeability of the membrane, derived from Darcy’s Law, was measured as a function 
of the permeability ratio.  This is a ratio of the permeability coefficient of the organic 
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solvent vs. the intrinsic permeability coefficient of the membrane using pure water, 
and is a measure of the effect of the organic solvent on the structure of the membrane 
(Nguyen et al., 1979).  A permeability ratio of greater than 1 suggests that the 
membrane has increased permeability in the presence of the organic solvent than 
compared to pure water.  A permeability ratio equal to 1 suggests no change in 
membrane permeability when comparing organic solvent with pure water.   The 
results of the research indicate that analytical grade (96%, v/v) water miscible solvents 
(ethanol, methanol, butanol and acetone) increased the permeability and therefore 
altered the structure of polysulfone membranes.  Although no evidence was provided 
for the mechanism that resulted in increased permeability of the membrane, Nguyen 
et al., (1979) suggested that the increase could be attributed to the solvation of the 
polymeric chains of the membrane network.  Note that polysulfone membranes are 
generally the type of membrane used for UF of albumin at NBI.  The permeability 
ratio for the polysulfone membrane was the highest measured for all types and equal 
to 3.6.  This suggests that extremely high concentration (>90%, v/v) of ETOH in the 
feed solution, prior to UF of proteins, may impact the hydraulic permeability of the 
membrane and this may negatively affect membrane performance, since solute 
rejection may be lowered whilst flux during UF of proteins may increase.  The ETOH 
concentration in the HSA solution prior to UF is approximately 10% (v/v) and might 
be too low to have any impact on membrane permeability.  Further, the studies 
conducted by Nguyen et al., (1979) were independent of solutes and therefore does 
not provide any evidence for combined impact of ETOH on membranes and solutes 
with respect to UF.     
 
Lencki and Williams (1995) conducted similar studies to those of Nguyen et al., 
(1979), and further attempted to quantitatively demonstrate the effect of solvents on 
flux behaviours of UF membranes.  Lencki and Williams (1995) examined the effect 
of methanol, ethanol and acetonitrile solutions on the flow resistance (or hydraulic 
permeability) of cellulose and polysulfone membranes (10kDa and 30kDa MWCO).  
The experimental results were plotted in terms of relative resistance as a function of 
solvent concentration.  The effect of solvent on membrane hydraulic permeability 
depended on the physical properties of the membrane as well as nature of 
solvent/membrane interactions.  Also, the results showed that increasing 
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concentrations of ETOH (from 0% to 100%, v/v), increased the flow resistance of a 
10kDa membrane.              
      
3.4.4 TEMPERATURE 
Temperature is a critical process parameter in UF of proteins due to its significant 
impact on membrane performance and protein fouling, since temperature is known to 
impact the physic-chemical properties of both the membrane and the protein of interest 
(Mo et al., 2008).  The solution chemistry and the thermodynamic state of a solution 
impacts the ability of proteins to maintain their stable, native conformations; any 
variation in these factors (solution chemistry and temperature) can lead to denaturation 
of proteins (Franzosa et al., 2010; Farrugia and Pico, 1999).   Temperature is not only 
a critical process parameter for UF of proteins but is also critical for primary plasma 
fractionation processes since the solubility characteristics of plasma proteins are greatly 
influenced by the temperature of the system they encompass (Cohn et al., 1946).    
 
3.4.4.1 IMPACT OF TEMPERATURE ON PROTEINS 
Temperature is the most common physical factor that causes denaturation of proteins 
since slight variations in temperature impact the thermodynamic properties of the 
protein molecules causing them to transition from their native, three dimension 
configurations to several alternate transitional configurations (Grigoryan and 
Shilajyan, 2013; Park et al., 2011).  This alteration of the three dimensional structure 
of proteins at a certain temperature causes the denaturation of these molecules by the 
breaking of hydrogen bonds in the peptide resulting in a decrease in the solubility of 
the proteins.  This decrease in the solubility of the proteins induces the aggregation of 
proteins (Park et al., 2011).    
 
The impact of temperature on proteins, especially albumin, has been well documented 
by several authors.  During the early 1970’s, Knut Wallevik (1972) explored the 
thermal denaturation of HSA under varying pH conditions and guanidine 
hydrochloride – a common protein denaturant.  The polarimetric experiments 
employed by Wallevik (1972) showed that HSA, like most proteins, is highly stable 
at low temperatures, especially below 0°C.  All folding and unfolding of the HSA 
molecules was reversible up to a temperature of 50°C and most significantly, α helices 
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content (which is a measure of conformational stability in the native structure) is 
lowest (26.8%) at high temperature (50°C) and highest (45.8%) at low temperature 
(2°C).  This indicates the thermodynamic preference for native, stable confirmation 
of HSA at constant pH and solution chemistry.  Wetzel et al., (1980) not only showed 
the impact of temperature on α helical content of HSA but also correlated an increase 
in temperature with increase in β sheets which corresponds to denaturation of HSA.  
It was also noted that aggregation of HSA solutions by β sheet development at high 
temperatures where dependent on protein concentration, i.e. as protein concentration 
increased and temperature increased, the denaturing of the HSA protein occurred at 
lower temperatures.  The results obtained by Wetzel et al., (1980) were confirmed by 
Wu et al., (2000) who conducted heat-induced structural studies on HSA using infra-
red spectroscopy and noted that during the thermal transition of HSA the protein 
undergoes distinct structural conversion from α helix (stable form) to β strands to β 
turns as temperature increases within a range of 45°C to 80°C.     
 
Meireles et al., (1991) determined the turbidity and flux of the retentate during UF of 
BSA at various temperatures (5°C, 8°C, 15°C, 22°C, 30°C) using set operating 
conditions of 100kPa, 1m/s feed circulation and 8g/kg protein feed concentration.  In 
this study, turbidity was an indication of protein denaturation, as determined by size 
exclusion HPLC and light scattering experiments.  At temperatures below 8°C, no 
increase in turbidity was noted whilst permeate flux decreased over a certain period 
of time and then remained in a steady-state condition.  At temperatures greater than 
8°C, an increase in turbidity of retentate is noted, as temperature increases.  At 22°C, 
the flux does not achieve a steady state condition but rather continuously decreases 
during a time period of 140 minutes.  These results suggest that an increase in 
temperature may result in denaturation of the protein resulting in MF that significantly 
inhibits permeate flux, during UF. 
 
The denaturation and aggregation of proteins during UF at high temperatures (22°C, 
30°C) noted by Meireles et al., (1991) was explained further by Mo et al., in 2008.  
This group evaluated the impact of various process conditions, including temperature 
on cross flow reverse osmosis system, using BSA as a test protein.  They postulated 
that as the temperature (18°C, 25°C and 35°C) increases, the BSA molecule is 
unfolded to expose the hydrophobic centre core of the protein (contains the functional 
Stellenbosch University  https://scholar.sun.ac.za
Page 83 of 238 
 
groups of the protein) to the solvent.  The solvent molecules attach to the functional 
groups of the protein thereby decreasing the electrostatic repulsion between BSA 
molecules and the interaction between the BSA molecule and the membrane.  This 
results in aggregation and denaturation of the BSA protein, which corresponds to a 
decrease in permeate flux during UF of this protein.  This denaturation of the BSA 
protein noted at higher temperature of 25°C and 35°C shows an increased decline in 
flux during UF of this protein at neutral pH i.e. pH = 7.0 (Mo et al., 2008).       
 
Darcy’s Law states that the fluid flow through a porous membrane is dependent on 
the viscosity of the solution (Jonsson and Tragardh, 1990).  Therefore, temperature is 
extremely influential during UF of proteins, since according to Darcy’s Law we 
anticipate that as the temperature increases, a solution will become less viscous and 
will flow through the membrane with increased flux (Jonsson and Tragardh, 1990).  
The Arrhenius Equation correlates the relationship between viscosity and temperature 
and indicates that as the temperature increases, the viscosity of a solution decreases 
(Monkos, 1996).  In a study conducted by Monkos (1996), he showed that the 
viscosity of solution containing BSA of concentration 335kg/m3 (335g/L), decreased 
with increase in temperature.  These experiments were completed in the temperature 
range 5°C to 45°C since it has been proven that HSA undergoes irreversible 
transformations at temperatures > 45°C.  This irreversible transformation of HSA at 
temperatures greater than 45°C is also confirmed through studies conducted by Yadav 
et al., (2014) and Rezaei-Tavirani et al., (2006).  This phenomenon is especially true 
during the microfiltration/clarification of fruit juices such as kiwi fruit, cherry juice 
and star fruit (Wang et al., 2005).  Similar studies to Monkos (1996) were conducted 
by Masuelli (2013).  In this study, Masuelli (2013) studied the impact of temperature 
(35°C - 40°C), protein concentration (0.2%; 36.71%) on the viscosity (and other 
thermodynamic properties) of BSA.  The intrinsic viscosity of BSA was analysed 
using the Huggins’ method, which is defined as the ratio of viscosity to protein 
concentration, as protein concentration tends to zero.  The results showed that as 
temperature increases, viscosity decreases for BSA solutions at both protein 
concentrations.  The solution with higher protein concentration (36.71%) measured 
higher intrinsic viscosity of approximately 6.8cm3/g when compared to the lower 
protein concentration (0.2%) which had an intrinsic viscosity of approximately 4.9 
cm3/g.  In the microfiltration of West Indian cherry juice, Wang et al., (2005) showed 
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the impact of temperature on permeate flux; at constant TMP and cross flow feed 
rates, the temperature of feed solutions was increased from 10°C to 40°C.  This 
increase in temperature resulted in a decrease in viscosity from 148.9 cP.s at 10°C to 
68.0 cP.s at 40°C which resulted in highest permeate flux (approximately 52.5LMH) 
at 40°C. 
 
The strict application of Darcy’s Law or the Arrhenius Equation may force one to 
operate UF of proteins at high temperatures, however, it is well known that high 
temperatures denature proteins through aggregation since the hydrophobic core of the 
protein becomes exposed to the solvent at high temperatures (Campbell et al., 1993; 
Mo et al., 2008).  It is therefore preferable to complete UF of proteins at low 
temperatures to maintain protein stability and conformation.   
 
The Darcy’s Law does not consider the effect of CP and gel layer formation caused 
by the presence of solutes during UF.  Thus for semipermeable or non-porous 
membranes the impact of temperature on flux can be derived from the osmotic 
pressure model (Jonsson and Tragardh, 1990).  The osmotic pressure model suggests 
that the impact of temperature on flux is less pronounced than that described by the 
Darcy’s equation, and is rather more dependent on concentration of the bulk feed 
solution.  Further, it proposes that flux decreases as temperature increases since the 
increased CVF due to high temperatures inducing a less viscous solution, causes 
increased CP at the membrane surface due to the increase in convection of solute to 
the membrane, which in turn increases the osmotic pressure (Shirazi et al., 2010; 
Jonsson and Tragardh, 1990).   Further, high temperatures are known to cause 
denaturing and aggregation of proteins by initiating an unfolding of the proteins that 
exposes the inner, hydrophobic core of the protein to solvent molecules which 
increases aggregation and adsorption (Mo et al., 2008).     
 
3.4.4.2 IMPACT OF TEMPERATURE ON MEMBRANES 
High temperatures are known to impact the polymeric structure of membranes and 
therefore negatively impact membrane performance (Kallioinen et al., 2007).  The 
impact of temperature on performance is normally detected by the non-linear increase 
in flux with increasing temperature.  The PES membranes used in this study can 
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withstand temperatures up to 50°C and are considered mechanically durable to 
withstand extremes in temperature without compromising membrane performance.   
 
3.4.5 PULSED ULTRAFILTRATION 
Numerous techniques have been evaluated to reduce the impact of CP and MF during 
the process of UF, especially the UF of proteins.  The techniques investigated include 
TMP pulsing (gas or solute), vibrating UF modules and cross flow flushing.  Ma et al., 
(2001) evaluated the effectiveness of various techniques (cross flow flushing, gas and 
water pulsation) in reducing MF.  The results of their study confirmed the observations 
of other studies discussed below in that pulsation increased permeate flux by almost 
two fold and had a more significant impact on permeate flux when compared to other 
methods (Ma et al., 2001).  Transmembrane pressure pulsing is a technique that could 
be used to decrease CP and MF during UF of human serum proteins.  The process 
optimization of refining of human serum proteins will involve an increase in protein 
concentration at the start of the refining process, it is therefore important to evaluate 
mechanisms, such as pulsing, to reduce the impact of MF and CP on permeate flux 
during UF.  
 
In 1991, Rodgers and Sparks reported on a study to evaluate the impact of negative 
TMP pulsing on permeate flux, solute flux, solute retention and membrane selectivity.  
In this study, various types of membranes (polysulfone, polyvinylidene difluoride) were 
used and the impact of negative TMP pulsing on the parameters indicated above, was 
measured at different shear rates and pulse frequencies.  The technique of negative TMP 
pulsing was first described by Rodgers in his DSc thesis of 1989; he concluded that a 
frequent, negative transmembrane force of significant amplitude can be used to reduce 
MF phenomenon such as adsorption and pore plugging whilst improving permeate flux 
rates and separation efficiency.  This negative pressure primarily dislodges the gel layer 
that forms during ultrafiltration as well as any solute particles that adsorb or block the 
pores of the membrane.  Further, this pulsing impacts the solute concentration at the 
membrane interface by aiding solute transport away from the membrane surface back 
into the bulk product.  Most significantly, Rodgers and Sparks (1991) showed that 
pulsing at fixed shear rates of 700sec-1 and 160sec-1 and pulsing frequencies of 0.5Hz, 
2Hz, 5Hz, increased total permeate flux by more than twice that of normal UF with no 
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pulsation.  They attributed this increase in permeate flux to the reduction of CP and MF 
according to the mechanism described above; although they did not quantitatively 
determine the impact of pulsing on CP or MF.  Further, they also noted that increased 
pulse frequency was required at increased feed bulk concentrations i.e. the impact of 
pulsing is reduced at high feed concentrations.  During this study, pulsing also had a 
positive impact on solute flux at all shear rates.  Rodgers and Sparks (1991) 
conclusively proved that negative TMP significantly increased permeate flux during 
UF, when compared to non-pulsed UF.  However, no quantitative data were presented 
with respect to the reduction in CP or MF.  
 
Rodgers and Sparks (1992) attempted to model the effect of TMP pulsing on CP.  They 
attempted to formulate the parameters of this model, by determining if pulsing caused 
an alteration to CP and if so, which operating parameters significantly impacted the CP 
and the mechanism of CP reduction.  In determining the impact of pulsing on CP, it was 
important to understand the dynamic development of CP during UF.  The results of this 
study was in close agreement with that of the previous study in that pulsing during UF 
increased permeate flux, measured at similar conditions to previous work ( 0Hz, 0.5Hz, 
2Hz and 5Hz; shear rate of 700sec-1 and 160sec-1).  The key operational parameter that 
influenced effectiveness of pulsing was frequency of the pulse and a negative TMP 
during pulsing.  Wilharm and Rodgers (1996) conducted studies to determine the 
significance of pulse duration and amplitude on cross flow UF of protein solutions 
containing BSA (1%) and immunoglobulin G (IgG – 0.3%).  The results obtained 
during this study also showed that the frequency of the pulse, rather than pulse duration 
or amplitude, was the key operating parameter with respect to inducing increased 
permeate flux through TMP pulsing.  Rodgers and Sparks (1992) further suggested that 
CP resistance is reduced by transmission of a force during pulsation that causes slight 
membrane motion which disrupts the CP gel layer.  They referred to this model as the 
minimum flux model.   
 
The previous studies noted in this literature review were directed towards determining 
the impact of pulsing on concentration polarization.  Miller et al., (1993) explored the 
impact of pulsing on MF.  Previous studies (Rodgers and Sparks, 1992) indicated that 
pulsing had minimal impact on CP in dead end UF modules.  Therefore Miller et al., 
(1993) observed the impact of pulsing on solvent flux, in dead end batch cell system 
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using binary and single solutes.  The results of their study showed that permeate flux 
measurements increased during pulsing, when compared to non-pulsed UF.  Although 
the overall effect varied when compared to the cross flow UF, the overall effect of 
transmembrane pulsing i.e. increase permeate flux, was synonymous.  They therefore 
concluded that transmembrane pulsing not only reduced the effects of CP but also MF.   
   
3.5 CONCLUSION 
The review of current literature available has revealed that indeed optimization of the UF 
of HSA is possible by analysing the impact of process and operating variables such as 
pH, temperature, back pulsing, ETOH concentration on UF of HSA.  The overall goal of 
optimization strategy is to reduce CP and MF during UF of HSA, at the optimum 
operating parameters. Although a significant amount of literature is available on UF 
optimization strategies relating to proteins and related flux modelling concepts, the 
optimization of UF of HSA has not been significantly examined.  However, it is 
important to note that much UF research has been completed by using BSA as a model 
protein which is very similar to HSA in terms of molecular structure and amino acid 
sequence.   
 
During this study, ionic strength was varied within the range 0M to 3M.  This broad range 
was selected to evaluate the effect of high ionic strength diafiltration diluents on permeate 
flux during UF of HSA, particularly at concentrations beyond the physiological range 
(0.1M).  Literature informs us that ionic strength diluents of low molarity can decrease 
permeate flux during UF of proteins.  However, in UF of HSA screening experiments, a 
minimal increase in flux was noted when ionic diluents were used during UF of HSA.  
Note that a key requirement for parenteral solutions is low Na content, therefore, if ionic 
solutions within the concentration range of 0M to 1M do indeed have an increasing effect 
on permeate flux during UF of HSA, then the study will have to evaluate a strategy to 
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In the process optimization of the UF of HSA, the feed concentration of the protein is 
dependent on the dissolution volume of solvents required for this process.  Equipment 
requirements e.g. feed tank size play a key role in UF process optimization strategies.  It 
is therefore important to determine the maximum feed concentration at which to 
complete UF of proteins since this not only reduces the capital expenditure cost for 
equipment but also reduces the “UF equipment footprint” within the manufacturing 
facility.  Most significantly, permeate flux reduction at high protein concentrations must 
be avoided due to the increased economic costs associated with increased processing 
times, cleaning and replacement of membranes – which is due to CP and MF.  Thus the 
evaluation of the optimum protein feed concentration for the UF of HSA is of vital 
importance to this optimization strategy.  A further benefit of the determination of 
optimal protein feed concentration is to ensure that the trade-off between diafiltration 
diluent and process time is adequately achieved; thereby influencing the productivity of 
the UF of HSA.  During this study, protein feed concentration was varied within the 
range 60g/L to 220g/L.  It was noted in UF of HSA screening experiments (data not 
shown), that membrane retention of HSA was <90% for protein feed concentrations 
>220g/L.  These results established the upper limit for protein concentration.  Literature 
review suggests that as protein feed concentration increases, permeate flux during UF of 
the protein decreases therefore, lower protein feed concentrations are favoured for UF of 
HSA.  The lower limit for protein feed concentration is limited by the Fraction V paste 
dissolved in a fixed volume of WFI-ETOH admixture.  An analysis of current process 
data indicates that the protein concentration for a defined mass of Fraction V paste in a 
fixed volume of WFI-ETOH is approximately 60g/L.  Therefore, the lower limit for 
protein feed concentration was set at 60g/L. 
 
Currently, Fraction V paste containing HSA, is dissolved in an admixture of purified 
water containing ETOH of final concentration 10% (v/v); not only is this a regulatory 
requirement but also has an impact on subsequent process steps namely depth filtration. 
A key point of this study is to evaluate the impact of ETOH concentration on UF of HSA 
performance and protein stability since the literature review has clearly established that 
ETOH has a significant impact on UF membranes, protein structure and UF performance.  
The performance of UF and stability of proteins in ETOH at various concentrations are 
closely linked to temperature.  Therefore, the combined effect of temperature in 
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conjunction with ETOH concentration, on UF performance and protein stability, was also 
evaluated as part of this study.  During this study, ETOH concentration was varied within 
the range 1% (v/v) to 10% (v/v).  The required ETOH concentration during dissolution 
of Fraction V paste will never exceed 10% since this is the ETOH concentration at which 
glycoproteins, present in the dissolved Fraction V paste at low concentrations, will be 
precipitated out of solution.  Further, this concentration of ETOH in the protein feed 
material ensures no freezing of this solution during depth filtration, which is conducted 
at a temperature of -3.5°C ± 0.5°C.  Lastly, increased concentrations of ETOH (>20% 
v/v) are known to increase the permeability of PES membranes.  Provided that scientific 
evidence confirms an improvement in UF performance, resulting from a change in ETOH 
concentration, the regulatory requirements stated above may be challenged.       
 
Temperature is a key factor that influences the UF of proteins since CP and MF are 
modulated by temperature.  Temperature of the protein solution impacts viscosity and 
the back diffusion of proteins away from the gel boundary layer.  Further evidence is 
provided to show that ETOH in conjunction with temperature of the protein feed material 
has an impact on UF performance.  The literature review confirms that stability of 
proteins is increased at low temperatures whilst higher temperatures will lead to 
denaturation (reversible and irreversible) of proteins.  Although the temperature profile 
of HSA indicates irreversible denaturation of this protein at >45°C, the inclusion of 
inorganic solvents such as ETOH will further increase the instability of the protein at 
high temperatures (>25°C).  Lastly, current UF of HSA process temperatures do not 
exceed 20°C ± 2.0°C.  Therefore, considering the stability of the protein of interest and 
the solution matrix, the selected temperature range for UF of HSA used in this study was 
5°C to 25°C.   
 
Note that although pulsed UF was discussed in Section 3.4.5, it was not selected as a 
factor for this study since the UF rig that will be used for the UF of HSA will have to be 
modified to accommodate pulsed UF techniques.  This will require capital expenditure 
to modify the equipment; following a careful cost benefit analysis it was confirmed that 
pulsed UF will not be included in this study, but will considered in all future work.  The 
literature survey confirms the importance of the selected key factors on UF of HSA.  
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4 METHODOLOGY 
4.1 DESIGN OF EXPERIMENTS 
The key benefit of DOE is that it eliminates the OFAT approach and demonstrates any 
interactive effects between factors (varied according to the specific level for each factor) 
with reduced number of test runs.  The CCD statistical methodology was used to design 
the experiments, evaluate the significance of each factor against the output variables and 
determine the optimum conditions for UF of HSA.  Following a careful evaluation of the 
current NBI process, extensive literature review and several screening experiments, it 
was determined that the key factors that influence permeate flux during the UF of HSA 
at NBI are protein concentration (g/L); ionic strength (M); temperature (°C) and ethanol 
concentration (%).  The levels for each factor was selected based on the literature review, 
regulatory guidelines, GMP compliance, screening experiments, equipment limitations 
and current, validated process parameters, the ranges of the level for each factor is 
indicated in Table 4:1.   
 
Table 4:1:  Table indicating the various factors and their corresponding levels. 
INPUT VARIABLE/FACTOR  
MINIMUM STAR 




Protein feed concentration (g/l) 60g/L 150g/L 
 
220g/L 
Ionic strength (M) 0M 1.5M 
 
3M 
Temperature (°C) 5°C 15°C 
 
25°C 





The minimum star point and maximum star point were defined for each factor and by 
using CCD, the experimental design matrix/array (Table 4:2) consisting of twenty six 
experiments including two repetitions at the central point (experiment number 25[c] and 
26[c]) was generated.  The order in which experiments where completed was randomized 
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Table 4:2:  Table showing experimental matrix/array including levels for each factor per experiment.  The levels 











CONCENTRATION (%, v/v) 
1 100.00 0.75 10.00 3.25 
2 100.00 0.75 10.00 7.75 
3 100.00 0.75 20.00 3.25 
4 100.00 0.75 20.00 7.75 
5 100.00 2.25 10.00 3.25 
6 100.00 2.25 10.00 7.75 
7 100.00 2.25 20.00 3.25 
8 100.00 2.25 20.00 7.75 
9 180.00 0.75 10.00 3.25 
10 180.00 0.75 10.00 7.75 
11 180.00 0.75 20.00 3.25 
12 180.00 0.75 20.00 7.75 
13 180.00 2.25 10.00 3.25 
14 180.00 2.25 10.00 7.75 
15 180.00 2.25 20.00 3.25 
16 180.00 2.25 20.00 7.75 
17 60.00 1.50 15.00 5.50 
18 220.00 1.50 15.00 5.50 
19 140.00 0.00 15.00 5.50 
20 140.00 3.00 15.00 5.50 
21 140.00 1.50 5.00 5.50 
22 140.00 1.50 25.00 5.50 
23 140.00 1.50 15.00 1.00 
24 140.00 1.50 15.00 10.00 
25 (C) 140.00 1.50 15.00 5.50 
26 (C) 140.00 1.50 15.00 5.50 
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The key output/variable responses that were measured during this study can be broadly 
defined as membrane performance (Table 4:3).  Membrane performance was determined 
by measuring permeate flux (LMH) during UF of HSA, membrane flux recovery after 
UF (%) of HSA and protein retention (%).  Permeate flux was measured during all the 
steps of UF of HSA, membrane flux recovery was measured before and after each 
experiment and protein retention was analytically determined for diafiltration step five.   
 
Table 4:3:  The output variables that were measured during these experiments were permeate flux (LMH), 
membrane flux recovery after UF (%) and protein retention (%). 
ULTRAFILTRATION PERFORMANCE 
OUTPUT VARIABLE UNITS 
Permeate flux LMH 
Membrane flux recovery after UF % 
Protein retention % 
 
 
The UF of HSA was classified into distinct steps (Figure 4:1) namely first concentration 
step, diafiltration steps one to five and second concentration step.  The permeate mass 
flow rate data for each step was converted to volumetric flow rate, using specific gravity 
of 1, which was experimentally determined by weighing a fixed volume of permeate.  
Permeate weights varied from approximately 1.02g/mL when WFI was used as 
diafiltration diluent to 1.05g/mL when high concentration (3M) ionic strength diluents 
was used as diafiltration diluent.  The permeate flux data for each experiment was 
statistically evaluated using the Fisher’s Test for ANOVA.  The desirability function for 
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Figure 4:1:  Ultrafiltration is classified into distinct steps namely first concentration step, diafiltration steps one 
to five and second concentration step.  The protein concentration (g/L) and volumes are indicated for each step 
of ultrafiltration as per the current NBI process.  Also, typical start and end masses of HSA are shown to provide 
an indication of the product recovery (>85%) for the current manufacturing process.   
 
 
• 55g/L to 80g/L
• Start volume = 800L




• Constant volume diafiltration
• Volume = 585L
DIAFILTRATION STEP 1
• 80g/L
• Constant volume diafiltration
• Volume = 585L
DIAFILTRATION STEP 2
• 80g/L
• Constant volume diafiltration
• Volume = 585L
DIAFILTRATION STEP 3
• 80g/L
• Constant volume diafiltration
• Volume = 585L
DIAFILTRATION STEP 4
• 80g/L
• Constant volume diafiltration
• Volume = 585L
DIAFILTRATION STEP 5
• 80g/L to220g/L
• End volume = 213L
• End Mass HSA - 39-42kg
SECOND CONCENTRATION 
STEP 
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4.2  MATERIALS AND REAGENTS 
4.2.1 MEMBRANE CASSETTE 
The membrane cassette used in this study was the 10kDa, T series Centramate cassette 
supplied by Pall Corp LTD.  This hydrophilic, anisotropic, PES membrane has low 
protein binding characteristics with high protein selectivity and enhanced flux rates 
(when compared to similar type membranes from Pall Corp LTD).  The operating 
temperature range of this membrane is -5°C to 55°C; membrane is compatible with both 
acids and bases within the pH range pH 2 – 14 and the maximum permissible TMP is 4 
bar at 55°C.  The membrane surface area is equivalent to 0.1m2.  Appendix A describes 
the specifications and performance data including the quality certificate for the T series 
Centramate cassette which was used in these studies.      
 
4.2.2 PREPARATION OF FEED MATERIALS 
The Fraction V paste, containing HSA, used in the dissolution process was produced 
by NBI according to the methods described by Kistler and Nitschmann (1962); as 
referred in Chapter two, Figure 2:3.  The dissolution of the Fraction V paste containing 
HSA, was based on the current NBI process described in Chapter two, Figure 2:4.    
Laboratory scale batches of HSA was prepared according to Appendix B; thereafter the 
feed material protein concentration and ETOH concentration was analytically 
determined by the A280nm method and gas chromatography method respectively.  
Aliquots of this feed material was used for each experiment; protein concentration was 
volumetrically adjusted during the first concentration step and ETOH concentration was 
adjusted using analytical grade ETOH (96% - v/v) supplied by Merck Millipore.  
Following the first concentration step, a sample of the feed material was retrieved and 
tested for protein concentration and ETOH concentration, as previously described.       
 
4.2.3 PREPARATION OF REAGENTS 
Sodium chloride (NaCl) solutions were prepared in WFI using analytical grade NaCl 
crystals supplied by Macco Organiques (Czech Republic).  Sodium hydroxide (NaOH) 
cleaning solutions were prepared by dissolving NaOH pellets in WFI.  The analytical 
grade NaOH pellets were supplied by Merck Millipore (Germany).  All reagents were 
freshly prepared for each experiment.   
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4.3 EXPERIMENTAL SET UP 
A typical, laboratory scale TFF unit with cassette holder and accessories was used to 
complete HSA experiments.  Figure 4:2 is a schematic representation of the laboratory 
scale TFF unit used during this study.  This unit was purchased from Pall Corp LTD and 
is designated the PE Centramate Holder.  The holder is fabricated from stainless steel 
whilst associated connectors are fabricated from hard plastic.  The holder and associated 
connectors were assembled according to instructions outlined by the supplier.  The holder 
is equipped with three pressure gauges; one each for the permeate line, retentate line and 
feed line.  All pressure gauges are manufactured locally (Guth SA) and calibrated 
annually.  Transmembrane pressure of 1 ± 0.2 bar was maintained through all 
experiments by adjusting CFV and using a clamp on the retentate line.  The experimental 
setup included a 2L plastic beaker as feed vessel.  The feed solution in the beaker was 
continuously stirred using a bench stop mechanical stirrer with propeller type agitator 
(three blades connected to main shaft).  A four piston diaphragm pump, Quattroflo 
1200S, was used to generate the driving force for the UF of protein solutions.  This 
positive displacement pump is designed to pump plasma proteins such as HSA and the 
pump chamber has no moving parts therefore heating of product or shedding of pump 
particles is negligible.  Pump gaskets are FDA pharmaceutical classified, ethylene 
propylene diene monomer (EPDM) type.  The Quattroflo 1200S has a maximum 
discharge pressure of 8 bar (room temperature) and a maximum CFV of 1200L/H at 0 
bar.  A Watson-Marlow, 4 head, peristaltic dosing pump was used to maintain constant 
volume during diafiltration, by addition of diafiltration diluent.  The temperature 
requirements for each experiment was achieved to within ±2°C of the experimental 
specified temperature by using a Labotec heater chiller unit (Model No FTC300T).  
Temperature during the experiments was determined using a calibrated thermometer.  All 
experiments were completed using a single, 10kDa, T series Centramate membrane 
cassette supplied by Pall Corp LTD with a surface area of 0.1m2.  Therefore, total 
membrane surface area used for the experiments completed in this study was 0.1m2.   
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PIR 1 – Infeed line pressure gauge 
PIR 2 – Retentate line pressure gauge 
PIR 3 – Permeate line pressure gauge 
V – Tube clamp/valve 
 
Figure 4:2:  Diagrammatic representation of a typical ultrafiltration equipment module set-up.  All the 
components illustrated in this diagram where used in the laboratory scale equipment set-up during this study. 
 
4.4 EXPERIMENTAL PROCEDURES 
4.4.1 INSTALLATION AND CONDITIONING OF MEMBRANES 
The installation and pre-use conditioning of the cassettes are clearly defined in the Pall 
Life Sciences User Guide for Membrane Cassette Care and Use Procedures, R00640 
Rev B and the Membrane Cassette Care and Use Procedures for Centramate and 
Centrasette Cassettes – T-Series Omega Membrane, USD 2453 Rev A 1.00 (Pall Corp, 
2015).  Membrane cassettes were removed from packaging and inspected for any 
defects.  The plastic gaskets provided with the cassettes were removed and rinsed 
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thoroughly with WFI.  The membrane was inserted into the cassette holder and 
tightened to a torque setting of 80 inch-lb.  Once installed, membrane cassettes were 
flushed (retentate and permeate lines to waste) with 5L of WFI and a constant permeate 
flux of 8L/min/m2 was maintained during this flushing step.  Upon completion of the 
flushing step, fresh WFI was recirculated through the membranes for a minimum of 30 
minutes at a permeate flux similar to the flushing step and at a maximum of 1 bar TMP.  
The membrane cassettes were then sanitized using 0.5M NaOH.  A bulk solution of 5L, 
0.5M NaOH was made, of which 2L was flushed through the membrane cassette and 
the remaining 3L was recirculated through the membrane cassette for 30 minutes at 
conditions similar to the WFI flushing step.  The normalized water permeability (NWP) 
for the new membrane cassette was determined as described in section below.  
Thereafter, the system was checked again for leaks and the standard integrity test 
completed.  The cassette was stored in 0.2M NaOH buffer, until further use.          
 
4.4.2 NORMALIZED WATER PERMEABILITY  
The NWP test is a key membrane performance indicator and is used to determine 
membrane permeate flux recovery before and after each UF experiment (determination 
of membrane permeate flux recovery is explained in detail in section 4.4.3).  Therefore, 
the NWP test determines the effectiveness of cleaning and sanitization procedures and 
is thus critical in providing information on the physical properties of the membranes.  
NWP was determined as the permeate flux of WFI, flushed through the membrane at 
varying TMP (0.17 Bar, 0.34 Bar, 0.51 Bar, 0.68 Bar) up to 0.68 Bar, were permeate 
flux is calculated according to Equation 4:2.  The permeate flux of the WFI was 
normalized to 20°C (Equation 4:1) using the temperature correction factors developed 
by Pall Corp LTD for this membrane since WFI is not temperature controlled and the 
temperature of the water impacts permeate flux. 
 
𝑁𝑊𝑃20°𝐶(𝐿𝑀𝐻) = 𝐽𝑊  ×   𝑇𝐶𝐹20°𝐶    
 
Jw   – Clean water (WFI) permeate flux (LMH) 
TCF20°C  – Temperature correction factor at 20°C 
 
Equation 4:1:  Calculation of normalized water permeability at 20°C, using temperature correction 
factors provided by Pall Corp LTD. 
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The NWP value for a new membrane is greater than 145LMH at 1 Bar TMP and for a 
used membrane approximately 145LMH at 1 Bar TMP.  During the first use of the 
membrane, the NWP is high and will reduce to a more consistent level as the membrane 
is used continuously.   
 
4.4.3 ULTRAFILTRATION PROCEDURE 
In the UF experiments, TMP was maintained consistently at 1 ± 0.2 bar, with a CFV of 
0.5-1.5m/s (see Appendix D for calculation of CFV).  The CFV and TMP is within the 
range allowed for UF of HSA, according to current GMP, regulatory, process 
requirements and supplier guidelines.  The CFV is the minimum recommended by Pall 
Corp LTD for UF of protein solutions using the T-series, membrane cassette.  The level 
for each factor was maintained as pre-determined for each experiment according to the 
design matrix/array indicated in Table 4:2.  Prior to each experiment, the storage buffer 
was removed from the membrane cassette by flushing with 5L of WFI.  Thereafter, the 
NWP of the membrane was determined as described in Section 4.4.2.  HSA UF 
experiments were completed at fixed temperature and protein concentration levels.  
Permeate flux was determined throughout all the steps of UF by periodically (5 minute 
intervals) weighing the mass of permeate collected in 1 minute.  This mass flow rate of 
permeate collected was then converted to permeate flux (LMH – litres/m2/hour) as 
follows: 
 
𝐽 (𝐿𝑀𝐻) =   
𝑄 
𝐴
    ×    𝑆𝐺 
J – Permeate flux (LMH) 
Q – Flow rate (L/h) 
A – Membrane area (m2) 
SG – Specific gravity 
 
Equation 4:2:  Calculation of permeate flux (LMH) derived from the mass flow rate of permeate (g/min) 
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Following the completion of the UF of HSA experiment the membranes were cleaned 
as follows: 
 Membrane was flushed with 5L of WFI 
 5L of 0.5M NaOH was prepared in a 5L beaker using WFI.  3L of this solution 
was flushed through the membrane.  Thereafter the remaining volume of 
solution was recirculated for a minimum of 30 minutes at a permeate flux of 
8L/min/m2 and at a minimum of 1 bar TMP.  Following the recirculation, the 
remaining volume (approximately 1.8L) of 0.5M NaOH was flushed through 
the membranes.  
 Fresh WFI of 5L volume was flushed through the membrane to remove the 
NaOH.  Thereafter, the pH of the WFI flushed through the membrane was 
checked; if pH was approximately pH 7.0, fresh WFI was recirculated through 
the membranes for a minimum of 30 minutes at a permeate flux of  8L/min/m2 
and at a maximum of 1 bar TMP. 
 NWP was determined using fresh WFI as described in section 4.4.2.   
 
Once the cleaning of the membranes was completed and the NWP (section 4.4.2) 
determined, the membrane flux recovery was determined according to Equation 4:3 
below: 
 
𝑀𝑒𝑚𝑏𝑟𝑎𝑛𝑒 𝑓𝑙𝑢𝑥 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦 (%) =  
𝐿𝑃
𝐿𝑃,0
 × 100% 
  Lp – NWP after cleaning  
  Lp, 0 – Initial NWP  
 
Equation 4:3:  Determination of membrane flux recovery as a function of NWP before and after ultrafiltration 
experiments. 
 
The membrane flux recovery (%) of ≥80% was considered as a suitable flux recovery 
that confirms that the membrane is sufficiently clean and is suitable for the next UF 
experiment.  The membrane was stored in 0.1M NaOH, until next use.   
 
During each experiment, samples of permeate were taken after each step of UF.  These 
permeate samples were tested for protein concentration by measuring the absorbance at 
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A280nm using the Amersham Biosciences Ultrospec 2100 Pro spectrophotometer.  The 
protein concentration in the sample was calculated using Equation 4:4 below: 
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑚𝑔/𝑚𝐿)  =  




A280nm = Measured UV absorbance at 280nm 
L = Length of the curvette (cm) 
ɛ280 = Sedimentation co-efficient of HSA (5.8g/L) 
 
Equation 4:4:  Determination of protein concentration of permeate and feed samples using absorbance 
at 280nm. 
These permeate samples were tested to determine the protein retention efficiency of the 
membrane and to ensure that no protein was lost to the permeate stream.  After 
diafiltration step five, an aliquot of the feed and permeate was tested for protein 
concentration, to determine membrane retention efficiency and loss of protein to the 
permeate stream at the end of constant volume diafiltration.  The calculated protein 
concentrations for feed and permeate was used to determine the protein retention 
efficiency (%) of the membrane according to the following equation:  
 
𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑅𝑒𝑡𝑒𝑛𝑡𝑖𝑜𝑛 (%) = 1 −  
𝐶𝑝
𝐶𝑓
 × 100% 
     
 Cp = Concentration in permeate 
 Cf = Concentration in feed 
 
Equation 4:5:  Determination of protein retention (%) by determining the ratio of the concentration of the 
macromolecule/protein (HSA) in permeate to that in the feed. 
 
A protein retention efficiency of greater than 90% suggests that the membrane is 
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5 RESULTS AND DISCUSSION 
5.1 PERMEATE FLUX DATA 
The average mass flow rate (g/min), calculated at the end of the first concentration step, 
each diafiltration step and the second concentration step is shown in Table 5:1.  The 
average mass flow rate during all steps of UF of HSA is displayed as average (g/min).  
Note that the mass flow rates for all experiments were converted to permeate flux data 
and attached to this study as Appendix C.  Specific gravity of permeate was determined 
to be approximately equal to 1.     
  
Table 5:1:  Average permeate mass flow rate (g/min) per step of ultrafiltration for all experiments conducted in 
this study.  Table shows the experiment/run number, date experiment completed, mass flow rates (g/min) for 
first concentration step (FCS), diafiltration step one (DFS 1), diafiltration step two (DFS 2), diafiltration step three 
(DFS3), diafiltration step four (DFS4), diafiltraton step five (DFS 5), second concentration step (SCS).  The average 






















28-Mar-15 1 45.44 43.51 45.86 45.86 47.04 47.04 38.13 44.70
02-Mar-15 2 32.57 35.48 37.24 38.81 38.81 38.81 35.29 36.71
01-Apr-15 3 46.31 39.40 43.81 44.39 44.49 44.69 37.21 42.90
22-Mar-15 4 38.99 40.57 42.34 43.22 43.51 43.51 36.84 41.28
31-Mar-15 5 40.76 36.46 35.13 35.08 35.08 34.69 26.31 34.79
16-Mar-15 6 32.04 34.10 35.28 36.06 36.26 36.46 34.84 35.01
08-Mar-15 7 48.75 47.04 44.69 44.69 44.69 44.69 36.88 44.49
20-Mar-15 8 34.76 39.00 40.57 39.40 41.75 38.81 36.01 38.61
01-Apr-15 9 17.39 17.39 18.44 18.61 18.85 19.03 18.00 18.25
12-Mar-15 10 18.86 15.26 17.38 17.84 18.11 18.20 16.91 17.51
10-Mar-15 11 36.81 22.97 24.83 25.64 25.97 26.38 24.88 26.78
30-Mar-15 12 33.24 25.03 26.20 25.57 26.16 26.78 26.30 27.04
22-Mar-15 13 25.78 17.46 18.28 18.37 18.43 18.58 19.67 19.51
27-Mar-15 14 21.17 15.80 17.02 17.48 17.77 18.15 17.31 17.82
14-Mar-15 15 30.54 21.87 22.64 22.87 22.96 23.41 21.11 23.63
02-Apr-15 16 21.50 16.23 18.38 18.92 19.15 19.35 18.06 18.80
10-Mar-15 17 43.01 52.92 52.63 52.33 52.33 52.33 41.80 49.62
29-Mar-15 18 18.26 11.65 11.92 12.55 12.67 12.91 0.00 11.42
11-Mar-15 19 30.83 24.70 24.70 24.40 23.96 24.40 20.92 24.84
23-Mar-15 20 30.62 29.60 29.20 29.40 29.40 29.40 24.89 28.93
27-Mar-15 21 28.96 24.93 27.33 27.98 29.30 30.27 26.42 27.88
09-Mar-15 22 37.75 33.71 34.10 34.40 34.69 34.69 31.78 34.45
04-Mar-15 23 36.76 36.16 33.71 32.93 33.32 32.54 26.89 33.19
31-Mar-15 24 31.31 24.92 27.24 28.13 28.84 29.26 27.00 28.10
13-Mar-15 25 (C) 36.24 31.16 31.75 31.75 31.75 31.75 27.70 31.73
09-Mar-15 26 (C) 30.01 29.99 30.97 31.16 31.36 31.56 19.60 29.24
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5.2 MEMBRANE FLUX RECOVERY DATA 
Membrane flux recovery after each UF experiment (Equation 4:3) was derived from the 
NWP, which is a function of permeate flux (Equation 4:2) at a defined TMP.  The 
permeate flux for the NWP was measured using WFI at four different TMP (0.17 Bar, 
0.34 Bar, 0.51 Bar, 0.68 Bar).  This permeate flux was normalized to 20°C (Equation 
4:1) using the temperature correction factor table supplied by Pall Corp LTD since WFI 
is not temperature controlled.  Table 5:2 indicates the NWP, normalized to 20°C at a 
TMP of 0.68 Bar.  The results for the normalized, NWP calculated from permeate flux 
at 0.17 Bar, 0.34 Bar and 0.51 Bar is not shown.  NWP for the virgin membrane was high 
(approximately 225LMH, 20°C, 0.68Bar) and became consistent after several UF of 
HSA pre-experiments (experiments that are not part of the experimental design).  The 
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Table 5:2:  Membrane permeate flux recovery (%) data calculated from the nominal water permeability data 
determined before each ultrafiltration experiment, at a TMP of 0.68Bar. 
 
 
The data in table 5:2 indicates that the membrane flux recovery (%) was ≥80% for all 
experiments except for experiment 12 and 24.  The analysis of this data indicated a drop 
in membrane flux recovery from experiments 18,with experiments 12 and 24 showing 
membrane flux recovery lower than the recommended 140LMH at 1 Bar TMP.  
Following experiment 24, the membrane was cleaned twice according to procedures 
outlined in section 4.4.3.  Therefore, before experiment 5, membrane flux was restored 
to original values after cleaning the membrane twice.  Experiments 18, 12 and 24 were 
completed at protein concentrations of 220g/L, 180g/L and 140g/L respectively.  This 
suggests that increased cleaning of membranes is required for UF of HSA at high protein 
concentrations.  The membrane flux recovery data shows that membrane age did not 
DATE EXPERIMENT NO NWP (20°C) MEMBRANE FLUX RECOVERY (%) NWP (20°C)/Bar
02-Mar-15 2 119.52 175.76
04-Mar-15 23 114.84 96.08 168.88
08-Mar-15 7 135.24 113.15 198.88
09-Mar-15 26 109.06 91.25 160.38
09-Mar-15 22 120.00 100.40 176.47
10-Mar-15 17 117.30 98.14 172.50
10-Mar-15 11 113.27 94.77 166.57
11-Mar-15 19 105.60 88.35 155.29
12-Mar-15 10 122.54 102.53 180.21
13-Mar-15 25 107.01 89.53 157.37
14-Mar-15 15 102.06 85.39 150.09
16-Mar-15 6 114.84 96.08 168.88
20-Mar-15 8 107.10 89.61 157.50
22-Mar-15 13 134.16 112.25 197.29
22-Mar-15 4 127.68 106.83 187.76
23-Mar-15 20 105.84 88.55 155.65
27-Mar-15 21 111.93 93.65 164.60
27-Mar-15 14 94.51 79.07 138.99
28-Mar-15 1 129.36 108.23 190.24
29-Mar-15 18 105.44 88.22 155.06
30-Mar-15 12 83.64 69.98 123.00
31-Mar-15 24 77.26 64.64 113.62
31-Mar-15 5 123.00 102.91 180.88
01-Apr-15 9 132.48 110.84 194.82
01-Apr-15 3 122.76 102.71 180.53
02-Apr-15 16 127.09 106.33 186.90
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negatively impact the performance of the membrane, provided that the membrane 
cleaning strategy is effective, especially at high protein concentrations (>140g/L).     
 
5.3 PROTEIN RETENTION ANALYSIS 
The protein retention analysis was determined from permeate and feed samples taken 
after diafiltration step five since this step represents the end of CVD.  Permeate and feed 
samples were subjected to absorbance at 280nm to determine protein concentration 
according to Equation 4:4.  The protein retention (%) of the membrane was determined 
according to Equation 4:5.  Note that permeate samples for all steps during the UF of 
HSA, for all experiments, were taken and tested for protein concentration (data not 
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Table 5:3:  Protein rejection (%) of the membrane used during ultrafiltration experiments.  The results show that 
HSA was retained by the membrane with an efficiency >90%. 
 
 
The results in Table 5:3 indicate that the HSA protein is retained by the membrane with 
an efficiency >90%, for all experiments completed during this study.  We conclude that 
the membrane is able to retain the protein of interest whilst allowing unwanted salts and 
solvents to pass through the membrane.  More significantly, these results show that the 
membrane used during this study is able to retain HSA across the range of HSA protein 
concentrations tested during this study.   
 
DATE EXPERIMENT NO
A280nm CP (g/L) CF (g/L) PROTEIN RETENTION (%)
02-Mar-15 2 0.040 0.007 84.50 99.99
04-Mar-15 23 0.348 0.060 126.30 99.95
08-Mar-15 7 0.170 0.029 86.50 99.97
09-Mar-15 26 0.164 0.028 122.40 99.98
09-Mar-15 22 0.147 0.025 122.60 99.98
10-Mar-15 17 0.138 0.024 51.00 99.95
10-Mar-15 11 0.274 0.047 159.60 99.97
11-Mar-15 19 0.057 0.010 136.70 99.99
12-Mar-15 10 0.600 0.103 163.70 99.94
13-Mar-15 25 0.052 0.009 120.60 99.99
14-Mar-15 15 0.341 0.059 160.10 99.96
16-Mar-15 6 0.048 0.008 91.90 99.99
20-Mar-15 8 0.030 0.005 87.50 99.99
22-Mar-15 13 0.179 0.031 88.70 99.97
22-Mar-15 4 0.000 0.000 154.00 100.00
23-Mar-15 20 0.087 0.015 122.30 99.99
27-Mar-15 21 3.000 0.517 123.70 99.58
27-Mar-15 14 1.296 0.223 153.30 99.85
28-Mar-15 1 0.048 0.008 92.90 99.99
29-Mar-15 18 1.180 0.203 195.80 99.90
30-Mar-15 12 0.534 0.092 161.60 99.94
31-Mar-15 24 0.797 0.137 120.00 99.89
31-Mar-15 5 0.091 0.016 93.00 99.98
01-Apr-15 9 0.773 0.133 160.30 99.92
01-Apr-15 3 0.091 0.016 103.30 99.98
02-Apr-15 16 0.121 0.021 171.90 99.99
DIAFILTRATION STEP 5
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5.4 STATISTICAL ANALYSIS OF THE FACTORS THAT EFFECT THE STEPS 
OF ULTRAFILTRATION 
The UF of HSA is divided in to seven key steps namely: first concentration step, CVD 
(diafiltration steps one to five) and the second concentration step.  Constant volume 
diafiltration step is further broken down into five, consecutive steps.  The end of each of 
these diafiltration steps are determined as the volume of permeate collected equal to the 
volume of the feed solution at the start of diafiltration i.e. if the volume of the feed 
solution after the first concentration step is 650mL, then each diafiltration will end after 
collection of 650mL of permeate.  Thus the effect of each factor on permeate flux was 
evaluated over the seven steps of the UF of HSA, where the measured outputs from each 
process step represents a unique set of dependent variables.  However, it is important to 
note that although the impact of each factor on permeate flux during UF of HSA will be 
evaluated for each step, the steps are not mutually exclusive and are dependent on each 
other since UF by nature, is a dynamic process where process efficiency of each step is 
dependent on the efficiency of the preceding step.  The magnitude of the effects of each 
factor, that had a significant impact on permeate flux during the steps of UF of HSA is 
also discussed in the sections below.  Note that the magnitude of the effects of each factor 
has been considered for a GMP compliant UF rig with maximum membrane surface area 
of 30m2.  Therefore, the magnitude of the effects of significant factors that influence 
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5.4.1 STATISTICAL ANALYSIS OF THE FIRST CONCENTRATION STEP 
During the first concentration step, the dissolved Fraction V paste is concentrated from 
an initial protein concentration to a pre-determined starting protein concentration at 
which CVD will begin.  The average mass flow rates (g/min) recorded during the first 






Figure 5:1:  Pareto chart of the standardized effects for the first concentration step of ultrafiltration.  No factor 
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Figure 5:2:   Profile for predicted values and desirability for all factors for the first concentration step of 
ultrafiltration. The desirability function is maximized to achieve highest permeate flux for all factors, during the 
ultrafiltration of human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable 
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Table 5:4:  ANOVA table for the first concentration step of ultrafiltration; indicating the p-value, Beta co-efficient, 




The analysis of variance (Table 5:4) of the permeate flux relating to the first 
concentration step for all experiments, revealed that none of the factors (temperature, 
protein concentration, ionic strength and ETOH concentration) had a significant impact 
on permeate flux during this step of the UF of HSA, within the specified level for each 
factor.  Figure 5:1 is a graphical representation (Pareto chart) of the standardized effects 
of the factors on permeate flux during the first concentration step.  This Pareto chart 
shows that all factors have a p-value greater than 0.05 (p > 0.05) and therefore all factors 
have no significant impact on the permeate flux during the first concentration step.  
Further, the t-value (Table 5:4) determined for all factors is approximately 0; this 
indicates little or no variation between the sample means of all the factors with respect 
to permeate flux.  Note also that the interactive effects between factors did not have a 
significant impact on permeate flux during this step.  The validity of the above 
conclusions are supported by the linearity of the normal probability plot vs. raw 
residuals (data not shown).  The profile for predicted values and desirability (Figure 
5:2) show distinct trends; however, these trends are considered not significant when 











Adjusted R2 = 80.71%
Mean/Interc 33.13 3.11 10.64 0.060 33.13 3.11 -6.44 72.69
(1) Protein concentration (L) -13.65 1.80 -7.60 0.083 -6.83 0.90 -18.25 4.60
Protein concentration (Q) -1.04 2.11 -0.50 0.709 -0.52 1.05 -13.91 12.87
(2) Ionic strength (L) -1.23 1.80 -0.68 0.619 -0.61 0.90 -12.04 10.81
Ionic strength (Q) -0.99 2.11 -0.47 0.720 -0.50 1.05 -13.89 12.89
(3) Temperature(L ) 6.20 1.80 3.45 0.180 3.10 0.90 -8.32 14.52
Temperature(Q ) 0.32 2.11 0.15 0.904 0.16 1.05 -13.23 13.55
(4) Ethanol concentration (L) -5.79 1.80 -3.22 0.192 -2.90 0.90 -14.32 8.53
Ethanol concentration (Q) 0.66 2.10 0.31 0.807 0.33 1.05 -13.06 13.72
1L by 2L -0.04 2.20 -0.02 0.989 -0.02 1.10 -14.01 13.97
1L by 3L 2.61 2.20 1.19 0.446 1.31 1.10 -12.68 15.29
1L by 4L 3.39 2.20 1.54 0.366 1.70 1.10 -12.29 15.69
2L by 3L -3.16 2.20 -1.43 0.387 -1.58 1.10 -15.57 12.41
2L by 4L -1.76 2.20 -0.80 0.571 -0.88 1.10 -14.87 13.11
3L by 4L -1.15 2.20 -0.52 0.694 -0.57 1.10 -14.56 13.41
Stellenbosch University  https://scholar.sun.ac.za
Page 110 of 238 
 
The permeate flux during the first concentration step showed a rapid decline, for all 
experiments (data not shown).  This decline in flux is in line with the fouling theory 
suggested by Marshall et al., (1993) who suggested that the initial rapid decline in 
permeate flux at the start of UF of proteins is due to CP.  Several other studies have also 
shown that reversible (gel and cake layer formation) and irreversible (protein 
adsorption) pore blocking mechanisms have contributed to this rapid flux decline at the 
start of UF of proteins (Verma and Sarkar, 2015; Vincent-Vela et al., 2012).  The 
continued decline in flux, during the first concentration step is also attributed to the 
increased adsorption of protein on the membrane surface resulting in the formation of 
a protein monolayer, referred to as cake formation. 
 
The statistical analysis of the first concentration step revealed that none of the factors 
had a significant impact on permeate flux during this step of the UF of HSA, within the 
range of the factor selected for this study.  This step (first concentration step) represents 
a volumetric reduction of the feed solution to achieve an acceptable protein 
concentration at which to complete CVD.  Therefore, no diluent is added to the feed 
solution during this step.  The CP and MF mechanisms responsible for decline in flux 
during this step are primarily driven by the hydrodynamic conditions, protein-
membrane interactions and protein-protein interactions.   
 
5.4.2 STATISTICAL ANALYSIS OF DIAFILTRATION STEP ONE 
Diafiltration step one is the second step of the UF of HSA and the first step of CVD, 
using either WFI or NaCl as a diluent.  The end of diafiltration step one was defined as 
the collection of permeate volume equal to one bed volume of the bulk solution 
(dissolved Fraction V paste) which was determined at the end of the first concentration 
step.  The average mass flow rates (g/min) recorded during diafiltration step one for all 
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Figure 5:3:  Pareto chart of the standardized effects for diafiltration step one of ultrafiltration.  Protein 




Table 5:5:  ANOVA table for diafiltration step one of ultrafiltration; indicating the p-value, Beta co-efficient, t 




Pareto Chart of Standardized Effects; Variable: df1 g/min









































Adjusted R2 = 91.49%
Mean/Interc 30.58 0.59 52.00 0.012 30.58 0.59 23.10 38.05
(1) Protein concentration (L) -20.51 0.34 -60.41 0.011 -10.25 0.17 -12.41 -8.10
Protein concentration (Q) 0.65 0.40 1.64 0.348 0.33 0.20 -2.20 2.86
(2) Ionic strength (L) -0.15 0.34 -0.45 0.730 -0.08 0.17 -2.23 2.08
Ionic strength (Q) -1.91 0.40 -4.81 0.130 -0.96 0.20 -3.49 1.57
(3) Temperature(L ) 4.52 0.34 13.31 0.048 2.26 0.17 0.10 4.42
Temperature(Q ) -0.83 0.40 -2.08 0.285 -0.41 0.20 -2.94 2.12
(4) Ethanol concentration (L) -3.92 0.34 -11.56 0.055 -1.96 0.17 -4.12 0.19
Ethanol concentration (Q) -0.22 0.40 -0.54 0.683 -0.11 0.20 -2.64 2.42
1L by 2L -0.87 0.42 -2.09 0.285 -0.43 0.21 -3.08 2.21
1L by 3L 0.47 0.42 1.12 0.465 0.23 0.21 -2.41 2.87
1L by 4L 1.24 0.42 2.97 0.207 0.62 0.21 -2.02 3.26
2L by 3L 0.50 0.42 1.20 0.442 0.25 0.21 -2.39 2.89
2L by 4L -1.34 0.42 -3.23 0.191 -0.67 0.21 -3.31 1.97
3L by 4L 0.47 0.42 1.13 0.462 0.23 0.21 -2.41 2.88
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The analysis of variance (Table 5:5) of the mass flow rate relating to the diafiltration 
step for all experiments, revealed that protein concentration (t = -60.41, p= 0.0105, 95% 
CI[-12.41, -8.10]) and temperature (t = 13.31, p = 0.0477, 95% CI[0.10, 4.42]) had 
statistically significant impacts on permeate flux during this step of the UF of HSA.  
Ionic strength (t = -0.45, p = 0.7299, 95% CI[-2.23, 2.08]) does not have a statistically 
significant impact on permeate flux.  ETOH concentration (t = -11.56, p = 0.0549, 95% 
CI[-4.12, 0.20]) does not have a statistically significant impact on permeate flux.  
However the substantive effect (Seltman, 2012) of ETOH concentration on permeate 
flux during this step of UF of HSA can be considered significant since the p-value (p = 
0.0549) is close to p-value ≤ 0.05 and this factor has a corresponding reducing effect 
on permeate flux of 4.11g/min to 0.20g/min within a certainty of 95%.  An increase in 
the protein concentration of 1g/L resulted in a decrease in the permeate flux between 
12.41g/min and 8.10g/min.  An increase in the temperature of 1°C resulted in an 
increase in the permeate flux between 0.10g/min and 4.42g/min.  The adjusted R2 value 
(Table 5:5) suggested that at least 91.49% of the variability in permeate flux during 
diafiltration step one was accounted for by taking into consideration the effects of 
protein concentration and temperature.  The validity of the above conclusions are 
supported by the linearity of the normal probability plot vs. raw residuals (data not 
shown).  Note that the interactive effects between factors (Figure 5:3) did not have a 
significant impact on permeate flux during this step.   
 
 
Table 5:6:  Table showing the magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step one. 
Permeate Flux  Protein Concentration (g/L) Temperature (°C)  Ethanol Concentration (%) 
Co-efficient (β = +/-) -10.25 2.26 -1.96 
-95% (g/min) -12.41 0.10 -4.12 
+95% (g/min) -8.10 4.42 0.19 
-95% (ml/min) -12.16 0.10 -4.04 
+95% (ml/min) -7.94 4.33 0.19 
-95% (LMH) -7.30 0.06 -2.42 
+95% (LMH) -4.76 2.60 0.11 
L/\h (30m2) -218.92 1.80 -72.66 
 -142.83 77.89 3.43 
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The magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step one are displayed in table 5:6.  Protein concentration and 
temperature had a statistically significant impact on permeate flux during this step of 
UF of HSA.  Ethanol concentration had a significant substantive effect on permeate 
flux.  Protein concentration had an effect magnitude of -7.30LMH within the 95% 
confidence interval.  This translates to a reduction of permeate flow rate of almost 
220L/H, if 30m2 of membrane area is used for the UF of HSA.  Temperature has an 
effect magnitude of +2.60LMH within the 95% confidence interval, although the effect 
of temperature on permeate flux is smaller when compared to protein concentration.  
Ethanol concentration had a substantively significant impact on permeate flux during 
diafiltration step one; with an effect magnitude of -2.42LMH which is similar to the 
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Figure 5:4:  Profile for predicted values and desirability for all factors for diafiltration step one of ultrafiltration.  
The desirability function is maximized to achieve highest permeate flux for all factors, during the ultrafiltration 
of human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable response.  The 
predicted value for protein concentration that achieves the higher permeate flux during diafiltration step one is 
60g/L.  The predicted value for temperature that achieves the highest permeate flux during diafiltration step one 
is 25°C. 
 
The permeate flux during diafiltration step one showed a consistent rate, for all 
experiments.  This consistent permeate flux is in line with the fouling theory suggested 
by Marshall et al., (1993), which proposed that a quasi-steady state flux is achieved 
following the formation of the gel boundary layer on the membrane surface.  The 
statistical analysis of diafiltration step one revealed that protein concentration and 
temperature had significant impacts (Figure 5:3) on permeate flux during this step of 
UF of HSA.  The profile for predicted values and desirability (Figure 5:4) showed that 
permeate flux clearly decreased as protein concentration increased.  Further, the desired 
value for protein concentration during diafiltration step one is equal to 60g/L.  
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Membrane fouling and CP are dependent on protein concentration at the start of UF of 
HSA, therefore maximum permeate flux during this process is always achieved at the 
lowest protein concentration.  The profile for predicted values and desirability also 
indicated that the permeate flux increased with an increase in temperature during this 
step of UF of HSA, with the optimum temperature for maximum permeate flux 
specified at 25°C, for diafiltration step one.  It is also noted that a temperature of 20°C 
produced a desirability value close to +1.000 and may be considered when determining 
the optimum temperature set point for the optimization strategy for UF of HSA, 
considering the impact of temperature on protein stability.  Ethanol concentration had 
a substantive significance on permeate flux during diafiltration step one, it was noted 
that increased ETOH concentration in the feed solution resulted in lower permeate flux 
during UF of HSA.  The profile for predicted values and desirability declared a desired 
value within the range 0% (v/v) to 5.5% (v/v) for ETOH concentration, during this step 
of the UF of HSA.  The primary goal of UF of proteins is to remove unwanted 
micromolecules (e.g. sodium, potassium and aluminium) and solvents (e.g. ETOH).  
During diafiltration step one the ETOH concentration is at a maximum when compared 
to other steps of UF of HSA, therefore, a significant turning point (5.5%, v/v) towards 
a decrease in flux (and therefore towards a non-desirable value of 0.000) is noted in the 
statistical analysis of the desired values for this factor.  The profile for predicted value 
and desirability for ionic strength was not considered further, since this factor did not 
have a statistically significant impact on flux (p > 0.05).   
 
5.4.3 STATISTICAL ANALYSIS OF DIAFILTRATION STEP TWO 
Diafiltration step two is the third step of the UF of HSA and the second step of CVD; 
immediately following diafiltration step one.  The end of diafiltration step two was 
defined as the collection of permeate volume equal to two times the bed volume of the 
bulk solution (dissolved Fraction V paste) which was determined at the end of the first 
concentration step.  The average mass flow rates (g/min) recorded during diafiltration 
step two for all experiments are presented in Table 5:1.  The statistical trends (Figure 
5:5) between dependent and independent variables in the second diafiltration step are 
similar to those observed for diafiltration step one.   
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Figure 5:5:  Pareto chart of the standardized effects for diafiltration step two of ultrafiltration.  Protein 
concentration and temperature had a statistically significant (p < 0.05) effect on permeate flux during this step 





Table 5:7:  ANOVA table for diafiltration step two of ultrafiltration; indicating the p-value, Beta co-efficient, t 
value and 95% confidence intervals. 
 
Pareto Chart of Standardized Effects; Variable: df2 g/min









































Adjusted R2 = 91.80%
Mean/Interc 31.36 0.39 80.00 0.008 31.36 0.39 26.38 36.34
(1) Protein concentration (L) -20.26 0.23 -89.54 0.007 -10.13 0.11 -11.57 -8.69
Protein concentration (Q) 0.59 0.27 2.22 0.269 0.29 0.13 -1.39 1.98
(2) Ionic strength (L) -1.26 0.23 -5.56 0.113 -0.63 0.11 -2.07 0.81
Ionic strength (Q) -2.07 0.27 -7.80 0.081 -1.04 0.13 -2.72 0.65
(3) Temperature(L ) 4.36 0.23 19.28 0.033 2.18 0.11 0.74 3.62
Temperature(Q ) -0.19 0.27 -0.71 0.608 -0.09 0.13 -1.78 1.59
(4) Ethanol concentration (L) -2.69 0.23 -11.87 0.054 -1.34 0.11 -2.78 0.09
Ethanol concentration (Q) -0.31 0.27 -1.16 0.453 -0.15 0.13 -1.84 1.53
1L by 2L 0.38 0.28 1.37 0.401 0.19 0.14 -1.57 1.95
1L by 3L 0.38 0.28 1.38 0.400 0.19 0.14 -1.57 1.95
1L by 4L 1.10 0.28 3.99 0.157 0.55 0.14 -1.21 2.31
2L by 3L 0.29 0.28 1.05 0.485 0.15 0.14 -1.62 1.91
2L by 4L 0.04 0.28 0.13 0.918 0.02 0.14 -1.74 1.78
3L by 4L 0.29 0.28 1.05 0.484 0.15 0.14 -1.62 1.91
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The analysis of variance (Table 5:7) of the permeate flux relating to the diafiltration 
step two  for all experiments, revealed that protein concentration (t = -89.54, p= 0.0071, 
95% CI[-11.51, -8.69]) and temperature (t = 19.28, p = 0.0330, 95% CI[0.74, 3.61]) had 
statistically significant impacts on permeate flux during this step of the UF of HSA.  
Ethanol concentration (t = -11.87, p = 0.0535, 95% CI[-2.78, 0.10]) and ionic strength 
(t = -5.56, p = 0.1134, 95% CI[-2.07, 0.81]) did not have a statistically significant 
impact on permeate flux during diafiltration step two.  Similar to diafiltration step one, 
the substantive effect of ETOH concentration on permeate flux during this step of UF 
of HSA can be considered significant since the p-value (p = 0.0535) is close to p≤0.05 
and this factor has a corresponding reducing effect on permeate flux of 2.78g/min to 
0.10g/min within a certainty of 95%.  An increase in the protein concentration of 1g/L 
decreased the permeate flux between 11.57g/min to 8.69g/min.  An increase in the 
temperature of 1°C increased the permeate flux between 0.74g/min to 3.62g/min.  The 
adjusted R2 value (Table 5:7) suggested that at least 92.00% of the variability in 
permeate flux during diafiltration step two was accounted for by taking into 
consideration the effects of protein concentration and temperature.  The validity of the 
above conclusions are supported by the linearity of the normal probability plot vs. raw 
residuals (data not shown).  Note that the interactive effects between factors did not 
have significant impacts  (Figure 5:5) on the permeate flux during this step.    
 
Table 5:8:  Table showing the magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step two. 
Permeate Flux  Protein Concentration (g/L) Temperature (°C)  Ethanol Concentration (%) 
Co-efficient (β = +/-) -10.13 2.18 -1.34 
-95% (g/min) -11.57 0.74 -2.78 
+95% (g/min) -8.69 3.62 0.09 
-95% (ml/min) -11.34 0.73 -2.73 
+95% (ml/min) -8.52 3.55 0.09 
-95% (LMH) -6.80 0.44 -1.64 
+95% (LMH) -5.11 2.13 0.06 
L/h (30m2) -204.09 13.13 -49.06 
 -153.37 63.85 1.67 
 
The magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step two are displayed in Table 5:8.  Protein concentration and 
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temperature had a statistically significant impact on permeate flux during this step of 
UF of HSA.  Ethanol concentration had a significant substantive effect on permeate 
flux.  Protein concentration had an effect magnitude of -6.80LMH within the 95% 
confidence interval.  This translates to a reduction of permeate flow rate of almost 
205L/h, if 30m2 of membrane area is used for the UF of HSA.  Temperature has an 
effect magnitude of +2.13LMH within the 95% confidence interval, although the effect 
of temperature on permeate flux is smaller when compared to protein concentration.  
Ethanol concentration had a substantively significant impact on permeate flux during 
diafiltration step two; with an effect magnitude of -1.64LMH which is similar to the 
effect of temperature on permeate flux during this diafiltration step.   
 
 
Figure 5:6:  Profile for predicted values and desirability for all factors for diafiltration step two of ultrafiltration.  
The desirability function is maximized to achieve highest permeate flux for all factors, during the ultrafiltration 
of human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable response.  The 
predicted value for protein concentration that achieves the higher permeate flux during diafiltration step two is 
60g/L.  The predicted value for temperature that achieves the highest permeate flux during diafiltration step two 
is 25°C. 
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The formation of a gel boundary layer, coupled with CP causes permeate flux decline 
during UF of protein solutions until a relatively constant permeate flux (quasi-steady 
state permeate flux) is achieved, during steady state conditions (Marshall et al., 1993).  
This phenomenon relating to permeate flux decline was observed in diafiltration step 
two for all experiments.  The profile for predicted values and desirability (Figure 5:6) 
for diafiltration step two showed that permeate flux clearly decreased as protein 
concentration increased, with desired value for protein concentration during 
diafiltration step two equal to 60g/L.  This value is similar to that obtained for 
diafiltration step one; the desired value for maximum permeate flux is dependent on CP 
and MF which in turn is dependent on the protein concentration at the start of UF of 
HSA, therefore maximum permeate flux during this process is always achieved at the 
lowest protein concentration.  Permeate flux increased with increase in temperature 
during this step of UF of HSA, with the optimum temperature for maximum flux 
specified at 25°C.  Similar to diafiltration step one, a temperature of 20°C produced a 
desirability value close to 1.000 and will also be considered when determining the 
optimum temperature set point for this study, for reasons stated previously.  The 
predicted values for diafiltration step two with respect to protein concentration and 
temperature were identical to those determined for diafiltration step one.  Ethanol 
concentration had a substantive significance on permeate flux during diafiltration step 
two, with decrease in permeate flux with increase in ETOH concentration noted within 
the selected range of this factor.  The profile for predicted values and desirability for 
diafiltration step two declared a desired value for ETOH concentration within the range 
0% (v/v) to 7.5% (v/v).  Ethanol concentration shows a turning point towards lower 
permeate flux at 7.5% (v/v).  The profile for predicted value and desirability for ionic 
strength was not be analysed since the impact of this factor on flux was considered 
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5.4.4 STATISTICAL ANALYSIS OF DIAFILTRATION STEP THREE 
Diafiltration step three is the fourth step of the UF of HSA and the third step of CVD; 
immediately following diafiltration step two.  The end of diafiltration step three was 
defined as the collection of permeate volume equal to three times the bed volume of the 
bulk solution (dissolved Fraction V paste) which was determined at the end of the first 
concentration step.  The average mass flow rates (g/min) recorded during diafiltration 





Figure 5:7:  Pareto chart of the standardized effects for diafiltration step three  of ultrafiltration.  Protein 
concentration, temperature and ethanol concentration had a statistically significant (p < 0.05) effect on 









Pareto Chart of Standardized Effects; Variable: df3 g/min
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Table 5:9:  ANOVA table for diafiltration step three  of ultrafiltration; indicating the p-value, Beta co-efficient, t 




The analysis of variance (Table 5:9) of the permeate flux relating to the diafiltration 
step three for all experiments, revealed that protein concentration (t = -118.70, p= 
0.0054, 95% CI[-11.15, -9.00]), temperature (t = 19.28, p = 0.0262, 95% CI[0.98, 3.14]) 
and ETOH concentration (t = -13.66, p = 0.0465, 95% CI[-2.24, -0.08])  had statistically 
significant impacts on permeate flux during this step of the UF of HSA.  Ionic strength 
(t = -8.38, p = 0.0756, 95% CI[-1.79, 0.37]) does not have a statistically significant 
impact on permeate flux during diafiltration step three.  An increase in the protein 
concentration of 1g/L results in a decrease of the permeate flux between 11.15g/min to 
9.00g/min.  An increase in the temperature of 1°C results in an increase of the permeate 
flux between 0.98g/min to 3.14g/min.  An increase in the ETOH concentration of 1% 
results in a decrease of the permeate flux between 2.24g/min to 0.08g/min.  The adjusted 
R2 value (Table 5:9) suggested that at least 92.00% of the variability in permeate flux 
during diafiltration step three is accounted for by taking into consideration the effects 
of protein concentration, temperature and ETOH concentration.  The validity of the 
above conclusions are supported by the linearity of the normal probability plot vs. raw 
residuals (data not shown).  Note that the interactive effects (Figure 5:7) between factors 











Adjusted R2 = 91.90%
Mean/Interc 31.46 0.29 107.00 0.006 31.46 0.29 27.72 35.19
(1) Protein concentration (L) -20.15 0.17 -118.70 0.005 -10.07 0.08 -11.15 -9.00
Protein concentration (Q) 0.67 0.20 3.36 0.184 0.33 0.10 -0.93 1.60
(2) Ionic strength (L) -1.42 0.17 -8.38 0.076 -0.71 0.08 -1.79 0.37
Ionic strength (Q) -2.10 0.20 -10.55 0.060 -1.05 0.10 -2.31 0.21
(3) Temperature(L ) 4.12 0.17 24.26 0.026 2.06 0.08 0.98 3.14
Temperature(Q ) 0.04 0.20 0.22 0.861 0.02 0.10 -1.24 1.29
(4) Ethanol concentration (L) -2.32 0.17 -13.66 0.047 -1.16 0.08 -2.24 -0.08
Ethanol concentration (Q) -0.29 0.20 -1.44 0.387 -0.14 0.10 -1.41 1.12
1L by 2L 0.88 0.21 4.23 0.148 0.44 0.10 -0.88 1.76
1L by 3L 0.60 0.21 2.90 0.211 0.30 0.10 -1.02 1.62
1L by 4L 0.86 0.21 4.13 0.151 0.43 0.10 -0.89 1.75
2L by 3L 0.15 0.21 0.71 0.607 0.07 0.10 -1.25 1.39
2L by 4L -0.01 0.21 -0.04 0.978 0.00 0.10 -1.32 1.32
3L by 4L -0.35 0.21 -1.66 0.345 -0.17 0.10 -1.49 1.15
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Table 5:10:  Table showing the magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step three. 
Permeate Flux  Protein Concentration (g/L) Temperature (°C)  Ethanol Concentration (%) 
Co-efficient (β = +/-) -10.07 2.06 -1.16 
-95% (g/min) -11.15 0.98 -2.24 
+95% (g/min) -9.00 3.14 -0.08 
-95% (ml/min) -10.93 0.96 -2.19 
+95% (ml/min) -8.82 3.07 -0.08 
-95% (LMH) -6.56 0.58 -1.32 
+95% (LMH) -5.29 1.84 -0.05 
L/h (30m2) -196.73 17.30 -39.47 
 -158.69 55.35 -1.43 
 
The magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step three are displayed in Table 5:10.  Protein concentration, 
temperature and ETOH concentration had a statistically significant impact on permeate 
flux during this step of UF of HSA.  Protein concentration had an effect magnitude of -
6.56LMH within the 95% confidence interval.  This translates to a reduction of 
permeate flow rate of almost 197L/H, if 30m2 of membrane area is used for the UF of 
HSA.  Temperature has an effect magnitude of +1.84LMH within the 95% confidence 
interval, although the effect of temperature on permeate flux is smaller when compared 
to protein concentration.  Ethanol concentration had an effect magnitude of -1.32LMH 
which is similar to the effect of temperature on permeate flux during this diafiltration 
step.   
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Figure 5:8:  Profile for predicted values and desirability for all factors for diafiltration step three of ultrafiltration.  
The desirability function is maximized to achieve highest permeate flux for all factors, during the ultrafiltration 
of human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable response.  The 
predicted value for protein concentration that achieves the higher permeate flux during diafiltration step three 
is 60g/L; for temperature the highest flux is achieved at 25°C and for ethanol concentration the highest flux is 
achieved within the range 1% to 7.75%.   
 
The quasi-steady state permeate flux noted in diafiltration step two, continues in 
diafiltration step three, for all experiments (Marshall et al.,1993).  The statistical 
analysis of diafiltration step three revealed that protein concentration, ETOH 
concentration and temperature had significant impacts (Figure 5:7) on permeate flux 
during this step of UF of HSA.  The profile for predicted values and desirability (Figure 
5:8) showed that permeate flux clearly decreases as protein concentration increases; 
with desired value for protein concentration during diafiltration step three equal to 
60g/L.  This value is similar to diafiltration steps one and two; similar conclusions can 
be derived based on the CP and MF effects due to protein concentration.  Permeate flux 
increases with increase in temperature during this step of UF of HSA; with the optimum 
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temperature for maximum flux specified at 25°C.  Similar to diafiltration steps one and 
two, a temperature of 20°C produced a desirability value close to 1.000 and will also 
be considered when determining the optimum temperature set point for this study, for 
reasons stated previously.  Figure 5:8 clearly indicated that optimum ETOH 
concentration lies within the range 0% (v/v) to 7.5% (v/v); with a distinct turning point 
towards lower permeate flux at 7.75% (v/v) ETOH concentration, which is similar to 
diafiltration step two.  The profile for predicted value and desirability for ionic strength 
will not be analysed since the impact of this factor on flux was considered insignificant 
(p > 0.05).   
 
5.4.5 STATISTICAL ANALYSIS OF DIAFILTRATION STEP FOUR 
Diafiltration step four is the fifth step of the UF of HSA and the fourth cycle of CVD; 
immediately following diafiltration step three. The end of diafiltration step four was 
defined as the collection of permeate volume equal to four times the bed volume of the 
bulk solution (dissolved Fraction V paste) which was determined at the end of the first 
concentration step.  The average mass flow rates (g/min) recorded during diafiltration 
step four for all experiments are presented in Table 5:1.     
 
 
Figure 5:9:  Pareto chart of the standardized effects for diafiltration step four of ultrafiltration.  Protein 
concentration, temperature, ethanol concentration and ionic strength had a statistically significant (p < 0.05) 
effect on permeate flux during this step of ultrafiltration. 
Pareto Chart of Standardized Effects; Variable: df4 g/min
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Table 5:11:  ANOVA table for diafiltration step four of ultrafiltration; indicating the p-value, Beta co-efficient, t 




The analysis of variance (Table 5:11) of the permeate flux relating to the diafiltration 
step four for all experiments, revealed that protein concentration (t = -179.36, p= 
0.0035, 95% CI[-10.87, -9.43]), temperature (t = 36.17, p = 0.0175, 95% CI[1.33, 2.77]) 
and ETOH concentration (t = -18.37, p = 0.0346, 95% CI[-1.76, -0.32])  had statistically 
significant impacts on permeate flux during this step of the UF of HSA.  Ionic strength 
(t = -11.76, p = 0.0540, 95% CI[-1.38, 0.05]) does not have a statistically significant 
impact on permeate flux during diafiltration step four .  However the substantive effect 
of ionic strength on permeate flux during this step of UF of HSA can be considered 
significant since the p-value (p = 0.0540) is close to p-value ≤ 0.05 and this factor has 
a corresponding reducing effect on permeate flux of 1.38g/min to 0.05g/min within a 
certainty of 95%.  An increase in the protein concentration of 1g/L resulted in a decrease 
of the permeate flux between 10.87g/min to 9.43g/min.  An increase in the temperature 
of 1°C resulted in an increase of the permeate flux between 1.33g/min to 2.77g/min.  
An increase in the ETOH concentration of 1% resulted in a decrease of the permeate 
flux between 1.76g/min to 0.05g/min.  The adjusted R2 value (Table 5:11) suggested 
that at least 90.43% of the variability in permeate flux during diafiltration step four is 
accounted for by taking into consideration the effects of protein concentration, 
temperature and ETOH concentration.  The validity of the above conclusions are 
FACTOR EFFECT
STD. ERR. 







Adjusted R2 = 90.43%
Mean/Interc 31.56 0.20 161.00 0.004 31.56 0.20 29.07 34.05
(1) Protein concentration (L) -20.30 0.11 -179.36 0.004 -10.15 0.57 -10.87 -9.43
Protein concentration (Q) 0.68 0.13 5.13 0.123 0.36 0.07 -0.50 1.18
(2) Ionic strength (L) -1.33 0.11 -11.76 0.054 -0.67 0.06 -1.38 0.05
Ionic strength (Q) -2.23 0.13 -16.80 0.038 -1.11 0.07 -1.96 -0.27
(3) Temperature(L ) 4.09 0.11 36.17 0.018 2.05 0.06 1.33 2.77
Temperature(Q ) 0.43 0.13 3.23 0.191 0.21 0.07 -0.63 1.06
(4) Ethanol concentration (L) -2.08 0.11 -18.37 0.035 -1.04 0.06 -1.76 -0.32
Ethanol concentration (Q) -0.03 0.13 -0.22 0.864 -0.01 0.07 -0.86 0.83
1L by 2L 0.66 0.13 4.78 0.131 0.33 0.07 -0.55 1.21
1L by 3L 0.48 0.13 3.45 0.179 0.24 0.07 -0.64 1.12
1L by 4L 0.75 0.13 5.38 0.117 0.37 0.07 -0.51 1.25
2L by 3L 0.46 0.13 3.32 0.186 0.23 0.07 -0.65 1.11
2L by 4L 0.44 0.13 3.17 0.194 0.22 0.07 -0.66 1.10
3L by 4L 0.11 0.13 0.82 0.562 0.06 0.07 -0.82 0.94
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supported by the linearity of the normal probability plot vs. raw residuals (data not 
shown).  Note that the interactive effects (Figure 5:9) between factors does not have a 
significant impact on permeate flux during this step. 
 
Table 5:12:  Table showing the magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step four. 
Permeate Flux  Protein Concentration (g/L) Temperature (°C)  Ethanol Concentration (%) 
Co-efficient (β = +/-) -10.15 2.05 -1.04 
-95% (g/min) -10.87 1.33 -1.76 
+95% (g/min) -9.43 2.77 -0.32 
-95% (ml/min) -10.65 1.30 -1.72 
+95% (ml/min) -9.24 2.71 -0.31 
-95% (LMH) -6.39 0.78 -1.03 
+95% (LMH) -5.54 1.63 -0.19 
L/h (30m2) -191.70 23.42 -31.01 
 -166.34 48.78 -5.65 
 
The magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step four are displayed in Table 5:12.  Protein concentration, 
temperature and ETOH concentration had a statistically significant impact (Figure 5:9) 
on permeate flux during this step of UF of HSA.  Protein concentration had an effect 
magnitude of -6.39LMH within the 95% confidence interval.  This translates to a 
reduction of permeate flow rate of almost 191L/H, if 30m2 of membrane area is used 
for the UF of HSA.  Temperature has an effect magnitude of +1.63LMH within the 95% 
confidence interval, although the effect of temperature on permeate flux is smaller when 
compared to protein concentration.  Ethanol concentration had an effect magnitude of -
1.03LMH which is similar to the effect of temperature on permeate flux during this 
diafiltration step.   
  
The CP and MF phenomenon during UF of HSA continues to effect permeate flux 
during diafiltration step four such that the flux was noted to be steady, with minimal 
increase in flux noted.  This was noted for diafiltration step four, for all experiments 
completed during this study.  The statistical analysis of diafiltration step four revealed 
that protein concentration, ETOH concentration and temperature had significant 
impacts on permeate flux during this step of UF of HSA.    
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Figure 5:10:  Profile for predicted values and desirability for all factors for diafiltration step four of ultrafiltration.  
The desirability function is maximized to achieve highest permeate flux for all factors, during the ultrafiltration 
of human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable response.  The 
predicted value for protein concentration that achieves the higher permeate flux during diafiltration step four  is 
60g/L; for temperature the highest flux is achieved at 25°C and for ethanol concentration the highest flux is 
achieved within the range 1% to 10.0%.  A turning point between permeate flux increase/decrease occurs at 
1.5M ionic strength. 
 
The profile for predicted values and desirability (Figure 5:10) for diafiltration step four 
showed that permeate flux clearly decreases as protein concentration increases; with 
desired value for protein concentration during diafiltration step four equal to 60g/L.  
Permeate flux increased with increase in temperature during this step of UF of HSA; 
with the optimum temperature for maximum flux specified at 25°C.  Similar to 
diafiltration steps one, two and three, another predicted value for temperature is 20°C 
and this could be used as an alternate temperature level for this factor, for reasons stated 
previously.  The profile for predicted values and desirability (Figure 5:10) clearly 
indicated that optimum ETOH concentration lies within the range 0% (v/v) to 10.0% 





























Stellenbosch University  https://scholar.sun.ac.za
Page 128 of 238 
 
(v/v); with no distinct turning point towards lower permeate flux within this range.  
Since ionic strength had a minimal, substantive effect on permeate flux during this step 
of UF of HSA, the ionic strength predicted value lies within a range of 0.75M and 
2.25M, with definite turning points showing a decrease of flux at values lower or higher 
than this stipulated range.     
 
5.4.6 STATISTICAL ANALYSIS OF DIAFILTRATION STEP FIVE 
Diafiltration step five is the fifth step of the UF of HSA and the fourth cycle of CVD.  
Diafiltration step five follows immediately after diafiltration step four.  The end of 
diafiltration step five was defined as the collection of permeate volume equal to five 
times the bed volume of the bulk solution (dissolved Fraction V paste) which was 
determined at the end of the first concentration step.  The mass flow rates (g/min) during 
diafiltration step five for all experiments are presented in Table 5:1.    
  
 
Figure 5:11:  Pareto chart of the standardized effects for diafiltration step five of ultrafiltration.  All factors had 
a statistically significant (p < 0.05) effect on permeate flux during this step of ultrafiltration.  Further, protein 







Pareto Chart of Standardized Effects; Variable: df5 g/min
































Stellenbosch University  https://scholar.sun.ac.za
Page 129 of 238 
 
 
Table 5:13:  ANOVA table for diafiltration step five of ultrafiltration; indicating the p-value, Beta co-efficient, t 
value and 95% confidence intervals. 
 
 
The analysis of variance (Table 5:13) of the permeate flux relating to the diafiltration 
step five for all experiments, reveals that protein concentration (t = -350.05, p= 0.0018, 
95% CI[-10.26, -9.54]), temperature (t = 67.02, p = 0.0094, 95% CI[1.54, 2.26]), ETOH 
concentration (t = -36.80, p = 0.0172, 95% CI[-1.40, -0.68]) and ionic strength 
concentration (t = -29.90, p = 0.0213, 95% CI[-1.21, -0.49]) have a statistically 
significant impact on permeate flux during this step of the UF of HSA.  Several 
interactive effects are noted but these will be discussed later.  An increase in the protein 
concentration of 1g/L resulted in a decrease of the permeate flux between -10.26g/min 
(-5.61LMH) to -9.54g/min (-6.03LMH).  An increase in the temperature of 1°C resulted 
in an increase of the permeate flux between 1.54g/min (0.90LMH) to 2.26g/min 
(1.333LMH).  An increase in the ETOH concentration of 1% resulted in a decrease of 
the permeate flux between -1.40g/min (-0.82LMH) to -0.68g/min (-0.40LMH).  An 
increase in the ionic strength by 1M resulted in a decrease of the permeate flux between 
-1.21g/min (-0.71LMH) to -0.49g/min (-0.29MH).  The adjusted R2 value (Table 5:13) 
suggests that at least 90.43% of the variability in permeate flux during diafiltration step 
five is accounted for by taking into consideration the effects of protein concentration, 
temperature, ionic strength and ETOH concentration.  The validity of the above 
conclusions are supported by the linearity of the normal probability plot vs. raw 
FACTOR EFFECT
STD. ERR. 







Adjusted R2 = 89.56%
Mean/Interc 34.65 0.10 323.00 0.002 31.65 0.10 30.41 32.90
(1) Protein concentration (L) -19.81 0.06 -350.05 0.002 -9.90 0.03 -10.26 -9.54
Protein concentration (Q) 0.63 0.07 9.46 0.067 0.31 0.03 -0.11 0.74
(2) Ionic strength (L) -1.69 0.06 -29.90 0.021 -0.85 0.03 -1.21 -0.49
Ionic strength (Q) -2.23 0.07 -33.63 0.019 -1.12 0.03 -1.54 -0.69
(3) Temperature(L ) 3.79 0.06 67.02 0.009 1.90 0.03 1.54 2.26
Temperature(Q ) 0.56 0.07 8.42 0.075 0.28 0.03 -0.14 0.70
(4) Ethanol concentration (L) -2.08 0.06 -36.79 0.017 -1.04 0.03 -1.40 -0.68
Ethanol concentration (Q) -0.23 0.07 -3.50 0.177 -0.12 0.03 -0.54 0.31
1L by 2L 1.06 0.07 15.35 0.041 0.53 0.03 0.09 0.97
1L by 3L 0.91 0.07 13.10 0.049 0.45 0.03 0.01 0.89
1L by 4L 1.08 0.07 15.54 0.041 0.54 0.03 0.10 0.98
2L by 3L 0.01 0.07 0.15 0.904 0.01 0.03 -0.44 0.45
2L by 4L 0.15 0.07 2.21 0.271 0.08 0.03 -0.36 0.52
3L by 4L -0.37 0.07 -5.37 0.117 -0.19 0.03 -0.63 0.25
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residuals (data not shown).  During diafiltration step five several interactive effects are 
considered significant (Figure 5:11).  These significant interactive effects are between 
protein concentration and ionic strength (t = -15.35, p = 0.0414, 95% CI[0.0915, -
0.9720]); protein concentration and ETOH concentration (t = 13.096, p = 0.0485, 95% 
CI[0.0135, 0.8940]) and protein concentration and temperature ((t = 15.542, p = 0.0409, 
95% CI[0.0983, -0.9788]).      
 
Table 5:14:  Table showing the magnitude of the effects of the significant factors that influence permeate flux 
during diafiltration step five. 


















Co-efficient (β = 
+/-) -9.90 -0.85 1.90 1.04 
0.53 0.45 0.54 
-95% (g/min) -10.26 -1.21 1.54 -1.40 0.09 0.01 0.10 
+95% (g/min) -9.54 -0.49 2.26 -0.68 0.97 0.89 0.98 
-95% (ml/min) -10.06 -1.18 1.51 -1.37 0.09 0.01 0.10 
+95% (ml/min) -9.35 -0.48 2.21 -0.67 0.95 0.88 0.96 
-95% (LMH) 6.03 0.71 0.90 0.82 0.05 0.01 0.06 
+95% (LMH) 5.61 0.29 1.33 0.40 0.57 0.53 0.58 
L/h (30m2) 181.03 21.27 27.10 24.70 1.61 0.24 1.73 
 168.35 8.58 39.79 12.02 17.15 15.77 17.27 
 
The magnitude of the effects of significant factors is displayed in Table 5:14.  All 
factors had a significant effect (Figure 5:11) on permeate flux during diafiltration step 
five.  Further, the interactive effects between protein concentration and ionic strength, 
temperature and ETOH concentration was also considered statistically significant 
(Figure 5.11).  However, it is important to note that although all factors and interactive 
effects are considered statistically significant, only protein concentration has an effect 
magnitude of greater than 5LMH on permeate flux during this step of UF of HSA. All 
other factors, including the interactive effects have an effect magnitude of less than 
1.5LMH, within the 95% confidence interval determined for that factor or interactive 
factor.       
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Figure 5:12:  Profile for predicted values and desirability for all factors for diafiltration step five of ultrafiltration.  
The desirability function is maximized to achieve highest permeate flux for all factors, during the ultrafiltration 
of human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable response.  The 
predicted value for protein concentration that achieves the higher permeate flux during diafiltration step five is 
60g/L; for the highest flux is achieved at 25°C and for ethanol concentration the highest flux is achieved within 
the range 1% to 7.75%.  The desirable value for ionic strength lies within the range 0M to 1.5M. 
 
The permeate flux during diafiltration step five is described as quasi-steady state and 
similar to the permeate flux trend noted in diafiltration steps three and four.  This 
permeate flux trend is consistent with theory suggested by other authors (Marshall et 
al., 1983).  The statistical analysis of diafiltration step five revealed that all factors had 
significant impact (Figure 5:11) on permeate flux during this step of UF of HSA.  The 
profile for predicted values and desirability (Figure 5:12) for diafiltration step five 
showed that permeate flux decreased as protein concentration increased; with desired 
value for protein concentration during diafiltration step five equal to 60g/L.  Permeate 
flux increased with increase in temperature during this step of UF of HSA; with the 
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optimum temperature for maximum flux specified at 25°C.  Similarly to diafiltration 
steps three and four, the predicted value for temperature is also very close to 20°C and 
this value could be used as an alternate temperature level for this factor.  During 
diafiltration step five, ETOH concentration decreased permeate flux when used in 
concentrations greater than 7.75%.  Therefore the optimum ETOH concentration for 
this step of diafiltration is between the range 0% to 7.75%.  Lastly, an increase in ionic 
strength resulted in a decrease of permeate flux.  The optimum range for ionic strength 
lies between 0M and 0.75M.    
 
5.4.7 STATISTICAL ANALYSIS OF THE SECOND CONCENTRATION STEP 
During the second concentration step, the diafiltered HSA solution is concentrated to a 
final protein concentration of approximately 220g/L.   
 
 
Figure 5:13:  Pareto chart of the standardized effects for the second concentration step of ultrafiltration.  No 










Pareto Chart of Standardized Effects; Variable: 2nd conc
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Table 5:15:  ANOVA table for second concentration step of ultrafiltration; indicating the p-value, Beta co-
efficient, t value and 95% confidence intervals. 
 
 
The analysis of variance (Table 5:15) of the permeate flux related to the second 
concentration step for all experiments, reveals that no factors (temperature, protein 
concentration, ionic strength and ETOH concentration) had a significant impact on 
permeate flux during this step of the UF of HSA, within the specified level for each 
factor.  This is very similar to the results obtained for the first concentration step.  The 
Pareto chart (Figure 5:13) shows that all factors have a p value greater than 0.05 (p > 
0.05) and therefore all factors had no statistically significant impact on the permeate 
flux during this step of UF of HSA.  This is further emphasized by the t value which is 
approximately 0; which indicated that there is little or no variation between the sample 
means of all the factors with respect to permeate flux.  The interactive effects between 
factors were considered insignificant with respect to impact on permeate flux during 
this step.  The validity of the above conclusions are supported by the linearity of the 
normal probability plot vs. raw residuals (data not shown).  The profile for predicted 
values and desirability (data not shown) showed distinct trends; however, these trends 












Adjusted R2 = 75.00%
Mean/Interc 23.65 4.05 5.84 0.108 23.65 4.05 -27.77 75.07
(1) Protein concentration (L) -16.90 2.34 -7.24 0.087 -8.45 1.17 -23.30 6.39
Protein concentration (Q) -0.45 2.74 -0.16 0.896 -0.22 1.37 -17.63 17.18
(2) Ionic strength (L) -1.29 2.34 -0.55 0.680 -0.64 1.17 -15.49 14.20
Ionic strength (Q) 0.55 2.74 0.20 0.873 0.28 1.37 -17.13 17.68
(3) Temperature(L ) 3.46 2.34 1.48 0.378 1.73 1.17 -13.11 16.58
Temperature(Q ) 3.65 2.74 1.33 0.410 1.82 1.37 -15.58 19.23
(4) Ethanol concentration (L) -0.03 2.34 -0.01 0.991 -0.02 1.17 -14.86 14.83
Ethanol concentration (Q) 2.57 2.74 0.94 0.520 1.29 1.37 -16.12 18.69
1L by 2L 0.44 2.86 0.15 0.904 0.22 1.43 -17.96 18.40
1L by 3L 0.76 2.86 0.27 0.836 0.38 1.43 -17.80 18.56
1L by 4L -1.19 2.86 -0.42 0.749 -0.60 1.43 -18.78 17.59
2L by 3L -0.37 2.86 -0.13 0.918 -0.19 1.43 -18.37 17.99
2L by 4L 0.64 2.86 0.22 0.860 0.32 1.43 -17.86 18.50
3L by 4L -0.64 2.86 -0.22 0.861 -0.32 1.43 -18.50 17.86
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5.5 IMPACT OF SELECTED FACTORS ON PERMEATE FLUX DURING 
ULTRAFILTRATION 
The steps of UF of HSA (first concentration step, diafiltration steps one to five and the 
second concentration step) and there inter-dependence on each other is important to note 
when analysing the results in this section.  The effect of each factor (protein 
concentration, ETOH concentration, ionic strength and temperature) on permeate flux 
was evaluated over the seven steps of the UF of HSA. 
 
5.5.1 IMPACT OF PROTEIN FEED CONCENTRATION 
During this study, protein concentration is the most statistically significant factor that 
impacts permeate flux during UF of HSA.  The effect of protein concentration on each 
step of the UF of HSA is discussed and exemplified according to the mechanisms of 
membrane and protein fouling such that an optimum protein concentration for the UF 




Figure 5:14:  Permeate flux (LMH) during the various steps of ultrafiltration.  Note the steep decline in flux during 
the first concentration step; the quasi-steady state flux during diafiltration steps one to five and the decline in 
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Protein concentration, within the range of 60g/L to 220g/L, does not have a significant 
impact on permeate flux during the first and second concentration steps of UF of HSA.  
The p-value for both steps is p > 0.05 (first concentration step p = 0.0834; second 
concentration step p = 0.0874).  During the first concentration step of UF of HSA a 
dramatic reduction in permeate flux is noted for all experiments completed in this study.  
Figure 5:14, illustrates the permeate flux profile during the steps of UF for the control 
experiment (experiment no 26) completed during this study.  Further, this figure 
highlights the rapid flux decline during the first concentration step.  This flux decline 
was noted for all experiments, irrespective of start levels for each factor.  This rapid 
flux decline during this step is attributed to the CP and MF phenomenon (Palecek and 
Zydney, 1994; Marshall et al., 1993).  During the first concentration step, the rapid flux 
decline is attributed to initial protein-membrane interactions whereby protein molecules 
are deposited onto the membrane surface thus initiating the formation of the protein 
monolayer or gel boundary layer.  The formation of this gel boundary layer causes pore 
blocking or constriction which negatively impacts the hydraulic permeability of the 
membrane.  This constriction of the pores of the membrane coupled with gel boundary 
layer formation and CP layer contribute to the rapid decline in flux in the first 
concentration step.  The permeate flux effects noted in the first concentration step are 
exemplified by other studies including Palacek and Zydney (1994) and Marshall et al., 
(1993).   
 
During the second concentration step the decline in permeate flux is similar to that 
observed during the first concentration step.  The decline in flux during this step of UF 
of HSA is attributed to the compaction of the gel boundary layer due to increasing 
protein concentration as the volume of the bulk liquid is decreased (Palecek and 
Zydney, 1994; Marshall et al., 1993).  In some experiments completed during this study, 
a slight increase (<2LMH) in permeate flux was noted during the transition from the 
first concentration step to diafiltration step one (grey zone – Figure 5:14).  This increase 
in flux is due to an increase in TMP during the intermediate transition between these 
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During the diafiltration steps of UF of HSA, protein concentration is the most 
significant factor that influences permeate flux with p-value < 0.05 for all diafiltration 
steps one to five.  The statistical significance of the effect of protein concentration on 
permeate flux, increases from diafiltration step one (p = 0.0105) to diafiltration step 
five (p = 0.0018).  This trend of increasing statistical significance of protein 
concentration on permeate flux illustrates the inter-dependence of the steps of UF of 
HSA.  Further, this trend emphasizes that the mechanisms responsible for the effects of 
protein concentration on permeate flux namely CP and MF dominate the entire UF 
process since the impact of the input variable on the measured output significantly 
increases from diafiltration step one to diafiltration step five.  Figure 5:14 shows a 
quasi-steady state flux profile for the control experiment during diafiltration steps one 
to five.  A similar trend was noted for all experiments completed during this study.  
During this step the gel boundary layer is completely formed and remains consistent 
provided that the hydrodynamic conditions and solution chemistry remain unchanged 
(Marshall et al., 1993; Palecek and Zydney, 1994).   
 
Table 5:16:  Table of the standardized effects for protein concentration converted in permeate flux (LMH) data 
and related to volumetric flow rate to indicate the overall impact on process time. 
PROTEIN CONCENTRATION (g/L) 
Permeate Flux  DF 1 DF 2  DF 3  DF 4  DF 5  
Co-efficient (β = +/-) -10.25 -10.13 -10.07 -10.15 -9.90 
-95% (g/min) -12.41 -11.57 -11.15 -10.87 -10.26 
+95% (g/min) -8.10 -8.69 -9.00 -9.43 -9.54 
-95% (ml/min) -12.16 -11.34 -10.93 -10.65 -10.06 
+95% (ml/min) -7.94 -8.52 -8.82 -9.24 -9.35 
-95% (LMH) -7.30 -6.80 -6.56 -6.39 6.03 
+95% (LMH) -4.76 -5.11 -5.29 -5.54 5.61 
L/h (30m2) -218.92 -204.09 -196.73 -191.70 181.03 
  -142.83 -153.37 -158.69 -166.34 168.35 
 
The statistical analysis of the effects of protein concentration on the permeate flux 
during CVD (Table 5:16) indicates that the β co-efficient is negative, which shows that 
an increase in protein concentration results in a corresponding decrease in permeate 
flux within the range of the confidence interval, specified with 95% certainty.  Further 
the magnitude of the effect of protein concentration on permeate flux (Table5:16) is 
considered large since the lower limit (-95%) is >4.5LMH for all diafiltration steps.  
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This translates to a minimum decrease in flow rate of approximately 130L/h with every 
1g/L increase in protein concentration.  The decrease in permeate flux as protein 
concentration increases is explained by examining the protein-protein interactions and 
the membrane-protein interactions with respect to CP and MF.  Protein aggregation is 
generally caused by high protein concentrations in feed solutions, which causes 
denaturation of proteins resulting in low permeate flux during UF of proteins (Cromwell 
et al., 2006).  Also, an increase in feed concentration results in a decrease in the 
hydraulic permeability of the membrane, through mechanisms such as protein 
adsorption to membranes resulting in pore blocking and restriction.  This reduction in 
the hydraulic permeability of the membrane and the concurrent development of the gel 
boundary layer results in low permeate flux during UF of proteins (Reihanian et al., 
1983).  Protein solutions with high protein concentrations are known to exhibit gelling 
behaviour.  The experimentally determined wall concentration of BSA for a limiting 
flux is approximately 300g/L; further, the wall concentration depends on that of the 
bulk concentration and generally increases during UF of BSA if operating conditions 
are maintained at a constant (Meireles et al., 1991).  
 
It was noted during this study that protein concentration had a statistically significant 
interactive effects with all other factors during diafiltration step five only (Appendix E, 
Figure E-1 to Figure E-3).  The magnitude of the effects for all interactions between 
protein concentration and other factors was less than 1LMH (±95%).  Therefore, the 
overall effect of the interaction on permeate flux during UF of HSA was considered 
small.  Interestingly, β co-efficient for all interactive effects were positive.  This 
suggests that an increase in protein concentration with any increase in the other factors 
will result in a corresponding increase in permeate flux.  The key interpretation of this 
data is that protein concentration is the key factor that influences permeate flux during 
UF of HSA.   
 
The fitted response surface diagrams (Appendix E, Figure E-4 to Figure E-8) for 
permeate flux as a function of protein concentration, for all steps during CVD indicates 
that the optimum permeate flux is achieved at the lowest protein concentration.  These 
results correlate well with the desirability and predicted profiles for protein 
concentration, which indicates that the optimum protein concentration to achieve the 
highest permeate flux during UF of HSA is 60g/L; with permeate flux decreasing as 
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protein concentration increases within the range 60g/L to 220g/L.  These results concur 
with the statistical data presented above, on the impact of permeate flux with protein 
concentration.     
 
5.5.2 IMPACT OF ETHANOL CONCENTRATION 
Ethanol is predominantly used as a precipitating agent in the manufacture of plasma 
proteins and must be removed from the API, by UF, prior to formulation and final filling 
into containers (Cohn et al., 1946; Shukla and Cheryan, 2002).  The UF of plasma 
protein solutions removes the ETOH from the bulk feed solution.  During the first 
concentration step very little ETOH is removed from the bulk feed solution.  This 
finding was derived from a screening experiments using similar membranes and 
hydrodynamic conditions as those used in the present study, the ETOH concentration 
(mMol/L) was determined before and after the first concentration step, for five 
experiments (Figure 5:15).  Note that the slight variation in ETOH concentration 
between start (before first concentration) and end (after first concentration) of the first 
concentration step could be attributed to error in the experimental analysis.  Further, the 
bulk feed solution and the filtrate samples were analysed for ETOH content after each 
step of the UF of HSA i.e. after first concentration step, diafiltration steps one to five 
and the second concentration step.  The ETOH content in the bulk solution, determined 
after the selected steps (Figure 5:16) show clearly that ETOH is mostly removed during 
diafiltration steps one to five.  Interestingly, the reduction in ETOH concentration 
represents a logarithmic decrease (R2 > 85.00%) in concentration, with >90% of the 
EOTH (measured from the start of first concentration step) removed by diafiltration 
step three.  This information is critical for proposed optimization strategies and will be 
discussed in following sections.       
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Figure 5:16:  Graphical representation of the removal of ethanol (%) from the bulk feed during ultrafiltraiton.  
Note that >90% of ethanol is removed by the end of diafiltration step three. 
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Ethanol concentration had a significant substantive effect on permeate flux during 
diafiltration steps one and two and a statistically significant effect on permeate flux 
during diafiltration steps three to five.  The statistical significance (p-value) increases 
from diafiltration step one (p = 0.0549) to diafiltration step five (p = 0.0173).  Figure 
5:15 and Figure 5:16 shows the rate at which ETOH has been removed from the bulk 
feed solution; in conjunction with the statistical data it is concluded that as ETOH is 
removed from the bulk feed solution, the significance of the impact on permeate flux 
during UF of HSA increases.  Diafiltration steps are inter-dependent since they occur 
consecutively and each cycle removes a certain concentration of unwanted 
macromolecules and solutes.  Therefore, the effects of the selected factors (the 
measured outputs determined as a function of the input variables) will become more 
significant as the unwanted salts and solutes are removed.   
 
The statistical analysis of the effects of ETOH concentration on the permeate flux 
during UF of HSA indicates that the β co-efficient is negative, which shows that an 
increase in ETOH concentration results in a corresponding decrease in permeate flux 
within the range of the confidence interval, specified with 95% certainty.  During this 
study, the decline in permeate flux during UF of HSA with increase in ETOH 
concentration can be attributed to the denaturation/precipitation of proteins, resulting in 
increased viscosity of the feed solution.  This increased viscosity of the feed solution 
results in the decrease of permeate flux during UF of proteins according to Darcy’s 
Law.  An analysis of the free energy of proteins in stable and denatured states shows 
that proteins are unstable and insoluble in polar solvents e.g. ETOH such that the degree 
of stability or solubility is dependent on the concentration of the solvent; were an 
increase in solvent concentration results in increased instability (Pace et al., 2004).  An 
increased concentration of ETOH in protein solutions causes structural and 
conformational changes which results in increased viscosity of the feed solution 
(Szymanska et al., 2012).  Ethanol binds water molecules more efficiently than proteins 
therefore high concentrations of ETOH in feed solutions cause’s proteins to precipitate 
due to the dehydrating effect of this solvent which elicits increased electrostatic 
interaction between protein molecules. (Van Oss, 1989).  This precipitation of proteins 
at high ETOH concentrations contributes to the increase in viscosity of the feed 
solution.   
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Further, the increased viscosity of the feed solution may also contribute to the higher 
concentration of protein molecules in the gel boundary layer due to reduced back 
diffusion of protein into the bulk feed solution, at constant TMP and CFV.  Thus 
resulting in decreasing the hydraulic permeability of the UF membrane.  This theory 
was suggested by Jaffrin and colleagues in two separate studies (Jaffrin and Charrier, 
1994; Jaffrin et al., 1997).  The results of both studies confirmed that high ETOH 
concentrations induced increased viscosities of the feed solution which also caused 
“thickening” or increased concentration of protein molecules, of the gel boundary layer.  
This resulted in the decline of flux during UF of protein solutions, at fixed 
hydrodynamic conditions.  Therefore, an increase in viscosity of the protein feed 
solution may have caused an increase in protein concentration of the gel layer, resulting 
in low permeate flux, with increasing concentration of ETOH.             
 
Table 5:17:  Table of the standardized effects for ethanol concentration converted in permeate flux (LMH) data 
and related to volumetric flow rate to indicate the overall impact on process time. 
ETHANOL CONCENTRATION (%) 
Permeate Flux  DF 1 DF 2  DF 3  DF 4  DF 5  
Co-efficient (β = +/-) -1.96 -1.34 -1.16 -1.04 1.04 
-95% (g/min) -4.12 -2.78 -2.24 -1.76 -1.40 
+95% (g/min) 0.19 0.09 -0.08 -0.32 -0.68 
-95% (ml/min) -4.04 -2.73 -2.19 -1.72 -1.37 
+95% (ml/min) 0.19 0.09 -0.08 -0.31 -0.67 
-95% (LMH) -2.42 -1.64 -1.32 -1.03 0.82 
+95% (LMH) 0.11 0.06 -0.05 -0.19 0.40 
L/h (30m2) -72.66 -49.06 -39.47 -31.01 24.70 
 3.43 1.67 -1.43 -5.65 12.02 
 
 
Table 5:17 indicates the effects of EOTH concentration on permeate flux per 
diafiltration step; the flux values are translated into flow rates (L/h) to indicate the 
overall impact on process time.  The +95% confidence limit for diafiltration step one is 
-2.42LMH; for all other diafiltration steps this limit is < -2.00LMH.  In diafiltration 
steps one to three, the magnitude of the effect of ETOH concentration is very limited 
possibly because the range of ETOH concentration selected for this study was very 
narrow (0% to 10% - v/v).  This, coupled with the reducing concentration of ETOH 
from diafiltration step one to five will account for the low magnitude of the effect of 
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ETOH concentration.  In diafiltration step four and five, the +95% confidence limit is 
approximately 1.00LMH.  The magnitude of the effects of ETOH concentration on 
permeate flux, although considered significant, are very small.  This reduced effect of 
ETOH concentration in diafiltration steps four and five is expected since >90% of 
ETOH is removed before diafiltration step four (Figure 5:16).  In all experiments cited 
above, including Jaffrin and Charrier (1994) and Jaffrin et al., (1997), the limiting 
effects of ETOH concentration on permeate flux was conducted using ETOH 
concentrations at a minimum of 20% (v/v) since the authors recognized that the 
viscosity of albumin-ETOH solutions at 20°C showed minimal increase in viscosity 
(<2.00mPa.s) with increase in ETOH concentration (up to 30% v/v); across a range of 
protein concentrations (0g/L to 20g/L) with fixed hydrodynamic conditions (Table 3:3).  
Further, Szymanska et al., (2012) showed that from 0% to 60% (v/v) ETOH 
concentration, the rate of viscosity increase is slower than compared to viscosity 
increase with ETOH concentration >60%.  The range of this study was 0% (v/v) to 10% 
(v/v) and therefore, the results of this study is showing a minimal, limiting effect on 
permeate flux during UF of HSA due to the narrow range of the factor.     
    
The fitted response surface diagrams (Appendix E, Figure E-9 to Figure E-13) for 
permeate flux as a function of ETOH concentration and protein concentration, for all 
steps of constant volume diafiltration indicates that the optimum permeate flux is 
achieved at low ETOH concentrations.  These results correlate well with the desirability 
and predicted profiles for ETOH concentration, which indicates that the optimum 
ETOH concentration to achieve the highest permeate flux during UF of HSA lies in the 
range 0% (v/v) to 7.75% (v/v); with permeate flux decreasing as ETOH concentration 
increases.  However, the magnitude of the effect on permeate flux within the range of 
the factor is small.   
 
The optimization of ETOH concentration with respect to maximizing permeate flux 
must consider the following: 
 Mother liquor content of dissolve Fraction V paste is approximately 5-7% (v/v).  
Addition of ETOH (96%, v/v) during dissolution to increase concentration to 
approximately 10% (v/v) 
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 During this dissolution phase, the product temperature is reduced to -3.5°C ± 
1°C 
 Removal of 10% WFI-ETOH admixture for dissolution of HSA has a regulatory 
and process impact on upstream process of depth filtration.  Therefore a change 
will require process optimization, validation and regulatory approval.  
  Limited cost saving with respect to decreasing ETOH concentration.    
 
 
5.5.3 IMPACT OF TEMPERATURE 
Temperature is a critical process parameter in UF of proteins since it impacts the physic-
chemical properties of both the membrane and the protein of interest (Mo et al., 2008).  
During this study, temperature was varied within the range 5°C to 25°C, and the impact 
on permeate flux, across the range of several other parameters, was statistically 
determined.   
 
Table 5:18:  Table of the standardized effects for temperature converted to permeate flux (LMH) data and related 
to volumetric flow rate to indicate the overall impact on process time. 
TEMPERATURE (°C) 
Permeate Flux  DF 1 DF 2  DF 3  DF 4  DF 5  
Co-efficient (β = +/-) 2.26 2.18 2.06 2.05 1.90 
-95% (g/min) 0.10 0.74 0.98 1.33 1.54 
+95% (g/min) 4.42 3.62 3.14 2.77 2.26 
-95% (ml/min) 0.10 0.73 0.96 1.30 1.51 
+95% (ml/min) 4.33 3.55 3.07 2.71 2.21 
-95% (LMH) 0.06 0.44 0.58 0.78 0.90 
+95% (LMH) 2.60 2.13 1.84 1.63 1.33 
L/h (30m2) 1.80 13.13 17.30 23.42 27.10 
 77.89 63.85 55.35 48.78 39.79 
 
 
Temperature had a statistically significant effect on permeate flux during all 
diafiltration steps.  The statistical significance (p-value) increases from diafiltration step 
one (p = 0.0477) to diafiltration step five (p = 0.0095).  This increase in statistical 
significance across CVD is similar to that noted for ETOH concentration on permeate 
flux.  Therefore, the same inference can be concluded i.e. the interdependence of the 
consecutive diafiltration steps increases the significance of the effects of the factor on 
the measured outputs, during the steps of diafiltration.   
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The statistical analysis of the effects of temperature on the permeate flux during UF of 
HSA (Table 5:18) indicates that the β co-efficient is positive, which shows that an 
increase in temperature results in a corresponding increase in permeate flux within the 
range of the confidence interval, specified with 95% certainty.  The positive impact of 
temperature on permeate flux can be attributed to the low viscosity of HSA solutions at 
high temperature.  The interpretation of Darcy’s law suggests that the less viscous a 
solution, the greater the flow through the membrane (Jonsson and Tragardh, 1990).  
Further, the Arrhenius Equation confirms the relationship between viscosity and 
temperature by showing that as temperature increases, viscosity decreases (Monkos, 
1996).  The reduced viscosity of solutions at high temperatures increases the back 
diffusion of solutes away from the membrane i.e. increases the diffusion co-efficient of 
solutes, causing a reduction in the concentration of solutes at the gel boundary layer, 
resulting in increased permeate flux during UF of proteins (Mo et al., 2008).  The 
Monkos study of 1996 showed the logarithmic reduction in viscosity of a BSA solution 
of concentration 335g/L as temperature increases, up to a maximum temperature of 
45°C.  Masuelli (2013) showed a similar phenomenon with BSA, the viscosity of BSA 
solutions at two concentrations (20.0g/L; 367.1g/L) showed the same effect i.e. 
viscosity of the solution decreased as temperature increased.  Further, this study 
elucidated the correlation between protein concentration and temperature on viscosity 
in that the higher protein concentration solution showed a higher viscosity; which 
decreased as temperature was increased (Masuelli, 2013).  The effect of operating 
temperature on solution viscosity has been conclusively proven for other solutes e.g. 
cherry juice (Wang et al., 2005)       
 
The impact of ETOH on the viscosity of HSA has been explained in section 5.2.2.  
Literature supports the hypothesis that an increase in ETOH concentration causes an 
increase in the viscosity of HSA solutions, which results in decrease in permeate flux 
during UF of HSA (Syzmanska et al., 2012; Jaffrin and Charrier, 1994; Jaffrin et al., 
1997).  The removal of ETOH in the bulk feed solution, as a consequence of constant 
volume diafiltration, will result in a limited decrease of the viscosity of the feed 
solution.  Therefore, as ETOH is removed from the bulk feed, the impact of temperature 
on the steps of UF of HSA becomes more significant.  Thus the statistical significance 
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of temperature on permeate flux increases from diafiltration step one to diafiltration 
step five.   
 
The magnitude of the effects of temperature on permeate flux, within the range 5°C to 
25°C, during UF of HSA is less than +3.00LMH, for all diafiltration steps, at the +95% 
confidence interval.  This translates to an overall impact on flow rate of less than 
100L/h, for an UF membrane surface area of 30m2.  Therefore, although the impact of 
temperature on permeate flux during UF of HSA is considered significant, the 
magnitude of the impact is considered small, with limited impact on permeate flux 
during UF.  The temperature range (5°C to 25°C) selected for this study, could be too 
narrow, therefore the effect of temperature on permeate flux is limited.  HSA solubility 
within this temperature range is considered high and stable, therefore, MF due to protein 
denaturation is limited and thus the impact of temperature is considered statistically 
significant, with minimal impact but with increase in permeate flux as temperature 
increases.  The theoretical basis for HSA stability within this temperature, as a function 
of reversible/irreversible protein unfolding, will be explained further in paragraphs 
below.     
 
The fitted response surface diagrams (Appendix E) for permeate flux as a function of 
temperature and protein concentration for all steps of CVD indicate that the optimum 
permeate flux is achieved between 20°C to 25°C, for all protein concentrations within 
the range 60g/L to 220g/L.  The response surface diagrams correlates well with the 
predicted and desired value for temperature which indicates that the optimum 
temperature to achieve the highest flux during UF of HSA is 25°C.  The predicted and 
desired value analysis also showed that a temperature set point of 20°C, with a 
desirability value close to 1.000, may also be considered in the optimization analysis 
for the UF of HSA.  It is a well-known fact that proteins are stable at low temperatures 
and therefore, the lower temperature set point might be favourable.  However, the 
conformational and structural analysis of HSA suggests that this protein only undergoes 
irreversible change at temperatures greater than 45°C, with reversible change occurring 
at temperatures between lower than 45°C.  The increase in temperature is known to 
cause the conformational and structural change of HSA from the stable α helical 
structure to β sheets, characterized by a general unfolding of the protein towards the 
denatured state.  HSA is known to be stable in temperatures less than 30°C.  The results 
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obtained in this study are similar to those obtained by Campbell et al., (1993) who 
achieved a similar temperature set point for the UF of α amylase. 
 
5.5.4 IMPACT OF pH AND IONIC STRENGTH 
During this study, pH was maintained at pH 7.2 ± 0.2 for all experiments completed.  
This physiological pH maintains optimum stability of the HSA in the native state.  Also, 
the pH 7.2 ± 0.2 is further away from the IEP of HSA, determined to be pH 4.7.  This 
ensures that the impact of low permeate flux at IEP during UF of HSA is negligible for 
experiments completed during this study.  Flux during UF of proteins is greatly reduced 
at the IEP of the protein of interest (Swaminathan et al., 1981; Fane et al., 1983; Salgin 
et al., 2006).  This reduction in flux at the IEP is explained by decreased protein-protein 
electrostatic repulsion.  Protein adsorption to the membrane is a maximum at the IEP 
since HSA has a net zero charge thus increasing MF through enhanced protein 
adsorption onto the PES membrane, which is negatively charged at pH 4.7   (Wang and 
Tang, 2011; Lim and Mohammad, 2010).  When the pH of a solution deviates towards 
lower pH the protein molecules become protonated (Equation 5:1a, b) and carry a net 
positive charge whilst the PES membrane has a weak negative charge.  This results in 
an increase in protein adsorption to PES membranes.  Therefore, completing UF of 
HSA at low pH is not feasible due to the increased protein fouling and corresponding 
decrease in permeate flux.  In a key study, Salgin et al., (2006) showed that adsorption 
of protein to 10kDa PES membranes are even greater at pH<IEP.  When pH of a 
solution deviates from the IEP of a protein towards higher pH, the membrane and the 
protein both have negative surface charge due to the dissociation of the carboxyl group 
of the protein (Equation 5:2a, b).  This increases the force of electrostatic repulsion 
between proteins and the membrane surface (true only for negatively charges 
membranes such as those used in this study); MF is subsequently reduced by the 
reduction of protein adsorption to the membrane surface (Lim and Mohammad, 2010).  
When the pH of a solution is lower than the IEP of the protein, the protein is protonated 
(Equation 5:1a, b) and thus positively charged.  Therefore, if negatively charged 
membranes are used with positively charged proteins, MF will increase due to the 
electrostatic attraction between the positively charged proteins and the negatively 
charged membrane (Lim and Mohammad, 2010).    
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𝑅 − 𝑁𝐻3 + 𝑂𝐻−  →   𝑅 − 𝑁𝐻2 +  𝐻2𝑂 
𝑅 − 𝐶𝑂𝑂𝐻 + 𝑂𝐻−   →   𝑅 − 𝐶𝑂𝑂− +  𝐻2𝑂 
Equation 5:1a,b:  Chemical equations showing the dissociation of the carboxyl group of proteins in solutions at 
pH>IEP, resulting in net negative charge of the proteins (Lim and Mohammad, 2010). 
 
𝑅 − 𝑁𝐻2 + 𝐻+  → 𝑅 − 𝑁𝐻3
+ 
𝑅 − 𝐶𝑂𝑂− + 𝐻+   →   𝑅 − 𝐶𝑂𝑂𝐻 
Equation 5:2a,b:  Chemical equations showing the protonation of proteins in solutions at pH<IEP, resulting in 
net positive charge of the proteins (Lim and Mohammad, 2010).      
 
The UF of protein solutions removes various ions from the bulk feed solution including 
sodium, potassium, citrate and aluminium.  Similar to ETOH, little or no reduction in 
ion concentration is noted during the first concentration step.  In the studies conducted 
by this laboratory described in the section above, the ion concentration of four key ionic 
species (potassium; sodium; citrate; aluminium) was determined before and after the 
first concentration step, for five experiments.  The concentration of potassium (Figure 
5:17) and sodium (Figure 5:18) decreased not more than 2mol/L during the first 
concentration step.  A similar trend was noted for citrate and aluminium (data not 
shown).  Note that the slight variations in measured ion concentration before and after 
the first concentration step could also be due to experimental error.  The analysis of the 
removal of ions during UF of HSA showed that >90% of measured ions was removed 
from the bulk feed solution during the CVD step (Figure 5:19 and Figure 5:20).  The 
majority of these ions were removed by diafiltration step three.  This information is 
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Figure 5:18:  Graphical representation of the minimal loss of sodium (mol/L) during the first concentration step. 
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Figure 5:19:  Graphical representation of the removal of potassium (mol/L) from the bulk feed solution during 





Figure 5:20:  Graphical representation of the removal of aluminium (mol/L) from the bulk feed solution during 
ultrafiltration.  Note that >90% of the aluminium is removed by the end of diafiltration step three. 
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During this study, NaCl diluent of varying ionic strengths (0M – 3M) was used to 
determine the impact of ionic solutions on permeate flux during the UF of HSA.  Ionic 
strength had a significant substantive effect on permeate flux during diafiltration step 
four and a statistically significant effect on permeate flux during diafiltration step five.  
During diafiltration steps one to three, ionic strength did not have a statistically 
significant impact on permeate flux.  High ionic strength solutions, such as those used 
in this study, exhibit an electrostatic shielding effect of the protein molecules which 
decreases the protein-protein electrostatic repulsion force and the protein-membrane 
electrostatic attraction force (Salgin, 2007).  Therefore the statistically significant 
impact of ionic strength is only noted in diafiltration step five since by this step in UF 
of HSA the polar solvent (ETOH) and other competing ions e.g. aluminium and citrate 
are reduced to low concentrations and there is less competition for binding of NaCl ions 
to the HSA protein molecule.  The electrostatic shielding effect, caused by the binding 
of NaCl ions (high concentration greater than physiological salt concentrations) to the 
protein molecule, induces the decrease in permeate flux during UF of HSA (Zhang and 
Cremer, 2006).   
 
The statistical analysis of the effects of ionic strength on the permeate flux during UF 
of HSA indicates that the β co-efficient is negative, which shows that an increase in 
ionic strength results in a corresponding decrease in permeate flux within the range of 
the confidence interval, specified with 95% certainty.  Several authors have clearly 
demonstrated the reduction in permeate flux during UF of protein solutions with high 
ionic strength solutions where pH of the protein solution was above the isoelectric point 
pH.  Increase of ionic strength by the addition of NaCl solutions during constant volume 
diafiltration results in a charge screening or masking effect (electrostatic shielding) of 
the ions that reduces the overall net charge of the protein molecule which causes them 
to act as uncharged molecules.  Therefore, this reduces the electrostatic repulsion with 
respect to protein-protein and protein-membrane interactions, by double layer 
compression, resulting in increasing protein adsorption to the membrane and protein 
fouling which has a net effect of reducing permeate flux during UF of proteins (Lim 
and Mohammad, 2010; Wang and Tang, 2011).  Palecek et al., (1993) provided 
conclusive evidence that increase in ionic strength above and below the IEP of BSA 
decreases the permeability of the gel layer thus decreasing permeate flux.  The model 
explaining these interactions were similar to those expresses by Lim and Mohammad 
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(2010).  The analysis of the dominant forces that influence the movement of a protein 
in a solution during UF towards the gel boundary layer shows that the repulsive force 
between proteins is a function of the hydrodynamic radius of the protein as well as the 
Debye length; Debye length is inversely proportional to the square root of the solution 
ionic strength (Palecek and Zydney, 1994; Palecek et al., 1993).Permeate flux is 
increased when electrostatic repulsion between protein  molecules is increased since 
the increased diffusive back transport of protein molecules to the bulk liquid decreases 
the concentration of the protein molecules at the membrane interface (Peeva et al., 
2012).  
 
Table 5:19:  Table of the standardized effects for ionic strength converted in permeate flux (LMH) data and 
related to volumetric flow rate to indicate the overall impact on process time. 
IONIC STRENGTH (M) 
Permeate Flux  DF 4  DF 5  
Co-efficient (β = +/-) -0.665 -0.85 
-95% (g/min) -1.384 -1.21 
+95% (g/min) 0.054 -0.49 
-95% (ml/min) -1.36 -1.18 
+95% (ml/min) 0.05 -0.48 
-95% (LMH) -0.81 0.71 
+95% (LMH) 0.03 0.29 
L/h (30m2) -24.41 21.27 
 0.95 8.58 
 
Table 5:19 indicates the effects of ionic strength on permeate flux per diafiltration step; 
the flux values are translated into flow rates (L/h) to indicate the overall impact on 
process time.  The +95% confidence limit for diafiltration steps four and five is less 
than 1LMH.  The magnitude of the effects of ionic strength on permeate flux, although 
considered significant, are very small.   
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Figure 5:21:  Fitted surface response diagram for diafiltration step five showing protein concentration as a 
function of ionic strength and flow rate. 
 
The fitted response surface diagrams (Figure 5:21) for permeate flux as a function of 
ionic strength and protein concentration for diafiltration steps four and five of constant 
volume diafiltration indicate that the optimum permeate flux is achieved with 0M to 
1.5M NaCl, for all protein concentrations within the range 60g/L to 220g/L.  The 
response surface diagrams correlates well with the predicted and desired value for 
temperature which indicates that the optimum ionic strength to achieve the highest flux 
during UF of HSA lies within the stated range.  For the optimization of the UF of HSA, 
diafiltration solutions with 0M ionic strength will be used.  The results of this study 
showed that the range of ionic strength selected for this study was too broad since high 
ionic strength solutions have a screening effect on protein molecules.   
 
5.6 OPTIMIZATION OF THE ULTRAFILTRATION OF HSA 
The primary goal of optimization and innovation strategies relating to the UF of HSA 
include reducing operating costs and energy consumption by driving the process towards 
optimal operational control (Paulen et al., 2015).  The key elements relating to the 
optimal operational control of the UF of HSA are classified into two categories.  In the 
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first category the key factors (TMP, protein concentration, ETOH concentration, ionic 
strength, pH, temperature and stirring rate) that influence UF of HSA are optimized to 
establish the critical conditions to complete the process.  In the second category, diluent 
minimization strategies are considered and this involves maximizing the overall 
productivity of the UF of HSA where productivity is defined as the kilograms of protein 
processed per hour.  Productivity is not influenced by UF performance (permeate flux) 
but also by other routine operations including time taken to clean membranes after use, 
availability of start raw materials (Fraction V paste) for UF and availability of human 
resources to complete tasks e.g. day shift and night shift teams.      
 
5.6.1 OPTIMIZATION OF FEED CONCENTRATION 
Protein concentration is the key factor that influences permeate flux during UF of HSA.  
Therefore, the optimal set point of this factor is critical to achieve the purpose of this 
optimization strategy.  The statistical analysis of the data collected during this study 
suggests that the optimum protein concentration for maximum permeate flux is 60g/L.  
However, in optimization strategies for UF of HSA, the optimum protein concentration 
of the bulk feed solution is dependent on the trade-off between flux and diafiltration 
diluent (Millipore Application Note, 2013).  It has been established that CP and MF are 
the key factors that cause the decline of permeate flux during UF of HSA.  Therefore, 
one can use the gel polarization model (Equation 3:1) to determine the maximum 
protein concentration at which to complete UF of HSA (Asbi and Cheryan, 1992).  The 
gel concentration (Cg) of the protein solution is defined as the value of the bulk 
concentration (Cb) when permeate flux is zero (Asbi and Cheryan, 1992; Millipore 
Application Note, 2013).  Once Cg is determined, the optimum protein concentration 
(Copt) at which ultrafiltration can occur is Cg divided by the Napier’s number ɛ = 2.718 
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Copt = optimum protein concentration at which to complete UF 
Cg = gel concentration 
Equation 5:3:  Determination of the optimum protein concentration to complete ultrafiltration at optimum 
permeate flux with minimal membrane fouling.  Cg is the gel concentration and 2.718 is Napier’s Number. 
Equation 5:3 can only be used under the following conditions: 
 When proteins are 100% rejected 
 Plot of Flux (LMH) vs. protein concentration has a regression co-efficient of 
greater than 90.00% such that the concentration at zero flux can be accurately 
determined    
The above conditions have been satisfied for this study.   
 
  
Figure 5:22:  Extrapolation of Cg from a plot of permeate flux (LMH) vs. protein concentration (g/L); according to 
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The plot of Flux (LMH) vs. concentration for three experiments (experiment numbers 
17, 25 and 18) completed in this study is shown in Figure 5:22.  Note that the 
experiments 17, 25 and 18 where selected to determine the gel concentration of the 
ultrafiltration of HSA since the levels of all factors were identical except protein 
concentration, which was varied at 60g/L for experiment 17; 140g/L for experiment 25 
and 220g/L for experiment 18.  A plot of permeate flux (LMH) vs. protein concentration 
(g/L) using data from this study revealed a R2 value approaching 100%; extrapolating 
permeate flux to zero, Cg = 270g/L.  This value of 270g/L correlates well with the Cg 
value established by Jaffrin and Charrier (1992) of 300g/L.  Using Equation 5:3, the 
optimum protein concentration to complete UF of HSA is 99.34g/L.  Considering error 
in process equipment and related volumetric and mass measurement devices, the range 
for optimum protein concentration to complete UF of HSA is 100g/L ± 10g/L.  The 
deviation of ± 10g/L is equivalent to a variation of 10% from the expected value and is 
congruent with current process specifications, which are validated and GMP compliant.  
    
It is important to note that according to the process steps described in Figure 2:4, the 
step following the dissolution of Fraction V paste is depth filtration; this unit operation 
must be completed at a protein concentration of 60g/L and has not been optimized as 
part of this study.  By using a fixed batch start volume of 1150L (which is based on the 
maximum capacity of the current tank used for this process), the limiting protein 
concentration defined for the depth filtration unit operation and the yield of HSA from 
Fraction V paste, the theoretically determined mass of Fraction V paste to be dissolved 
in the WFI-ETOH admixture is 276kg.  This represents an increase on current batch 
size (190kg of Fraction V paste) of 31.16%.  Considering the current fill volumes per 
vial and the volume of HSA solution after formulation, the batch size increase with 
respect to number of vials filled is approximately 6%.   
 
5.6.2 OPTIMIZATION OF ETHANOL CONCENTRATION 
The optimum ETOH concentration that provided the highest permeate flux was within 
the range 0% to 7.75% (v/v).  The magnitude of the effect is considered small 
(<2LMH).  During the dissolution of Fraction V paste in WFI, ETOH (96% v/v) is 
added to a final concentration of 10% (v/v); note that the dissolved Fraction V paste 
has a mother liquor ETOH content of between 5-7% (v/v).  Therefore, a limited amount 
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(< 45L; dependent on mass of paste dissolved) of 96% ETOH is added to the dissolved 
Fraction V paste solution to achieve the final concentration of 10% (v/v).  The addition 
of ETOH to final concentration of 10% (v/v) is important since it lowers the freezing 
point of the solution whilst preventing freezing of the protein solution during the next 
unit operation which is depth filtration.  This depth filtration process is carried out at a 
temperature of -3.5°C ± 0.2°C.  This study provides evidence for the reduction of ETOH 
concentration to within the range 0% to 7.75% (v/v) which is within the range of the 
mother liquor ETOH content of dissolved Fraction V paste.  This suggests that no 96% 
(v/v) ETOH will be required to increase ETOH concentration to 10% (v/v).  This 
process change will impact the upstream unit operation of depth filtration, which will 
require the validation and regulatory approval of a process change in temperature from 
the current set point of -3.5°C ± 0.2°C since the freezing point of ETOH mixtures of 5-
7% (v/v) is <-3.5°C.  Considering the limited economic benefit, coupled with the 
limited benefit in increasing permeate flux by reducing ETOH content to within the 
range of 0% to 7.75% (v/v) and the process development, optimization and validation 
efforts required to adjust downstream unit operations; it is recommended that the EOTH 
concentration for the UF of HSA remain at 10% (v/v). 
 
5.6.3 OPTIMIZATION OF TEMPERATURE 
The optimum temperature for the UF of HSA as statistically determined during this 
study is 25°C.  Also, the temperature set point of 20°C was also considered to be 
favourable.  Currently, the UF of HSA is completed at 20°C ± 2°C.  The optimum 
statistically determined temperature set point and the current process temperature set 
point are within range and therefore the temperature set point for this process will not 
be changed.     
 
5.6.4 OPTIMIZATION OF pH AND IONIC STRENGTH 
The optimum pH for the UF of HSA is pH 7.2 for reasons established in Section 3.4.1.  
The statistical analysis of the data compiled during this study revealed that optimum 
ionic strength to achieve maximum permeate flux lies within the range 0M to 1.5M for 
NaCl solutions.  However, the magnitude of the effect on permeate flux was considered 
small (<1LMH).  Low Na content PDMP’s have significant physiological benefit, 
therefore, the maximum allowed concentration of Na in HSA produced by NBI is 
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100mMol.  Since the overall benefit of introducing a NaCl diafiltration diluent will 
result in little increase in permeate flux whilst increasing the Na content in the final 
product solution, it is recommended that the current process continue to use WFI as a 
diafiltration diluent.  The use of a NaCl buffer will increase process cost, with no benefit 
of reducing process time by increasing permeate flux during UF of HSA.     
 
 
5.6.5 OPTIMIZATION OF PRODUCTIVITY 
The productivity of the UF of HSA is limited by the availability of the starting raw 
material, which is Fraction V paste.  The maximum mass of Fraction V paste produced 
per week is approximately 520kg.  In the evaluation of an optimized strategy for UF of 
HSA the following assumptions are considered to eliminate the inconsistencies that 
might occur in a dynamic manufacturing environment.  These assumptions are: 
 Operator scheduling constraints have been removed and the UF of HSA is 
deemed a 24 hour operation encompassing two shifts.   
 Assume that raw materials are readily available.  Note that this is important 
since Fraction V paste (starting raw material for HSA UF) is produced through 
fractionation from Fraction IV/V by the Kistler and Nitschmann (1962) method 
and although large quantities are readily available a 24 hour, two shift operation 
will steadily deplete inventory and therefore production of Fraction V paste 
must satisfy at minimum the rate at which it is used.   
 Pre-UF of HSA activities e.g. storage buffer removal through rinsing with WFI 
and NWP measurements takes approximately 120 minutes to complete; the time 
for these activities have been factored into the overall time schedule.  
 Post-UF of HSA activities e.g. CIP of membranes take approximately 90 
minutes to complete; the time for these activities have been factored into the 
overall time schedule.  The overall process time calculated above was used to 
determine how many batches can be completed in 24 hours; transposed to a five 
day working week transposed to a working year.  This value (total batches 
produced in a year) was used to determine amount of protein mass produced in 
one year.   
 Total process time was determined for a standard batch size of 1150L volume, 
which is based on the capacity of the current tank used for this process.  
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 Permeate flux was determined using the mass flow rates documented in this 
study and a nominal 10m2 membrane surface area, which is the maximum 





Table 5:20:  Optimization of productivity with respect to total number of batches produced per year, translated 





The information described above was used to determine a productivity table for each 
experiment conducted based on the average permeate flux during diafiltration for that 
experiment.  The total process time and therefore the kilograms of protein produced per 
























































 per week 
(current)
17 60.00 49.62 5.92 4.06 4.00 72 20 1040 74880 1440.00 7 364 26208 504
2 100.00 36.71 6.77 3.55 3.00 120 15 780 93600 1800.00 4 208 24960 480
7 100.00 44.49 6.20 3.87 3.00 120 15 780 93600 1800.00 4 208 24960 480
6 100.00 35.01 6.93 3.46 3.00 120 15 780 93600 1800.00 4 208 24960 480
8 100.00 38.61 6.61 3.63 3.00 120 15 780 93600 1800.00 4 208 24960 480
4 100.00 41.28 6.41 3.75 3.00 120 15 780 93600 1800.00 4 208 24960 480
1 100.00 44.70 6.18 3.88 3.00 120 15 780 93600 1800.00 4 208 24960 480
5 100.00 34.79 6.95 3.45 3.00 120 15 780 93600 1800.00 4 208 24960 480
3 100.00 42.90 6.30 3.81 3.00 120 15 780 93600 1800.00 4 208 24960 480
23 140.00 33.19 7.12 3.37 3.00 168 15 780 131040 2520.00 3 156 26208 504
22 140.00 34.45 6.98 3.44 3.00 168 15 780 131040 2520.00 3 156 26208 504
26 (C) 140.00 29.24 7.60 3.16 3.00 168 15 780 131040 2520.00 3 156 26208 504
19 140.00 24.84 8.33 2.88 2.00 168 10 520 87360 1680.00 3 156 26208 504
25 (C) 140.00 31.73 7.28 3.30 3.00 168 15 780 131040 2520.00 3 156 26208 504
20 140.00 28.93 7.65 3.14 3.00 168 15 780 131040 2520.00 3 156 26208 504
21 140.00 27.88 7.80 3.08 3.00 168 15 780 131040 2520.00 3 156 26208 504
24 140.00 28.10 7.77 3.09 3.00 168 15 780 131040 2520.00 3 156 26208 504
11 180.00 26.78 7.98 3.01 3.00 216 15 780 168480 3240.00 2 104 22464 432
10 180.00 17.51 10.35 2.32 2.00 216 10 520 112320 2160.00 2 104 22464 432
15 180.00 23.63 8.58 2.80 2.00 216 10 520 112320 2160.00 2 104 22464 432
13 180.00 19.51 9.65 2.49 2.00 216 10 520 112320 2160.00 2 104 22464 432
14 180.00 17.82 10.24 2.34 2.00 216 10 520 112320 2160.00 2 104 22464 432
12 180.00 27.04 7.94 3.02 3.00 216 15 780 168480 3240.00 2 104 22464 432
9 180.00 18.25 10.08 2.38 2.00 216 10 520 112320 2160.00 2 104 22464 432
16 180.00 18.80 9.88 2.43 2.00 216 10 520 112320 2160.00 2 104 22464 432
18 220.00 11.42 14.01 1.71 1.00 264 5 260 68640 1320.00 2 104 27456 528
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Figure 5:23:  Pareto chart of the standardized effects for process time of ultrafiltration, considering a standard 




Table 5:21:  ANOVA table for process time of ultrafiltration; indicating the p-value, Beta co-efficient, t value and 
95% confidence intervals. 
 
 
Pareto Chart of Standardized Effects; Variable: Process time(hours)/1200L...









































Adjusted R2 = 86.31%
Mean/Interc 3.94 0.16 24.44 0.026 3.94 0.16 1.89 5.99
(1) Protein concentration (L) 3.21 0.09 34.48 0.018 1.61 0.05 1.01 2.20
Protein concentration (Q) 1.17 0.11 10.75 0.059 0.59 0.05 -0.11 1.28
(2) Ionic strength (L) 0.14 0.09 1.48 0.377 0.07 0.05 -0.52 0.66
Ionic strength (Q) 0.19 0.11 1.71 0.336 0.09 0.05 -0.60 0.79
(3) Temperature(L ) -0.74 0.09 -7.96 0.080 -0.37 0.05 -0.96 0.22
Temperature(Q ) -0.11 0.11 -1.01 0.496 -0.06 0.05 -0.75 0.64
(4) Ethanol concentration (L) 0.38 0.09 4.04 0.154 0.19 0.05 -0.40 0.78
Ethanol concentration (Q) -0.09 0.11 -0.79 0.576 -0.04 0.05 -0.74 0.65
1L by 2L 0.12 0.11 1.07 0.480 0.06 0.06 -0.66 0.79
1L by 3L -0.58 0.11 -5.06 0.124 -0.29 0.06 -1.01 0.44
1L by 4L 0.13 0.11 1.14 0.458 0.07 0.06 -0.66 0.79
2L by 3L 0.28 0.11 2.48 0.244 0.14 0.06 -0.58 0.87
2L by 4L 0.17 0.11 1.48 0.378 0.08 0.06 -0.64 0.81
3L by 4L 0.04 0.11 0.39 0.763 0.02 0.06 -0.70 0.75
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The Pareto chart (Figure 5:23) and the analysis of variance (Table 5:21) of the process 
time required to complete each experiment at prescribed factor levels reveals that only 
protein concentration (t = -34.48, p= 0.0019, 95% CI[2.20, 1.01]) has a statistically 
significant impact on process time during UF of HSA.  The positive β co-efficient 
indicates that an increase in protein concentration results in a corresponding increase in 
process time.  This is in good agreement with results confirmed for protein 
concentration which indicates that permeate flux decreases as protein concentration 
increases.  The adjusted R2 value suggests that at least 86.31% of the variability in 
process time is accounted for by taking into consideration protein concentration.  The 
validity of the above conclusions are supported by the linearity of the normal probability 
plot vs. raw residuals (data not shown).    
 
 
Figure 5:24:  Profile for predicted values and desirability for all factors for process time of ultrafiltration.  The 
desirability function is maximized to achieve highest permeate flux for all factors, during the ultrafiltration of 
human serum albumin, were 1.000 is most desirable response and 0.000 is least desirable response.  The 
predicted value for protein concentration that achieves the lowest process time is 60g/L and 100g/L. 
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The profile for predicted value and desirability (Figure 5:37) indicates that a 
protein concentration within the range 60g/L to 100g/L gives the lowest process 
time during UF of HSA.  This is in close agreement with the results obtained for 
protein concentration were the optimum protein concentration using the gel 
concentration model was determined to be approximately 100g/L.  
 
Results presented in this study regarding the removal of unwanted solvents 
(ETOH) and micromolecules (e.g. potassium, aluminium and sodium) confirms 
that these solvents and salts are removed by the end of diafiltration step three.  
In an effort to decrease process cost, it is advised to determine the feasibility of 
completing diafiltration steps four and five WFI + 50% permeate or 100% 
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6 CONCLUSIONS AND RECOMMENDATIONS 
6.1 CONCLUSIONS 
The UF of HSA is a key unit operation with potential for optimization initiatives based 
on reducing capital expenditure and improving process efficiency with respect to 
minimizing CP and MF.  This study was set out to evaluate the impact of protein 
concentration, ETOH concentration, ionic strength and temperature on permeate flux 
during the UF of HSA and to provide guidelines for the optimization of this unit operation 
through efficient process design and control strategies based on productivity and 
membrane performance.  The impact of each factor, within specified levels, was 
determined for each step of UF of HSA.  Key membrane performance indicators such as 
protein retention and permeate flux were also determined during experiments.   
 
6.1.1 PROTEIN FEED CONCENTRATION 
The UF of HSA is significantly impacted by protein concentration.  During all 
experiments conducted, a steep decline in permeate flux was noted during the first 
concentration step, followed by quasi-steady state equilibrium during CVD.  A further 
steep decline in permeate flux was noted during the second concentration step.  These 
observations were in line with the theoretical and experimental evidence provided by 
several authors that outline the development of CP and MF during UF of HSA.  It was 
further noted during this study that protein concentration does not have a significant 
impact on permeate flux during the first and second concentration steps, within the 
specified protein concentration range (60g/L to 220g/L), but it is the most significant 
factor that influences flux during CVD across diafiltration steps one to five.  In general, 
as protein concentration increased, permeate flux during CVD decreased.  This 
behaviour was explained through protein-protein interactions including the propensity 
for aggregation of proteins at high concentrations resulting in denaturation of proteins.  
Also the decline in permeate flux during CVD as protein concentration increased was 
also explained by protein-membrane interactions including protein adsorption, pore 
blocking and restrictions.  Statistical analysis of the data showed that highest flux is 
obtained at the lowest (60g/L) protein concentration.  This result was expected since 
the objectives of this study was related to maximizing permeate flux and therefore 
minimizing process time.  The optimum protein concentration at which to complete UF 
of HSA was completed using the gel concentration model since the linear, inverse 
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dependence of permeate flux  on protein concentration was established from the data 
accrued during this study.  Further, this inverse dependence of permeate flux on protein 
concentration is attributed to CP and MF.  The data from this study suggested a gel 
concentration (Cg) of 270g/L which correlates well with the Cg value (300g/L) for HSA 
UF established by Jaffrin and Charrier (1992).  The optimum protein concentration was 
determined by dividing the Cg value of 270g/L by Napier’s number (2.718) – the 
optimum protein concentration to complete UF of HSA according to the process 
defined by NBI is within the range 90g/L to 100g/L.  The productivity analysis 
indicated that a minimal process time is achieved at a protein concentration within the 
range 60g/L to 100g/L.  The protein concentration range for optimum productivity is in 
close agreement with the theoretical optimum protein concentration calculated using 
the gel concentration model.  The productivity analysis coupled with the calculated 
optimum protein concentration range for UF of HSA suggests that the current batch 
size can be increased to approximately 276kg of Fraction V paste at the point of 
dissolution, corresponding to >30% increase in batch size.   
 
6.1.2 ETHANOL CONCENTRATION 
Ethanol is a polar solvent that is used extensively in the plasma fractionation industry 
as a precipitating agent.  Ultrafiltration removes ETOH from the HSA solution to 
acceptable limits.  Ethanol concentration had a statistically significant impact on 
permeate flux during diafiltration steps three to five and no significant effect on flux 
during the first and second concentration steps, within the levels of this factor selected 
for this study (1% - 10% v/v).  Although the impact of ETOH during diafiltration steps 
three to five is considered statistically significant, the magnitude of the effect of ETOH 
is limited (<2.00LMH).  The results from this study indicated that as ETOH 
concentration increased, permeate flux during UF of HSA decreased.  Increased ETOH 
concentrations in protein feed solutions are known to induce structural and 
conformation changes to these proteins which results in an increase in the viscosity of 
the feed solution.  Further, ETOH is known to have a dehydrating effect in WFI 
admixtures which causes precipitation of proteins.  Increase in viscosity of feed 
solutions containing increased volumes of ETOH will result in decreasing the flow of 
solute through the membrane which results in low permeate flux during UF of HSA.  
Also, permeate flux during UF of protein solutions containing increased concentrations 
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of ETOH is low since the hydraulic permeability of the membrane is lowered due to the 
decrease in back-diffusion of protein molecules away from the protein-membrane 
interface resulting in a high concentration of protein molecules in the gel boundary 
layer. 
 
According to this study, the ideal ETOH concentration that achieved optimum permeate 
flux during UF of HSA is within the range 0% to 7.75% (v/v).  However, according to 
the fractionation process, the depth filtration step following the dissolution of Fraction 
V paste is completed at a process temperature of -3.5°C ± 0.2°C.  A reduction of ETOH 
concentration during the dissolution of HSA has significant impact on the depth 
filtration unit operation since a reduction in ETOH concentration will increase the 
freezing point of the ETOH-WFI admixture and the process temperature for depth 
filtration will have to change from the current set point.  Considering the requirement 
for the optimization of depth filtration, further validation requirements and most 
significantly the marginal negative effect of ETOH on permeate flux, it is proposed that 
the ETOH concentration remain unchanged (10% - v/v) until such time that the depth 
filtration process can be optimized.         
 
6.1.3 TEMPERATURE 
Temperature effects the physic-chemical properties of both the protein and membrane 
during UF and is therefore considered a key factor in the optimization of this unit 
operation.  During this study temperature was varied within the range 5°C to 25°C and 
it was noted that this factor has a significant impact on permeate flux during CVD but 
not during first or second concentration steps, within the selected levels of this factor.  
The effect of temperature on permeate flux during UF of HSA is positive in that as 
temperature increases, permeate flux increases.  The application of the Arrhenius 
Equation suggests that as temperature increases, viscosity decreases and according to 
Darcy’s Law, the lower the viscosity of a solution the higher the flow through the 
membrane.  Although the viscosity of HSA solutions during experiments was 
analytically determined, it is conferred from both Monkos (1996) and Masuelli (2013) 
that the viscosity of BSA solutions of varying concentrations, decreases as temperature 
is increased.  Therefore it was concluded that the low viscosity of the HSA solution 
coupled with the efficient back diffusion of protein molecules away from the protein-
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membrane interface resulted in reducing the concentration of protein in the gel 
boundary layer which caused an increase in permeate flux as temperature was increased.  
According to the results obtained in this study, the optimum permeate flux is achieved 
at the temperature set point of 25°C with marginally lower permeate flux achieved at 
20°C.  HSA is known to undergo reversible conformational and structural changes 
within certain temperature ranges; beyond a defined limit temperature of 45°C; beyond 
this temperature these changes become irreversible.  It is well established that HSA is 
stable in the native conformation at temperatures below 30°C.  It is recommended that 
the process temperature for the UF of HSA remain at the current set point of 20°C ± 
2°C since this set point is in close agreement with the optimum temperature set point 
recommended by this study.        
 
6.1.4 pH AND IONIC STRENGTH 
During this study, pH of the test solutions was maintained at pH 7.2 ± 0.2 for all 
experiments completed since this physiological pH maintains the optimum stability of 
the HSA protein in the native state.  Several studies have confirmed that the permeate 
flux during UF of proteins is at its lowest when completed at a pH close to the IEP of 
the protein being ultrafiltered; the selected pH for this study is further away from the 
IEP thus ensuring that pH does not inhibit permeate flux during UF of HSA.   
 
Ionic strength had no significant effect on permeate flux during first, second 
concentration step and diafiltration steps one to three, within the levels of the factor 
selected for this study (1M to 3M).  Ionic strength only had a statistically significant 
effect on permeate flux during diafiltration step five, whilst a substantive significant 
effect was noted during diafiltration step four.  The effect of ionic strength on permeate 
flux was negative in that an increase in ionic strength resulted in a decrease in permeate 
flux.  These results were extensively explained by the DLVO theory and double layer 
interactions of molecules whereby NaCl acts as an electrostatic shield which reduces 
the overall net charge of the protein molecule thus increasing protein adsorption to the 
membrane surface.  This results in decrease of permeate flux during UF of HSA.  These 
results indicated that NaCl ions only have a significant impact on permeate flux during 
UF of HSA when all other ions e.g. aluminium and citrate and polar solvents e.g. ETOH 
are removed from the solution.  This clearly suggests that when the competition for 
binding localities on the HSA molecule is reduced, NaCl molecules bind to the regions 
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and initiate the electrostatic shielding effects described herein; ultimately resulting in a 
decrease in permeate flux during UF of HSA. 
 
Considering the negative impact of ionic strength on permeate flux during the UF of 
HSA, as confirmed by this study, it is recommended that the current NBI process 
continue to use WFI as buffer during CVD. 
 
6.2 RECOMENDATIONS 
The key goal of this study has been clearly stated and can be summarized as the 
optimization of the factors that influence UF of HSA.  The recommended process 
changes based on the evidence provided in this study for a starting batch volume of 
1150L is as follows: 
 Maintain process temperature at 20°C ± 2°C. 
 The protein concentration during depth filtration is the process limiting step and 
this concentration is set at 60g/L.  Therefore dissolve 276kg of Fraction V paste 
in 1150L WFI containing 10% ETOH (v/v).   
 Complete first concentration step of the depth filtered HSA solution from 60g/L 
(~1150L) to approximately 100g/L ± 10g/L (target volume approximately 
694.58L). 
 Complete CVD using WFI as the diafiltration diluent to maintain constant 
volume. 
 Complete second concentration step to 210g/L, before formulation.  
 
Analytical test results indicate that ETOH and salts are removed to acceptable limits by 
the end of diafiltration step three.  It is recommended to complete a cost benefit analysis 
to determine the impact of using 50% permeate + 50% WFI or 100% permeate as the 
diafiltration diluent for diafiltration steps four and five.  This strategy may save money 
when compared to using WFI only as a diafiltration diluent during diafiltration steps four 
and five.     
  
Ultrafiltration is a key membrane technology that is influenced by several factors and 
also allows for significant optimization initiatives.  The various steps of UF of HSA is 
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dependent on various factors, however, protein concentration is the most significant of 
these factors.  Protein concentration has a direct impact on CP and MF, the effects of 
which are demonstrated through key membrane performance characteristics such as 
permeate flux, protein retention and membrane flux recovery.  This study has confirmed 
the optimum protein concentration at which to complete UF of HSA.  Further, the 
benefits of reducing ETOH concentration, reducing temperature or using an ionic 
solution is not feasible for the current process and is heavily reliant on optimization of 
related upstream unit operations, particularly depth filtration.     
 
The aims and objectives of this study have been achieved, however, future work should 
include the effect of different membrane types (e.g. ceramic membranes) on permeate 
flux during the UF of HSA and feasibility of incorporating a pulsation module to improve 
permeate flux during UF of HSA.  Future research should also consider developing a 
dynamic ultrafiltration model for this process.  Lastly, one may consider a review and 
optimization initiative with respect to the upstream process of depth filtration and the 
impact (process optimization and regulatory compliance) of reducing ETOH 
concentration on depth filtration.  An optimization study on depth filtration, especially 
with respect to the effects of ETOH, will have an effect on the downstream process of 
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A.1. Specifications and performance data for T-series membrane cassette.  
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9 APPENDIX B 
 
Protocol for preparing start protein feed material for ultrafiltration experiments i.e. 
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10 APPENDIX C 
 
Experimental data (nominal water permeability, permeate flux) for experiments completed as 
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D.1. Transmembrane pressure (TMP) 
 
𝑇𝑀𝑃 (𝐵𝑎𝑟)  =  (
𝑃𝑖  + 𝑃𝑜
2
) −  𝑃𝑝 
 
Pi – inlet pressure (Bar) 
Po – outlet pressure (Bar) 
Pp – permeate pressure (Bar) 
 
D.2. Cross Flow Velocity (CFV) 
 




Q – flow rate (m3/s) 
d – pipe diameter (m)  
 
D.3. Permeate Flux (J) 
 




Q – flow rate (L/h) 
A – membrane area (m2) 
 
D.4. Nominal Water Permeability 
 
𝑁𝑊𝑃20°𝐶(𝐿𝑀𝐻) = 𝐽𝑊  ×   𝑇𝐶𝐹20°𝐶    
 
Jw – Clean water (WFI) permeate flux (LMH) 
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D.5. Membrane Flux Recovery  
 
𝑀𝑒𝑚𝑏𝑟𝑎𝑛𝑒 𝑓𝑙𝑢𝑥 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦 (%) =  
𝐿𝑃
𝐿𝑃,0
 × 100% 
  Lp – NWP after cleaning  
  Lp, 0 – NWP before cleaning i.e. before start of experiment 
 
 
D.6. Protein Concentration (A280nm) 
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑚𝑔/𝑚𝐿)  =  




A280nm = measured UV absorbance at 280nm 
L = length of the curvette (cm) 
ɛ280 = sedimentation co-efficient of HSA (5.8g/L) 
 
D.7. Protein Rejection 
 
𝑅𝑒𝑗𝑒𝑐𝑡𝑖𝑜𝑛 (%) = 1 −  
𝐶𝑝
𝐶𝑓
 × 100% 
     
 Cp = concentration in permeate (mg/mL) 
 Cf = concentration in feed (mg/mL) 
 
 
D.8. Protein Concentration (Gel Polarization Model) 
 





Copt = optimum protein concentration at which to complete ultrafiltration 
Cg = gel concentration 
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Figure E-1:  Fitted surface response diagram for diafiltration step five showing protein concentration as a function of ionic 






Figure E-2:  Fitted surface response diagram for diafiltration step five showing protein concentration as a function of 
temperature and flow rate. 
 
 
Fitted Surface; Variable: df5 g/min
4 factors, 1 Blocks, 26 Runs; MS Pure Error=.019208
DV: df5 g/min
 > 50 
 < 50 
 < 40 
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 < 0 
Fitted Surface; Variable: df5 g/min
4 factors, 1 Blocks, 26 Runs; MS Pure Error=.019208
DV: df5 g/min
 > 60 
 < 54 
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 < 14 
 < 4 
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Figure E-3:  Fitted surface response diagram for diafiltration step five showing protein concentration as a function of ethanol 
concentration and flow rate. 
 
 
    
 
 
Figure E-4:  Fitted surface response diagram for diafiltration step one showing protein concentration as a function of 
temperature and flow rate. 
Fitted Surface; Variable: df5 g/min
4 factors, 1 Blocks, 26 Runs; MS Pure Error=.019208
DV: df5 g/min
 > 60 
 < 58 
 < 48 
 < 38 
 < 28 
 < 18 
 < 8 
Fitted Surface; Variable: df1 g/min
4 factors, 1 Blocks, 26 Runs; MS Pure Error=.691488
DV: df1 g/min
 > 50 
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 < 20 
 < 10 
 < 0 
Stellenbosch University  https://scholar.sun.ac.za




Figure E-5::  Fitted surface response diagram for diafiltration step 2 showing protein concentration as a function of 






Figure E-6:  Fitted surface response diagram for diafiltration step three showing protein concentration as a function of 
temperature and flow rate. 
Fitted Surface; Variable: df2 g/min
4 factors, 1 Blocks, 26 Runs; MS Pure Error=.307328
DV: df2 g/min
 > 60 
 < 52 
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 < 22 
 < 12 
 < 2 
Fitted Surface; Variable: df3 g/min
4 factors, 1 Blocks, 26 Runs; MS Pure Error=.172872
DV: df3 g/min
 > 60 
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 < 24 
 < 14 
 < 4 
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Figure E-7::  Fitted surface response diagram for diafiltration step four showing protein concentration as a function of 






Figure E-8:  Fitted surface response diagram for diafiltration step five showing protein concentration as a function of 
temperature and flow rate. 
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Figure E-9:  Fitted surface response diagram for diafiltration step one showing temperature as a function of ethanol 




Figure E-10::  Fitted surface response diagram for diafiltration step two showing temperature as a function of ethanol 
concentration and mass flow rate. 
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Figure E-11:  Fitted surface response diagram for diafiltration step three showing temperature as a function of ethanol 




Figure E-12:  Fitted surface response diagram for diafiltration step four showing temperature as a function of ethanol 
concentration and mass flow rate. 
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FigureE-13:  Fitted surface response diagram for diafiltration step five showing temperature as a function of ethanol 
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